ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,Count,ont,comparison,geneID,symbol
GO:0048565,digestive tract development,5/17,127/16992,1.240883607699608e-7,1.286605625658608e-4,5.896097442562995e-5,5,bp,PCR,3691/1956/6422/3576/7124,ITGB4/EGFR/SFRP1/CXCL8/TNF
GO:0055123,digestive system development,5/17,138/16992,1.8796283793405522e-7,1.286605625658608e-4,5.896097442562995e-5,5,bp,PCR,3691/1956/6422/3576/7124,ITGB4/EGFR/SFRP1/CXCL8/TNF
hsa05215,Prostate cancer,5/17,97/7430,1.8686690600798007e-6,2.223716181494963e-4,1.3375736430044888e-4,5,kg,PCR,2064/83439/898/1956/7113,ERBB2/TCF7L1/CCNE1/EGFR/TMPRSS2
hsa04151,PI3K-Akt signaling pathway,7/17,352/7430,6.502363650676379e-6,3.868906372152446e-4,2.3271617276104936e-4,7,kg,PCR,2064/898/3691/1956/4233/1946/3696,ERBB2/CCNE1/ITGB4/EGFR/MET/EFNA5/ITGB8
hsa04520,Adherens junction,4/17,72/7430,1.754076396466698e-5,5.218377279488426e-4,3.138873551571986e-4,4,kg,PCR,2064/83439/1956/4233,ERBB2/TCF7L1/EGFR/MET
hsa05226,Gastric cancer,5/17,149/7430,1.5450119322944384e-5,5.218377279488426e-4,3.138873551571986e-4,5,kg,PCR,2064/83439/898/1956/4233,ERBB2/TCF7L1/CCNE1/EGFR/MET
GO:0004714,transmembrane receptor protein tyrosine kinase activity,3/17,64/16982,3.3430323301199455e-5,0.0010984665829537072,5.441320534755207e-4,3,mf,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0035004,phosphatidylinositol 3-kinase activity,3/17,74/16982,5.169254508017446e-5,0.0010984665829537072,5.441320534755207e-4,3,mf,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0046934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",3/17,66/16982,3.6671454522661663e-5,0.0010984665829537072,5.441320534755207e-4,3,mf,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0052813,phosphatidylinositol bisphosphate kinase activity,3/17,69/16982,4.190997721554807e-5,0.0010984665829537072,5.441320534755207e-4,3,mf,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0019199,transmembrane receptor protein kinase activity,3/17,80/16982,6.527395670323586e-5,0.0011096572639550098,5.496754248693547e-4,3,mf,PCR,2064/1956/4233,ERBB2/EGFR/MET
hsa05165,Human papillomavirus infection,6/17,319/7430,4.948853158570669e-5,0.0011778270517398192,7.084673995427484e-4,6,kg,PCR,83439/898/3691/1956/3696/7124,TCF7L1/CCNE1/ITGB4/EGFR/ITGB8/TNF
hsa04510,Focal adhesion,5/17,199/7430,6.238489531844933e-5,0.0012373004238159116,7.442408564306236e-4,5,kg,PCR,2064/3691/1956/4233/3696,ERBB2/ITGB4/EGFR/MET/ITGB8
hsa05219,Bladder cancer,3/17,41/7430,1.0052469873714738e-4,0.0017089198785315055,0.0010279217314475221,3,kg,PCR,2064/1956/3576,ERBB2/EGFR/CXCL8
GO:0022612,gland morphogenesis,4/17,120/16992,5.243921599066147e-6,0.0023929762230405186,0.00109662360457664,4,bp,PCR,1956/3400/6422/7124,EGFR/ID4/SFRP1/TNF
GO:0019903,protein phosphatase binding,3/17,111/16982,1.728773083067838e-4,0.0024490952010127703,0.001213174093380939,3,mf,PCR,2064/1956/4233,ERBB2/EGFR/MET
hsa05144,Malaria,3/17,49/7430,1.7178357641696654e-4,0.0025552806992023775,0.0015370109468886481,3,kg,PCR,4233/3576/7124,MET/CXCL8/TNF
GO:0019838,growth factor binding,3/17,128/16982,2.6327532083233893e-4,0.0031969146101069727,0.0015836109523749713,3,mf,PCR,2064/3691/1956,ERBB2/ITGB4/EGFR
hsa05213,Endometrial cancer,3/17,58/7430,2.840561820220938e-4,0.0037558539622921288,0.0022591602780704535,3,kg,PCR,2064/83439/1956,ERBB2/TCF7L1/EGFR
hsa04010,MAPK signaling pathway,5/17,295/7430,3.980131055308791e-4,0.0043072259495945,0.0025908126012598493,5,kg,PCR,2064/1956/4233/1946/7124,ERBB2/EGFR/MET/EFNA5/TNF
hsa05230,Central carbon metabolism in cancer,3/17,65/7430,3.981469365171386e-4,0.0043072259495945,0.0025908126012598493,3,kg,PCR,2064/1956/4233,ERBB2/EGFR/MET
hsa05120,Epithelial cell signaling in Helicobacter pylori infection,3/17,68/7430,4.5487549630410386e-4,0.004510848671682363,0.0027132924340946547,3,kg,PCR,1956/4233/3576,EGFR/MET/CXCL8
GO:0030307,positive regulation of cell growth,4/17,154/16992,1.4087130030689245e-5,0.004821320253003394,0.002209455131129155,4,bp,PCR,2064/1956/1946/6422,ERBB2/EGFR/EFNA5/SFRP1
GO:0019902,phosphatase binding,3/17,155/16982,4.6164799450398533e-4,0.004905009941604844,0.0024297262868630807,3,mf,PCR,2064/1956/4233,ERBB2/EGFR/MET
hsa05412,Arrhythmogenic right ventricular cardiomyopathy (ARVC),3/17,72/7430,5.382626168075676e-4,0.004927173184623118,0.0029637131937582666,3,kg,PCR,83439/3691/3696,TCF7L1/ITGB4/ITGB8
GO:0018108,peptidyl-tyrosine phosphorylation,5/17,367/16992,2.285045990715789e-5,0.005351747989879086,0.0024525330067801587,5,bp,PCR,2064/1956/4233/1946/6422,ERBB2/EGFR/MET/EFNA5/SFRP1
GO:0018212,peptidyl-tyrosine modification,5/17,369/16992,2.3455433118535074e-5,0.005351747989879086,0.0024525330067801587,5,bp,PCR,2064/1956/4233/1946/6422,ERBB2/EGFR/MET/EFNA5/SFRP1
hsa01521,EGFR tyrosine kinase inhibitor resistance,3/17,79/7430,7.066645502132768e-4,0.005606205431691996,0.003372153643123005,3,kg,PCR,2064/1956/4233,ERBB2/EGFR/MET
hsa05202,Transcriptional misregulation in cancer,4/17,186/7430,7.008559435649782e-4,0.005606205431691996,0.003372153643123005,4,kg,PCR,8842/4233/3576/7113,PROM1/MET/CXCL8/TMPRSS2
hsa05410,Hypertrophic cardiomyopathy (HCM),3/17,83/7430,8.164282887911173e-4,0.006072185397883935,0.003652442344591841,3,kg,PCR,3691/3696/7124,ITGB4/ITGB8/TNF
GO:0000082,G1/S transition of mitotic cell cycle,4/17,241/16992,8.123664519478203e-5,0.006278471558770592,0.0028772204444483277,4,bp,PCR,898/1956/3400/990,CCNE1/EGFR/ID4/CDC6
GO:0007044,cell-substrate junction assembly,3/17,86/16992,8.08645907658306e-5,0.006278471558770592,0.0028772204444483277,3,bp,PCR,3691/1946/6422,ITGB4/EFNA5/SFRP1
GO:0030072,peptide hormone secretion,4/17,237/16992,7.613116062177278e-5,0.006278471558770592,0.0028772204444483277,4,bp,PCR,1956/1946/6422/7124,EGFR/EFNA5/SFRP1/TNF
GO:0034329,cell junction assembly,4/17,194/16992,3.489824554872401e-5,0.006278471558770592,0.0028772204444483277,4,bp,PCR,3691/1946/6422/7124,ITGB4/EFNA5/SFRP1/TNF
GO:0045860,positive regulation of protein kinase activity,5/17,478/16992,8.066602091498551e-5,0.006278471558770592,0.0028772204444483277,5,bp,PCR,2064/1956/990/1946/7124,ERBB2/EGFR/CDC6/EFNA5/TNF
GO:0045927,positive regulation of growth,4/17,242/16992,8.255112349004431e-5,0.006278471558770592,0.0028772204444483277,4,bp,PCR,2064/1956/1946/6422,ERBB2/EGFR/EFNA5/SFRP1
GO:0048144,fibroblast proliferation,3/17,85/16992,7.809201891072185e-5,0.006278471558770592,0.0028772204444483277,3,bp,PCR,1956/990/6422,EGFR/CDC6/SFRP1
GO:0048145,regulation of fibroblast proliferation,3/17,84/16992,7.538244034848477e-5,0.006278471558770592,0.0028772204444483277,3,bp,PCR,1956/990/6422,EGFR/CDC6/SFRP1
GO:0071900,regulation of protein serine/threonine kinase activity,5/17,474/16992,7.751837750149507e-5,0.006278471558770592,0.0028772204444483277,5,bp,PCR,2064/1956/990/6422/7124,ERBB2/EGFR/CDC6/SFRP1/TNF
GO:0090276,regulation of peptide hormone secretion,4/17,197/16992,3.705674072631466e-5,0.006278471558770592,0.0028772204444483277,4,bp,PCR,1956/1946/6422/7124,EGFR/EFNA5/SFRP1/TNF
GO:1901655,cellular response to ketone,3/17,84/16992,7.538244034848477e-5,0.006278471558770592,0.0028772204444483277,3,bp,PCR,1956/1946/6422,EGFR/EFNA5/SFRP1
GO:1901888,regulation of cell junction assembly,3/17,74/16992,5.160266329047675e-5,0.006278471558770592,0.0028772204444483277,3,bp,PCR,1946/6422/7124,EFNA5/SFRP1/TNF
GO:0034330,cell junction organization,4/17,250/16992,9.36332302570904e-5,0.006409194611097838,0.0029371265912224147,4,bp,PCR,3691/1946/6422/7124,ITGB4/EFNA5/SFRP1/TNF
GO:0046883,regulation of hormone secretion,4/17,249/16992,9.2191854911235593e-05,0.006409194611097838,0.0029371265912224147,4,bp,PCR,1956/1946/6422/7124,EGFR/EFNA5/SFRP1/TNF
GO:0044843,cell cycle G1/S phase transition,4/17,254/16992,9.956361669739467e-5,0.006490599583749205,0.0029744318572254244,4,bp,PCR,898/1956/3400/990,CCNE1/EGFR/ID4/CDC6
hsa05205,Proteoglycans in cancer,4/17,201/7430,9.379968633962963e-4,0.006565978043774074,0.00394946047745809,4,kg,PCR,2064/1956/4233/7124,ERBB2/EGFR/MET/TNF
hsa05414,Dilated cardiomyopathy (DCM),3/17,90/7430,0.0010335973917605368,0.006833227201083548,0.004110211850275819,3,kg,PCR,3691/3696/7124,ITGB4/ITGB8/TNF
GO:0004713,protein tyrosine kinase activity,3/17,181/16982,7.254048782302285e-4,0.006851046072174381,0.00339370703265604,3,mf,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0032103,positive regulation of response to external stimulus,4/17,261/16992,1.1059437026545911e-4,0.006881986040609705,0.0031537916113977813,4,bp,PCR,1956/4233/3576/7124,EGFR/MET/CXCL8/TNF
GO:0046854,phosphatidylinositol phosphorylation,3/17,99/16992,1.2294265810263677e-4,0.00731776082358738,0.0033534930997332502,3,bp,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0035635,entry of bacterium into host cell,2/17,18/16992,1.427929335792927e-4,0.008145146919585487,0.0037326573865464224,2,bp,PCR,4233/3576,MET/CXCL8
GO:0045598,regulation of fat cell differentiation,3/17,112/16992,1.7721926303039445e-4,0.00836597141684862,0.003833854111292744,3,bp,PCR,3400/6422/7124,ID4/SFRP1/TNF
GO:0045667,regulation of osteoblast differentiation,3/17,109/16992,1.6353744852751776e-4,0.00836597141684862,0.003833854111292744,3,bp,PCR,3400/6422/7124,ID4/SFRP1/TNF
GO:0046834,lipid phosphorylation,3/17,111/16992,1.7257904115671057e-4,0.00836597141684862,0.003833854111292744,3,bp,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0046879,hormone secretion,4/17,291/16992,1.6817168349688306e-4,0.00836597141684862,0.003833854111292744,4,bp,PCR,1956/1946/6422/7124,EGFR/EFNA5/SFRP1/TNF
GO:0050678,regulation of epithelial cell proliferation,4/17,289/16992,1.6377408760816784e-4,0.00836597141684862,0.003833854111292744,4,bp,PCR,2064/1956/6422/7124,ERBB2/EGFR/SFRP1/TNF
GO:0009914,hormone transport,4/17,303/16992,1.963794958222679e-4,0.008672371928409186,0.00397426755552026,4,bp,PCR,1956/1946/6422/7124,EGFR/EFNA5/SFRP1/TNF
GO:0071902,positive regulation of protein serine/threonine kinase activity,4/17,302/16992,1.9390654161474227e-4,0.008672371928409186,0.00397426755552026,4,bp,PCR,2064/1956/990/7124,ERBB2/EGFR/CDC6/TNF
GO:0001655,urogenital system development,4/17,315/16992,2.278685430372616e-4,0.009021617958406242,0.004134315715051417,4,bp,PCR,8842/3691/3400/6422,PROM1/ITGB4/ID4/SFRP1
GO:0030198,extracellular matrix organization,4/17,315/16992,2.278685430372616e-4,0.009021617958406242,0.004134315715051417,4,bp,PCR,4316/3691/3696/7124,MMP7/ITGB4/ITGB8/TNF
GO:0043062,extracellular structure organization,4/17,316/16992,2.3064764685479803e-4,0.009021617958406242,0.004134315715051417,4,bp,PCR,4316/3691/3696/7124,MMP7/ITGB4/ITGB8/TNF
GO:0048511,rhythmic process,4/17,315/16992,2.278685430372616e-4,0.009021617958406242,0.004134315715051417,4,bp,PCR,4316/79723/1956/3400,MMP7/SUV39H2/EGFR/ID4
GO:0030260,entry into host cell,3/17,129/16992,2.6891399002868226e-4,0.00920358130873165,0.004217703633081438,3,bp,PCR,4233/3576/7113,MET/CXCL8/TMPRSS2
GO:0043405,regulation of MAP kinase activity,4/17,325/16992,2.567753830327491e-4,0.00920358130873165,0.004217703633081438,4,bp,PCR,2064/1956/6422/7124,ERBB2/EGFR/SFRP1/TNF
GO:0044409,entry into host,3/17,129/16992,2.6891399002868226e-4,0.00920358130873165,0.004217703633081438,3,bp,PCR,4233/3576/7113,MET/CXCL8/TMPRSS2
GO:0051806,entry into cell of other organism involved in symbiotic interaction,3/17,129/16992,2.6891399002868226e-4,0.00920358130873165,0.004217703633081438,3,bp,PCR,4233/3576/7113,MET/CXCL8/TMPRSS2
GO:0051828,entry into other organism involved in symbiotic interaction,3/17,129/16992,2.6891399002868226e-4,0.00920358130873165,0.004217703633081438,3,bp,PCR,4233/3576/7113,MET/CXCL8/TMPRSS2
GO:0090322,regulation of superoxide metabolic process,2/17,25/16992,2.788352644040195e-4,0.009310377487051286,0.004266644867388848,2,bp,PCR,1956/7124,EGFR/TNF
GO:0048871,multicellular organismal homeostasis,4/17,335/16992,2.882444865596609e-4,0.009395397669051803,0.004305606866906213,4,bp,PCR,8842/1956/4233/7124,PROM1/EGFR/MET/TNF
GO:0060740,prostate gland epithelium morphogenesis,2/17,26/16992,3.018938641825646e-4,0.009611458141068162,0.004404620392969608,2,bp,PCR,3400/6422,ID4/SFRP1
GO:0000083,regulation of transcription involved in G1/S transition of mitotic cell cycle,2/17,27/16992,3.2585360589186345e-4,0.009701368445345642,0.00444582337736035,2,bp,PCR,898/990,CCNE1/CDC6
GO:0035239,tube morphogenesis,4/17,346/16992,3.259773181051129e-4,0.009701368445345642,0.00444582337736035,4,bp,PCR,1956/4233/6422/7124,EGFR/MET/SFRP1/TNF
GO:0050673,epithelial cell proliferation,4/17,343/16992,3.153531407870974e-4,0.009701368445345642,0.00444582337736035,4,bp,PCR,2064/1956/6422/7124,ERBB2/EGFR/SFRP1/TNF
GO:0060512,prostate gland morphogenesis,2/17,28/16992,3.507128767736796e-4,0.010215445283046114,0.0046814081647729685,2,bp,PCR,3400/6422,ID4/SFRP1
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,3/17,145/16992,3.7912081317881393e-4,0.010812841525870755,0.004955175540670462,3,bp,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:1901681,sulfur compound binding,3/17,221/16982,0.0012920492874033207,0.010982418942928226,0.005440207525908719,3,mf,PCR,4316/79723/6422,MMP7/SUV39H2/SFRP1
GO:0034614,cellular response to reactive oxygen species,3/17,147/16992,3.9464981595882325e-4,0.011026032613216918,0.00505287412054691,3,bp,PCR,1956/4233/7124,EGFR/MET/TNF
GO:0001503,ossification,4/17,373/16992,4.3353940965575445e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,1956/3400/6422/7124,EGFR/ID4/SFRP1/TNF
GO:0001558,regulation of cell growth,4/17,379/16992,4.6052400003409824e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,2064/1956/1946/6422,ERBB2/EGFR/EFNA5/SFRP1
GO:0002791,regulation of peptide secretion,4/17,419/16992,6.721699294934866e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,1956/1946/6422/7124,EGFR/EFNA5/SFRP1/TNF
GO:0006270,DNA replication initiation,2/17,39/16992,6.830745352981388e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,898/990,CCNE1/CDC6
GO:0007431,salivary gland development,2/17,38/16992,6.48426313770955e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,1956/7124,EGFR/TNF
GO:0007435,salivary gland morphogenesis,2/17,34/16992,5.18668552521272e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,1956/7124,EGFR/TNF
GO:0010001,glial cell differentiation,3/17,180/16992,7.126097764635602e-4,0.011663426087377641,0.005344970933894948,3,bp,PCR,2064/1956/3400,ERBB2/EGFR/ID4
GO:0014065,phosphatidylinositol 3-kinase signaling,3/17,163/16992,5.338299980745429e-4,0.011663426087377641,0.005344970933894948,3,bp,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0023061,signal release,4/17,414/16992,6.42526289646027e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,1956/1946/6422/7124,EGFR/EFNA5/SFRP1/TNF
GO:0030335,positive regulation of cell migration,4/17,395/16992,5.383590554393372e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,1956/4233/3576/7124,EGFR/MET/CXCL8/TNF
GO:0032886,regulation of microtubule-based process,3/17,155/16992,4.608589029504611e-4,0.011663426087377641,0.005344970933894948,3,bp,PCR,2064/4233/1946,ERBB2/MET/EFNA5
GO:0038128,ERBB2 signaling pathway,2/17,39/16992,6.830745352981388e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,2064/1956,ERBB2/EGFR
GO:0043588,skin development,4/17,402/16992,5.752083762222896e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,3691/1956/4233/7124,ITGB4/EGFR/MET/TNF
GO:0045429,positive regulation of nitric oxide biosynthetic process,2/17,40/16992,7.186030886559844e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,1956/7124,EGFR/TNF
GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,2/17,33/16992,4.884458624248766e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,1956/990,EGFR/CDC6
GO:0045744,negative regulation of G-protein coupled receptor protein signaling pathway,2/17,38/16992,6.48426313770955e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,4233/3576,MET/CXCL8
GO:0046328,regulation of JNK cascade,3/17,164/16992,5.434407931710568e-4,0.011663426087377641,0.005344970933894948,3,bp,PCR,1956/6422/7124,EGFR/SFRP1/TNF
GO:0048545,response to steroid hormone,4/17,383/16992,4.7917032649412e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,898/1956/6422/7124,CCNE1/EGFR/SFRP1/TNF
GO:0048566,embryonic digestive tract development,2/17,34/16992,5.18668552521272e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,3576/7124,CXCL8/TNF
GO:0048608,reproductive structure development,4/17,421/16992,6.842963255717008e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,1956/3400/6422/3696,EGFR/ID4/SFRP1/ITGB8
GO:0048732,gland development,4/17,417/16992,6.601977845387826e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,1956/3400/6422/7124,EGFR/ID4/SFRP1/TNF
GO:0050679,positive regulation of epithelial cell proliferation,3/17,161/16992,0.00051493792966516975,0.011663426087377641,0.005344970933894948,3,bp,PCR,2064/1956/6422,ERBB2/EGFR/SFRP1
GO:0050708,regulation of protein secretion,4/17,392/16992,5.230966963315549e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,1956/1946/6422/7124,EGFR/EFNA5/SFRP1/TNF
GO:0050796,regulation of insulin secretion,3/17,169/16992,5.931638183689709e-4,0.011663426087377641,0.005344970933894948,3,bp,PCR,1946/6422/7124,EFNA5/SFRP1/TNF
GO:0051272,positive regulation of cellular component movement,4/17,420/16992,6.782137747010634e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,1956/4233/3576/7124,EGFR/MET/CXCL8/TNF
GO:0061138,morphogenesis of a branching epithelium,3/17,180/16992,7.126097764635602e-4,0.011663426087377641,0.005344970933894948,3,bp,PCR,4233/6422/7124,MET/SFRP1/TNF
GO:0061458,reproductive system development,4/17,424/16992,7.027776423656701e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,1956/3400/6422/3696,EGFR/ID4/SFRP1/ITGB8
GO:0071364,cellular response to epidermal growth factor stimulus,2/17,39/16992,6.830745352981388e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,2064/1956,ERBB2/EGFR
GO:0071392,cellular response to estradiol stimulus,2/17,36/16992,5.817772235527822e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,1956/6422,EGFR/SFRP1
GO:1901031,regulation of response to reactive oxygen species,2/17,35/16992,5.497795384907263e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,4233/7124,MET/TNF
GO:1901224,positive regulation of NIK/NF-kappaB signaling,2/17,39/16992,6.830745352981388e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,1956/7124,EGFR/TNF
GO:1901654,response to ketone,3/17,181/16992,7.241718169664715e-4,0.011663426087377641,0.005344970933894948,3,bp,PCR,1956/1946/6422,EGFR/EFNA5/SFRP1
GO:1903900,regulation of viral life cycle,3/17,179/16992,7.011666739651025e-4,0.011663426087377641,0.005344970933894948,3,bp,PCR,3576/7124/7113,CXCL8/TNF/TMPRSS2
GO:1904031,positive regulation of cyclin-dependent protein kinase activity,2/17,36/16992,5.817772235527822e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,1956/990,EGFR/CDC6
GO:1904407,positive regulation of nitric oxide metabolic process,2/17,40/16992,7.186030886559844e-4,0.011663426087377641,0.005344970933894948,2,bp,PCR,1956/7124,EGFR/TNF
GO:2000147,positive regulation of cell motility,4/17,410/16992,6.194935254454516e-4,0.011663426087377641,0.005344970933894948,4,bp,PCR,1956/4233/3576/7124,EGFR/MET/CXCL8/TNF
GO:0030278,regulation of ossification,3/17,184/16992,7.595766636892556e-4,0.011952418995294149,0.005477407036404069,3,bp,PCR,3400/6422/7124,ID4/SFRP1/TNF
GO:0045668,negative regulation of osteoblast differentiation,2/17,41/16992,7.550103869838007e-4,0.011952418995294149,0.005477407036404069,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0040017,positive regulation of locomotion,4/17,438/16992,7.937604984465859e-4,0.012073979137481957,0.005533114117826493,4,bp,PCR,1956/4233/3576/7124,EGFR/MET/CXCL8/TNF
GO:0045620,negative regulation of lymphocyte differentiation,2/17,42/16992,7.922948453987565e-4,0.012073979137481957,0.005533114117826493,2,bp,PCR,2064/6422,ERBB2/SFRP1
GO:0046850,regulation of bone remodeling,2/17,42/16992,7.922948453987565e-4,0.012073979137481957,0.005533114117826493,2,bp,PCR,1956/6422,EGFR/SFRP1
GO:0045599,negative regulation of fat cell differentiation,2/17,43/16992,8.304548809938415e-4,0.012357529696527923,0.005663056167875624,2,bp,PCR,3400/7124,ID4/TNF
GO:0070849,response to epidermal growth factor,2/17,43/16992,8.304548809938415e-4,0.012357529696527923,0.005663056167875624,2,bp,PCR,2064/1956,ERBB2/EGFR
GO:0001763,morphogenesis of a branching structure,3/17,193/16992,8.723777415445326e-4,0.01274313324383877,0.005839765801643849,3,bp,PCR,4233/6422/7124,MET/SFRP1/TNF
GO:0007254,JNK cascade,3/17,194/16992,8.855318697538918e-4,0.01274313324383877,0.005839765801643849,3,bp,PCR,1956/6422/7124,EGFR/SFRP1/TNF
GO:0007623,circadian rhythm,3/17,196/16992,9.122184498876549e-4,0.01274313324383877,0.005839765801643849,3,bp,PCR,79723/1956/3400,SUV39H2/EGFR/ID4
GO:0030850,prostate gland development,2/17,45/16992,9.093953619633489e-4,0.01274313324383877,0.005839765801643849,2,bp,PCR,3400/6422,ID4/SFRP1
GO:0051701,interaction with host,3/17,196/16992,9.122184498876549e-4,0.01274313324383877,0.005839765801643849,3,bp,PCR,4233/3576/7113,MET/CXCL8/TMPRSS2
GO:0071229,cellular response to acid chemical,3/17,195/16992,8.988119428547249e-4,0.01274313324383877,0.005839765801643849,3,bp,PCR,1956/6422/7124,EGFR/SFRP1/TNF
GO:0007160,cell-matrix adhesion,3/17,197/16992,9.257518783798391e-4,0.012801558803050502,0.0058665403457138126,3,bp,PCR,3691/1946/6422,ITGB4/EFNA5/SFRP1
GO:0030073,insulin secretion,3/17,199/16992,9.532014422982641e-4,0.013049327745063235,0.00598008483799753,3,bp,PCR,1946/6422/7124,EFNA5/SFRP1/TNF
GO:0001649,osteoblast differentiation,3/17,204/16992,0.001024080314289742,0.013226093870402422,0.006061091035915454,3,bp,PCR,3400/6422/7124,ID4/SFRP1/TNF
GO:0032872,regulation of stress-activated MAPK cascade,3/17,202/16992,9.95339800551868e-4,0.013226093870402422,0.006061091035915454,3,bp,PCR,1956/6422/7124,EGFR/SFRP1/TNF
GO:0044089,positive regulation of cellular component biogenesis,4/17,466/16992,0.0010004024980624375,0.013226093870402422,0.006061091035915454,4,bp,PCR,4233/1946/6422/7124,MET/EFNA5/SFRP1/TNF
GO:0045444,fat cell differentiation,3/17,204/16992,0.001024080314289742,0.013226093870402422,0.006061091035915454,3,bp,PCR,3400/6422/7124,ID4/SFRP1/TNF
GO:0070302,regulation of stress-activated protein kinase signaling cascade,3/17,203/16992,0.001009644911429996,0.013226093870402422,0.006061091035915454,3,bp,PCR,1956/6422/7124,EGFR/SFRP1/TNF
GO:1903428,positive regulation of reactive oxygen species biosynthetic process,2/17,47/16992,9.91819206075816e-4,0.013226093870402422,0.006061091035915454,2,bp,PCR,1956/7124,EGFR/TNF
GO:0035272,exocrine system development,2/17,48/16992,0.001034333452978588,0.013233668197455018,0.0060645621050195615,2,bp,PCR,1956/7124,EGFR/TNF
GO:0009895,negative regulation of catabolic process,3/17,207/16992,0.0010681730223958393,0.013291803792313836,0.006091203767805194,3,bp,PCR,1956/4233/7124,EGFR/MET/TNF
GO:0010817,regulation of hormone levels,4/17,474/16992,0.00106583401512833,0.013291803792313836,0.006091203767805194,4,bp,PCR,1956/1946/6422/7124,EGFR/EFNA5/SFRP1/TNF
GO:0048015,phosphatidylinositol-mediated signaling,3/17,206/16992,0.0010533438964990755,0.013291803792313836,0.006091203767805194,3,bp,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0048546,digestive tract morphogenesis,2/17,49/16992,0.001077713820998419,0.013291803792313836,0.006091203767805194,2,bp,PCR,1956/6422,EGFR/SFRP1
GO:0008305,integrin complex,2/17,32/18122,4.0408516246762837e-4,0.013388947053618618,0.008490137637044147,2,cc,PCR,3691/3696,ITGB4/ITGB8
GO:0043235,receptor complex,4/17,321/18122,1.9162457186418607e-4,0.013388947053618618,0.008490137637044147,4,cc,PCR,2064/3691/1956/3696,ERBB2/ITGB4/EGFR/ITGB8
GO:0098636,protein complex involved in cell adhesion,2/17,35/18122,4.839378453115163e-4,0.013388947053618618,0.008490137637044147,2,cc,PCR,3691/3696,ITGB4/ITGB8
GO:0048017,inositol lipid-mediated signaling,3/17,209/16992,0.0010982282989914398,0.013423879833207869,0.006151729945478366,3,bp,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0001664,G-protein coupled receptor binding,3/17,254/16982,0.001925305642128352,0.013637581631742493,0.006755458393432814,3,mf,PCR,3691/6422/3576,ITGB4/SFRP1/CXCL8
GO:0005088,Ras guanyl-nucleotide exchange factor activity,3/17,250/16982,0.0018399743199802778,0.013637581631742493,0.006755458393432814,3,mf,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0009306,protein secretion,4/17,489/16992,0.0011966010494270586,0.013724349117701396,0.0062894253001807175,4,bp,PCR,1956/1946/6422/7124,EGFR/EFNA5/SFRP1/TNF
GO:0016049,cell growth,4/17,482/16992,0.001134242610074174,0.013724349117701396,0.0062894253001807175,4,bp,PCR,2064/1956/1946/6422,ERBB2/EGFR/EFNA5/SFRP1
GO:0045428,regulation of nitric oxide biosynthetic process,2/17,52/16992,0.001213035970227808,0.013724349117701396,0.0062894253001807175,2,bp,PCR,1956/7124,EGFR/TNF
GO:0045765,regulation of angiogenesis,3/17,215/16992,0.0011916039491389405,0.013724349117701396,0.0062894253001807175,3,bp,PCR,2064/6422/3576,ERBB2/SFRP1/CXCL8
GO:0046488,phosphatidylinositol metabolic process,3/17,216/16992,0.0012076395207838565,0.013724349117701396,0.0062894253001807175,3,bp,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0048146,positive regulation of fibroblast proliferation,2/17,52/16992,0.001213035970227808,0.013724349117701396,0.0062894253001807175,2,bp,PCR,1956/990,EGFR/CDC6
GO:0051893,regulation of focal adhesion assembly,2/17,51/16992,0.0011670666458174187,0.013724349117701396,0.0062894253001807175,2,bp,PCR,1946/6422,EFNA5/SFRP1
GO:0090109,regulation of cell-substrate junction assembly,2/17,51/16992,0.0011670666458174187,0.013724349117701396,0.0062894253001807175,2,bp,PCR,1946/6422,EFNA5/SFRP1
GO:1901185,negative regulation of ERBB signaling pathway,2/17,52/16992,0.001213035970227808,0.013724349117701396,0.0062894253001807175,2,bp,PCR,2064/1956,ERBB2/EGFR
GO:0043406,positive regulation of MAP kinase activity,3/17,217/16992,0.0012238114504243872,0.013732769472385132,0.006293284076384251,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0001885,endothelial cell development,2/17,54/16992,0.0013075526267487176,0.01387627555053484,0.00635904827043848,2,bp,PCR,4233/7124,MET/TNF
GO:0045216,cell-cell junction organization,3/17,222/16992,0.001306732388603256,0.01387627555053484,0.00635904827043848,3,bp,PCR,1946/6422/7124,EFNA5/SFRP1/TNF
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,3/17,222/16992,0.001306732388603256,0.01387627555053484,0.00635904827043848,3,bp,PCR,1956/1946/6422,EGFR/EFNA5/SFRP1
GO:0050918,positive chemotaxis,2/17,54/16992,0.0013075526267487176,0.01387627555053484,0.00635904827043848,2,bp,PCR,4233/3576,MET/CXCL8
GO:0060688,regulation of morphogenesis of a branching structure,2/17,54/16992,0.0013075526267487176,0.01387627555053484,0.00635904827043848,2,bp,PCR,6422/7124,SFRP1/TNF
GO:1901222,regulation of NIK/NF-kappaB signaling,2/17,53/16992,0.0012598651509736726,0.01387627555053484,0.00635904827043848,2,bp,PCR,1956/7124,EGFR/TNF
GO:1903391,regulation of adherens junction organization,2/17,54/16992,0.0013075526267487176,0.01387627555053484,0.00635904827043848,2,bp,PCR,1946/6422,EFNA5/SFRP1
GO:0005126,cytokine receptor binding,3/17,264/16982,0.002149395149185994,0.014053737513908421,0.0069616037220599,3,mf,PCR,1946/3576/7124,EFNA5/CXCL8/TNF
GO:0000302,response to reactive oxygen species,3/17,228/16992,0.001410831770344128,0.014857143796931626,0.00680854846255142,3,bp,PCR,1956/4233/7124,EGFR/MET/TNF
GO:0032768,regulation of monooxygenase activity,2/17,57/16992,0.0014557492404482341,0.015213135192165134,0.006971687804798293,2,bp,PCR,1956/7124,EGFR/TNF
GO:0006801,superoxide metabolic process,2/17,58/16992,0.0015068543222793768,0.015627905812124747,0.0071617637645814075,2,bp,PCR,1956/7124,EGFR/TNF
GO:1901342,regulation of vasculature development,3/17,239/16992,0.0016150006559330742,0.016499521626659543,0.00756119710083356,3,bp,PCR,2064/6422/3576,ERBB2/SFRP1/CXCL8
GO:1902105,regulation of leukocyte differentiation,3/17,239/16992,0.0016150006559330742,0.016499521626659543,0.00756119710083356,3,bp,PCR,2064/6422/7124,ERBB2/SFRP1/TNF
GO:0042063,gliogenesis,3/17,242/16992,0.0016737353497687565,0.016972916250617982,0.007778138545514066,3,bp,PCR,2064/1956/3400,ERBB2/EGFR/ID4
GO:0016323,basolateral plasma membrane,3/17,202/18122,8.268333501489692e-4,0.017156792015591112,0.010879386186170648,3,cc,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0006809,nitric oxide biosynthetic process,2/17,63/16992,0.0017751065339640906,0.01723489960990667,0.00789819704548412,2,bp,PCR,1956/7124,EGFR/TNF
GO:0034599,cellular response to oxidative stress,3/17,247/16992,0.0017745871467686953,0.01723489960990667,0.00789819704548412,3,bp,PCR,1956/4233/7124,EGFR/MET/TNF
GO:0045670,regulation of osteoclast differentiation,2/17,63/16992,0.0017751065339640906,0.01723489960990667,0.00789819704548412,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0048708,astrocyte differentiation,2/17,63/16992,0.0017751065339640906,0.01723489960990667,0.00789819704548412,2,bp,PCR,1956/3400,EGFR/ID4
GO:0070372,regulation of ERK1 and ERK2 cascade,3/17,247/16992,0.0017745871467686953,0.01723489960990667,0.00789819704548412,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0071383,cellular response to steroid hormone stimulus,3/17,246/16992,0.001754118773753218,0.01723489960990667,0.00789819704548412,3,bp,PCR,898/1956/6422,CCNE1/EGFR/SFRP1
GO:0071230,cellular response to amino acid stimulus,2/17,64/16992,0.0018312915165500474,0.017655197789838133,0.008090806107218889,2,bp,PCR,1956/7124,EGFR/TNF
GO:0051403,stress-activated MAPK cascade,3/17,251/16992,0.0018579631144446675,0.017787073452270978,0.008151240457924341,3,bp,PCR,1956/6422/7124,EGFR/SFRP1/TNF
GO:0030521,androgen receptor signaling pathway,2/17,66/16992,0.0019461836907830332,0.01824880460741077,0.008362836912088592,2,bp,PCR,898/6422,CCNE1/SFRP1
GO:0034103,regulation of tissue remodeling,2/17,66/16992,0.0019461836907830332,0.01824880460741077,0.008362836912088592,2,bp,PCR,1956/6422,EGFR/SFRP1
GO:0090316,positive regulation of intracellular protein transport,3/17,255/16992,0.001943762679117595,0.01824880460741077,0.008362836912088592,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0031098,stress-activated protein kinase signaling cascade,3/17,257/16992,0.00198757941621626,0.018510178372789524,0.008482616054886438,3,bp,PCR,1956/6422/7124,EGFR/SFRP1/TNF
GO:0046209,nitric oxide metabolic process,2/17,68/16992,0.002064428566608488,0.018841351384580134,0.008634381934727431,2,bp,PCR,1956/7124,EGFR/TNF
GO:1900407,regulation of cellular response to oxidative stress,2/17,68/16992,0.002064428566608488,0.018841351384580134,0.008634381934727431,2,bp,PCR,4233/7124,MET/TNF
GO:1903426,regulation of reactive oxygen species biosynthetic process,2/17,68/16992,0.002064428566608488,0.018841351384580134,0.008634381934727431,2,bp,PCR,1956/7124,EGFR/TNF
hsa05160,Hepatitis C,3/17,131/7430,0.003039637418785971,0.01903772909660687,0.011451265622019171,3,kg,PCR,1956/3576/7124,EGFR/CXCL8/TNF
GO:0006970,response to osmotic stress,2/17,69/16992,0.002124804433406371,0.019137218877192906,0.008769968437051225,2,bp,PCR,1956/7124,EGFR/TNF
GO:0070371,ERK1 and ERK2 cascade,3/17,263/16992,0.0021227358287462406,0.019137218877192906,0.008769968437051225,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0007045,cell-substrate adherens junction assembly,2/17,70/16992,0.0021860138783937697,0.019307438706587552,0.008847974679271217,2,bp,PCR,1946/6422,EFNA5/SFRP1
GO:0048041,focal adhesion assembly,2/17,70/16992,0.0021860138783937697,0.019307438706587552,0.008847974679271217,2,bp,PCR,1946/6422,EFNA5/SFRP1
GO:0050792,regulation of viral process,3/17,265/16992,0.0021690339012969393,0.019307438706587552,0.008847974679271217,3,bp,PCR,3576/7124/7113,CXCL8/TNF/TMPRSS2
GO:0051492,regulation of stress fiber assembly,2/17,71/16992,0.002248055373170437,0.01960247010108489,0.008983178024871474,2,bp,PCR,4233/6422,MET/SFRP1
GO:2001057,reactive nitrogen species metabolic process,2/17,71/16992,0.002248055373170437,0.01960247010108489,0.008983178024871474,2,bp,PCR,1956/7124,EGFR/TNF
GO:0030258,lipid modification,3/17,269/16992,0.002263517683925953,0.019612377906928036,0.00898771845183123,3,bp,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0046849,bone remodeling,2/17,72/16992,0.0023109273912538747,0.01965005961879848,0.009004986761603852,2,bp,PCR,1956/6422,EGFR/SFRP1
GO:0048661,positive regulation of smooth muscle cell proliferation,2/17,72/16992,0.0023109273912538747,0.01965005961879848,0.009004986761603852,2,bp,PCR,1956/7124,EGFR/TNF
GO:0071356,cellular response to tumor necrosis factor,3/17,270/16992,0.0022875341386931775,0.01965005961879848,0.009004986761603852,3,bp,PCR,6422/3576/7124,SFRP1/CXCL8/TNF
GO:0030279,negative regulation of ossification,2/17,73/16992,0.002374628408077402,0.020032698461624438,0.00918033776719708,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0071496,cellular response to external stimulus,3/17,274/16992,0.0023851934618296443,0.020032698461624438,0.00918033776719708,3,bp,PCR,4316/1956/6422,MMP7/EGFR/SFRP1
GO:0098797,plasma membrane protein complex,3/17,232/18122,0.0012334136309712365,0.020474666274122526,0.012983301378644596,3,cc,PCR,3691/1956/3696,ITGB4/EGFR/ITGB8
GO:0006672,ceramide metabolic process,2/17,75/16992,0.0025045113492451017,0.020654674922388823,0.009465369461953586,2,bp,PCR,3696/7124,ITGB8/TNF
GO:0071260,cellular response to mechanical stimulus,2/17,75/16992,0.0025045113492451017,0.020654674922388823,0.009465369461953586,2,bp,PCR,4316/1956,MMP7/EGFR
GO:1902882,regulation of response to oxidative stress,2/17,75/16992,0.0025045113492451017,0.020654674922388823,0.009465369461953586,2,bp,PCR,4233/7124,MET/TNF
GO:0072001,renal system development,3/17,280/16992,0.0025365044576759217,0.020793261093163692,0.009528879021587451,3,bp,PCR,8842/3691/6422,PROM1/ITGB4/SFRP1
hsa04310,Wnt signaling pathway,3/17,146/7430,0.004129265063346461,0.02177867749672828,0.013099956389009492,3,kg,PCR,4316/83439/6422,MMP7/TCF7L1/SFRP1
hsa05161,Hepatitis B,3/17,144/7430,0.003971977032253657,0.02177867749672828,0.013099956389009492,3,kg,PCR,898/3576/7124,CCNE1/CXCL8/TNF
hsa05206,MicroRNAs in cancer,4/17,299/7430,0.004036531797977255,0.02177867749672828,0.013099956389009492,4,kg,PCR,2064/898/1956/4233,ERBB2/CCNE1/EGFR/MET
hsa05224,Breast cancer,3/17,147/7430,0.004209324222056727,0.02177867749672828,0.013099956389009492,3,kg,PCR,2064/83439/1956,ERBB2/TCF7L1/EGFR
GO:0043903,"regulation of symbiosis, encompassing mutualism through parasitism",3/17,287/16992,0.0027204430746777097,0.022168372435915382,0.010159048073357864,3,bp,PCR,3576/7124/7113,CXCL8/TNF/TMPRSS2
GO:0034612,response to tumor necrosis factor,3/17,288/16992,0.0027473781923666196,0.022255389025739068,0.010198924962008752,3,bp,PCR,6422/3576/7124,SFRP1/CXCL8/TNF
GO:0032956,regulation of actin cytoskeleton organization,3/17,289/16992,0.002774478934724234,0.022342715656691037,0.010238943932480765,3,bp,PCR,4233/1946/6422,MET/EFNA5/SFRP1
GO:0006260,DNA replication,3/17,291/16992,0.0028291787212763593,0.022633229913004017,0.010372077219753485,3,bp,PCR,898/1956/990,CCNE1/EGFR/CDC6
GO:0034333,adherens junction assembly,2/17,80/16992,0.0028436198283686566,0.022633229913004017,0.010372077219753485,2,bp,PCR,1946/6422,EFNA5/SFRP1
GO:0032388,positive regulation of intracellular transport,3/17,293/16992,0.002884545277090199,0.022695071749060245,0.010400417333005193,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0071214,cellular response to abiotic stimulus,3/17,293/16992,0.002884545277090199,0.022695071749060245,0.010400417333005193,3,bp,PCR,4316/1956/6422,MMP7/EGFR/SFRP1
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,2/17,83/16992,0.0030568994681936263,0.02274399658672323,0.010422838003680785,2,bp,PCR,1956/990,EGFR/CDC6
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,2/17,81/16992,0.00291389817995703,0.02274399658672323,0.010422838003680785,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0030038,contractile actin filament bundle assembly,2/17,82/16992,0.002984991895071023,0.02274399658672323,0.010422838003680785,2,bp,PCR,4233/6422,MET/SFRP1
GO:0032147,activation of protein kinase activity,3/17,298/16992,0.0030258972520472165,0.02274399658672323,0.010422838003680785,3,bp,PCR,1956/1946/7124,EGFR/EFNA5/TNF
GO:0043149,stress fiber assembly,2/17,82/16992,0.002984991895071023,0.02274399658672323,0.010422838003680785,2,bp,PCR,4233/6422,MET/SFRP1
GO:0043506,regulation of JUN kinase activity,2/17,83/16992,0.0030568994681936263,0.02274399658672323,0.010422838003680785,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0045069,regulation of viral genome replication,2/17,82/16992,0.002984991895071023,0.02274399658672323,0.010422838003680785,2,bp,PCR,3576/7124,CXCL8/TNF
GO:0048709,oligodendrocyte differentiation,2/17,82/16992,0.002984991895071023,0.02274399658672323,0.010422838003680785,2,bp,PCR,2064/3400,ERBB2/ID4
GO:0051897,positive regulation of protein kinase B signaling,2/17,83/16992,0.0030568994681936263,0.02274399658672323,0.010422838003680785,2,bp,PCR,1956/7124,EGFR/TNF
GO:1903533,regulation of protein targeting,3/17,298/16992,0.0030258972520472165,0.02274399658672323,0.010422838003680785,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0005085,guanyl-nucleotide exchange factor activity,3/17,322/16982,0.003770205379150301,0.022890532659126828,0.011338963546316696,3,mf,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0021782,glial cell development,2/17,84/16992,0.0031296193957020446,0.022911491725754542,0.010499595608434668,2,bp,PCR,1956/3400,EGFR/ID4
GO:0032231,regulation of actin filament bundle assembly,2/17,84/16992,0.0031296193957020446,0.022911491725754542,0.010499595608434668,2,bp,PCR,4233/6422,MET/SFRP1
GO:1902106,negative regulation of leukocyte differentiation,2/17,84/16992,0.0031296193957020446,0.022911491725754542,0.010499595608434668,2,bp,PCR,2064/6422,ERBB2/SFRP1
GO:0016324,apical plasma membrane,3/17,283/18122,0.0021785613718980678,0.023291054704640362,0.014769216680177782,3,cc,PCR,2064/8842/1956,ERBB2/PROM1/EGFR
GO:0045121,membrane raft,3/17,285/18122,0.0022226623477582894,0.023291054704640362,0.014769216680177782,3,cc,PCR,1956/1946/7124,EGFR/EFNA5/TNF
GO:0098857,membrane microdomain,3/17,286/18122,0.0022449209353870227,0.023291054704640362,0.014769216680177782,3,cc,PCR,1956/1946/7124,EGFR/EFNA5/TNF
GO:2000379,positive regulation of reactive oxygen species metabolic process,2/17,85/16992,0.0032031501758656923,0.023325066972128366,0.010689123767166587,2,bp,PCR,1956/7124,EGFR/TNF
GO:0030316,osteoclast differentiation,2/17,86/16992,0.00327749030884426,0.023369188712540585,0.010709343333723568,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0031589,cell-substrate adhesion,3/17,305/16992,0.003230903374213432,0.023369188712540585,0.010709343333723568,3,bp,PCR,3691/1946/6422,ITGB4/EFNA5/SFRP1
GO:1903409,reactive oxygen species biosynthetic process,2/17,86/16992,0.00327749030884426,0.023369188712540585,0.010709343333723568,2,bp,PCR,1956/7124,EGFR/TNF
GO:1904029,regulation of cyclin-dependent protein kinase activity,2/17,86/16992,0.00327749030884426,0.023369188712540585,0.010709343333723568,2,bp,PCR,1956/990,EGFR/CDC6
GO:0001942,hair follicle development,2/17,87/16992,0.003352638296685768,0.0236585661245506,0.010841955642022342,2,bp,PCR,1956/7124,EGFR/TNF
GO:0060562,epithelial tube morphogenesis,3/17,309/16992,0.0033518157826397483,0.0236585661245506,0.010841955642022342,3,bp,PCR,4233/6422/7124,MET/SFRP1/TNF
hsa04934,Cushing's syndrome,3/17,154/7430,0.004796486914882769,0.023782580952960396,0.014305311851404752,3,kg,PCR,83439/898/1956,TCF7L1/CCNE1/EGFR
GO:0051341,regulation of oxidoreductase activity,2/17,88/16992,0.003428592643324609,0.02407047860877636,0.011030721810642198,2,bp,PCR,1956/7124,EGFR/TNF
GO:0022404,molting cycle process,2/17,89/16992,0.0035053518545796096,0.02435952633969282,0.011163183036759002,2,bp,PCR,1956/7124,EGFR/TNF
GO:0022405,hair cycle process,2/17,89/16992,0.0035053518545796096,0.02435952633969282,0.011163183036759002,2,bp,PCR,1956/7124,EGFR/TNF
GO:0033273,response to vitamin,2/17,90/16992,0.0035829144381520637,0.02464829078306621,0.01129551444135747,2,bp,PCR,1956/6422,EGFR/SFRP1
GO:0071347,cellular response to interleukin-1,2/17,90/16992,0.0035829144381520637,0.02464829078306621,0.01129551444135747,2,bp,PCR,6422/3576,SFRP1/CXCL8
GO:0001101,response to acid chemical,3/17,319/16992,0.003666242776823857,0.025095431807359302,0.011500424710457993,3,bp,PCR,1956/6422/7124,EGFR/SFRP1/TNF
GO:0007229,integrin-mediated signaling pathway,2/17,92/16992,0.0037404437624553215,0.025475957765180773,0.011674807449192833,2,bp,PCR,3691/3696,ITGB4/ITGB8
GO:0045446,endothelial cell differentiation,2/17,93/16992,0.0038204075279836616,0.02570257347996313,0.011778658101617028,2,bp,PCR,4233/7124,MET/TNF
GO:1901184,regulation of ERBB signaling pathway,2/17,93/16992,0.0038204075279836616,0.02570257347996313,0.011778658101617028,2,bp,PCR,2064/1956,ERBB2/EGFR
GO:1903706,regulation of hemopoiesis,3/17,324/16992,0.003830040167941913,0.02570257347996313,0.011778658101617028,3,bp,PCR,2064/6422/7124,ERBB2/SFRP1/TNF
GO:0032970,regulation of actin filament-based process,3/17,329/16992,0.003998279712594123,0.026571091876414342,0.01217667199134439,3,bp,PCR,4233/1946/6422,MET/EFNA5/SFRP1
GO:0042307,positive regulation of protein import into nucleus,2/17,95/16992,0.003982725841850871,0.026571091876414342,0.01217667199134439,2,bp,PCR,1956/7124,EGFR/TNF
GO:0001952,regulation of cell-matrix adhesion,2/17,96/16992,0.004065077426229776,0.026884497567674217,0.01232029568285251,2,bp,PCR,1946/6422,EFNA5/SFRP1
GO:0098773,skin epidermis development,2/17,97/16992,0.004148221989381711,0.02717184642805532,0.012451978371551244,2,bp,PCR,1956/7124,EGFR/TNF
GO:1904591,positive regulation of protein import,2/17,97/16992,0.004148221989381711,0.02717184642805532,0.012451978371551244,2,bp,PCR,1956/7124,EGFR/TNF
GO:0050729,positive regulation of inflammatory response,2/17,100/16992,0.0044023987877122575,0.028699447335133715,0.01315202845852885,2,bp,PCR,1956/7124,EGFR/TNF
hsa05225,Hepatocellular carcinoma,3/17,168/7430,0.006114876171346945,0.029106810575611458,0.017507855985330202,3,kg,PCR,83439/1956/4233,TCF7L1/EGFR/MET
GO:0006417,regulation of translation,3/17,344/16992,0.00453003467406604,0.029391551984817098,0.013469197634040206,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
hsa05164,Influenza A,3/17,171/7430,0.006423026480954337,0.029397698124367926,0.01768282593946943,3,kg,PCR,3576/7124/7113,CXCL8/TNF/TMPRSS2
GO:0006650,glycerophospholipid metabolic process,3/17,345/16992,0.00456694368264801,0.029409641133361624,0.01347748730574259,3,bp,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:1905477,positive regulation of protein localization to membrane,2/17,102/16992,0.004575787846169486,0.029409641133361624,0.01347748730574259,2,bp,PCR,2064/1956,ERBB2/EGFR
hsa05134,Legionellosis,2/17,55/7430,0.0068143379458034175,0.03003356353891136,0.018065301376788787,2,kg,PCR,3576/7124,CXCL8/TNF
GO:0042698,ovulation cycle,2/17,104/16992,0.00475231347791491,0.030260079773327963,0.01386721582784473,2,bp,PCR,4316/1956,MMP7/EGFR
GO:0045727,positive regulation of translation,2/17,104/16992,0.00475231347791491,0.030260079773327963,0.01386721582784473,2,bp,PCR,2064/7124,ERBB2/TNF
GO:0050709,negative regulation of protein secretion,2/17,106/16992,0.004931963961180571,0.03125860492063056,0.014324807606547856,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0043200,response to amino acid,2/17,108/16992,0.005114727603823933,0.03226756723334085,0.01478718240057756,2,bp,PCR,1956/7124,EGFR/TNF
GO:0042303,molting cycle,2/17,109/16992,0.005207273214203307,0.032403441046565125,0.014849448974474502,2,bp,PCR,1956/7124,EGFR/TNF
GO:0042552,myelination,2/17,109/16992,0.005207273214203307,0.032403441046565125,0.014849448974474502,2,bp,PCR,2064/3400,ERBB2/ID4
GO:0042633,hair cycle,2/17,109/16992,0.005207273214203307,0.032403441046565125,0.014849448974474502,2,bp,PCR,1956/7124,EGFR/TNF
GO:0005578,proteinaceous extracellular matrix,3/17,359/18122,0.004264979195480043,0.032685611711668935,0.020726450039105223,3,cc,PCR,4316/1946/6422,MMP7/EFNA5/SFRP1
GO:0045177,apical part of cell,3/17,351/18122,0.004003948304676433,0.032685611711668935,0.020726450039105223,3,cc,PCR,2064/8842/1956,ERBB2/PROM1/EGFR
GO:0098589,membrane region,3/17,361/18122,0.004331828058172991,0.032685611711668935,0.020726450039105223,3,cc,PCR,1956/1946/7124,EGFR/EFNA5/TNF
GO:0002761,regulation of myeloid leukocyte differentiation,2/17,110/16992,0.005300592743266528,0.03268698858347693,0.014979389639577291,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0019079,viral genome replication,2/17,110/16992,0.005300592743266528,0.03268698858347693,0.014979389639577291,2,bp,PCR,3576/7124,CXCL8/TNF
GO:0003158,endothelium development,2/17,111/16992,0.00539468473780065,0.033118042179592334,0.015176927560675891,2,bp,PCR,4233/7124,MET/TNF
GO:0002792,negative regulation of peptide secretion,2/17,112/16992,0.0054895477464328435,0.033253056924188326,0.015238800451206217,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0007272,ensheathment of neurons,2/17,112/16992,0.0054895477464328435,0.033253056924188326,0.015238800451206217,2,bp,PCR,2064/3400,ERBB2/ID4
GO:0008366,axon ensheathment,2/17,112/16992,0.0054895477464328435,0.033253056924188326,0.015238800451206217,2,bp,PCR,2064/3400,ERBB2/ID4
GO:0048660,regulation of smooth muscle cell proliferation,2/17,113/16992,0.005585180319628462,0.033576396700048715,0.015386976612378634,2,bp,PCR,1956/7124,EGFR/TNF
GO:0090150,establishment of protein localization to membrane,3/17,371/16992,0.005591978413156396,0.033576396700048715,0.015386976612378634,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0002687,positive regulation of leukocyte migration,2/17,115/16992,0.005778748370751078,0.03366428306194989,0.015427252089440726,2,bp,PCR,3576/7124,CXCL8/TNF
GO:0006275,regulation of DNA replication,2/17,115/16992,0.005778748370751078,0.03366428306194989,0.015427252089440726,2,bp,PCR,1956/990,EGFR/CDC6
GO:0033157,regulation of intracellular protein transport,3/17,373/16992,0.005676118098647807,0.03366428306194989,0.015427252089440726,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0046824,positive regulation of nucleocytoplasmic transport,2/17,115/16992,0.005778748370751078,0.03366428306194989,0.015427252089440726,2,bp,PCR,1956/7124,EGFR/TNF
GO:0060249,anatomical structure homeostasis,3/17,372/16992,0.005633952586403898,0.03366428306194989,0.015427252089440726,3,bp,PCR,8842/898/1956,PROM1/CCNE1/EGFR
GO:0070555,response to interleukin-1,2/17,115/16992,0.005778748370751078,0.03366428306194989,0.015427252089440726,2,bp,PCR,6422/3576,SFRP1/CXCL8
GO:1903829,positive regulation of cellular protein localization,3/17,375/16992,0.005761024163978622,0.03366428306194989,0.015427252089440726,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0051052,regulation of DNA metabolic process,3/17,376/16992,0.005803765226207368,0.033666756757109687,0.015428385703923244,3,bp,PCR,1956/990/3576,EGFR/CDC6/CXCL8
GO:0048659,smooth muscle cell proliferation,2/17,116/16992,0.005876680958782732,0.03380326148140151,0.01549094140395625,2,bp,PCR,1956/7124,EGFR/TNF
GO:0050680,negative regulation of epithelial cell proliferation,2/17,116/16992,0.005876680958782732,0.03380326148140151,0.01549094140395625,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0002683,negative regulation of immune system process,3/17,382/16992,0.006064259876666183,0.03459154904648335,0.015852188098653706,3,bp,PCR,2064/6422/7124,ERBB2/SFRP1/TNF
GO:0043900,regulation of multi-organism process,3/17,382/16992,0.006064259876666183,0.03459154904648335,0.015852188098653706,3,bp,PCR,3576/7124/7113,CXCL8/TNF/TMPRSS2
GO:0034248,regulation of cellular amide metabolic process,3/17,384/16992,0.006152639597815919,0.03495005647058089,0.016016480455550503,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0045785,positive regulation of cell adhesion,3/17,385/16992,0.006197120847489264,0.035057266281871086,0.016065611244469775,3,bp,PCR,2064/6422/7124,ERBB2/SFRP1/TNF
GO:0034332,adherens junction organization,2/17,120/16992,0.006276034764009523,0.03521267045872556,0.016136827952328195,2,bp,PCR,1946/6422,EFNA5/SFRP1
GO:0038061,NIK/NF-kappaB signaling,2/17,120/16992,0.006276034764009523,0.03521267045872556,0.016136827952328195,2,bp,PCR,1956/7124,EGFR/TNF
GO:0022407,regulation of cell-cell adhesion,3/17,394/16992,0.006606237163943761,0.03646749466709278,0.016711873300978276,3,bp,PCR,2064/1946/7124,ERBB2/EFNA5/TNF
GO:0030856,regulation of epithelial cell differentiation,2/17,123/16992,0.00658351451546585,0.03646749466709278,0.016711873300978276,2,bp,PCR,8842/7124,PROM1/TNF
GO:0034250,positive regulation of cellular amide metabolic process,2/17,123/16992,0.00658351451546585,0.03646749466709278,0.016711873300978276,2,bp,PCR,2064/7124,ERBB2/TNF
GO:0051250,negative regulation of lymphocyte activation,2/17,123/16992,0.00658351451546585,0.03646749466709278,0.016711873300978276,2,bp,PCR,2064/6422,ERBB2/SFRP1
GO:0051896,regulation of protein kinase B signaling,2/17,125/16992,0.006792272104167109,0.037343857472308326,0.01711348202952271,2,bp,PCR,1956/7124,EGFR/TNF
GO:0032355,response to estradiol,2/17,126/16992,0.006897777941962014,0.037621745030063734,0.017240828909244537,2,bp,PCR,1956/6422,EGFR/SFRP1
GO:1900182,positive regulation of protein localization to nucleus,2/17,126/16992,0.006897777941962014,0.037621745030063734,0.017240828909244537,2,bp,PCR,1956/7124,EGFR/TNF
GO:0050921,positive regulation of chemotaxis,2/17,127/16992,0.0070040332427839715,0.03804968852925102,0.01743694157351398,2,bp,PCR,4233/3576,MET/CXCL8
GO:0008277,regulation of G-protein coupled receptor protein signaling pathway,2/17,128/16992,0.007111036584443924,0.038478296775113566,0.01763335886968412,2,bp,PCR,4233/3576,MET/CXCL8
GO:0030518,intracellular steroid hormone receptor signaling pathway,2/17,129/16992,0.007218786546560701,0.03875497561663372,0.017760151833850064,2,bp,PCR,898/6422,CCNE1/SFRP1
GO:0051017,actin filament bundle assembly,2/17,129/16992,0.007218786546560701,0.03875497561663372,0.017760151833850064,2,bp,PCR,4233/6422,MET/SFRP1
GO:0006979,response to oxidative stress,3/17,409/16992,0.007323588674034606,0.039164034745130374,0.017947610401828226,3,bp,PCR,1956/4233/7124,EGFR/MET/TNF
GO:0001525,angiogenesis,3/17,411/16992,0.0074226208526754,0.039307323486819645,0.018013274997612173,3,bp,PCR,2064/6422/3576,ERBB2/SFRP1/CXCL8
GO:0031667,response to nutrient levels,3/17,411/16992,0.0074226208526754,0.039307323486819645,0.018013274997612173,3,bp,PCR,4316/1956/6422,MMP7/EGFR/SFRP1
GO:1903707,negative regulation of hemopoiesis,2/17,131/16992,0.007436520659668582,0.039307323486819645,0.018013274997612173,2,bp,PCR,2064/6422,ERBB2/SFRP1
GO:0070507,regulation of microtubule cytoskeleton organization,2/17,132/16992,0.007546501978920218,0.03973523541977607,0.018209373196098985,2,bp,PCR,4233/1946,MET/EFNA5
GO:0061572,actin filament bundle organization,2/17,133/16992,0.007657224255145968,0.04016375480955874,0.01840574977240168,2,bp,PCR,4233/6422,MET/SFRP1
GO:0044344,cellular response to fibroblast growth factor stimulus,2/17,135/16992,0.007880886034838256,0.041022558865755024,0.018799311894190915,2,bp,PCR,6422/3576,SFRP1/CXCL8
GO:0048568,embryonic organ development,3/17,420/16992,0.007878216133858236,0.041022558865755024,0.018799311894190915,3,bp,PCR,1956/3576/7124,EGFR/CXCL8/TNF
hsa05223,Non-small cell lung cancer,2/17,66/7430,0.009698736597964564,0.041219630541349396,0.02479376273163874,2,kg,PCR,2064/1956,ERBB2/EGFR
hsa04015,Rap1 signaling pathway,3/17,206/7430,0.01071823502332491,0.04224035230364423,0.025407730708958937,3,kg,PCR,1956/4233/1946,EGFR/MET/EFNA5
hsa04622,RIG-I-like receptor signaling pathway,2/17,70/7430,0.010861145526299529,0.04224035230364423,0.025407730708958937,2,kg,PCR,3576/7124,CXCL8/TNF
hsa04810,Regulation of actin cytoskeleton,3/17,208/7430,0.011003789255571186,0.04224035230364423,0.025407730708958937,3,kg,PCR,3691/1956/3696,ITGB4/EGFR/ITGB8
GO:0006261,DNA-dependent DNA replication,2/17,138/16992,0.008221900655796935,0.04247464904824907,0.019464757858411015,2,bp,PCR,898/990,CCNE1/CDC6
GO:0051493,regulation of cytoskeleton organization,3/17,426/16992,0.008191045518365702,0.04247464904824907,0.019464757858411015,3,bp,PCR,4233/1946/6422,MET/EFNA5/SFRP1
hsa05218,Melanoma,2/17,72/7430,0.011464494866174027,0.04263359028358466,0.025644264832231378,2,kg,PCR,1956/4233,EGFR/MET
GO:2000045,regulation of G1/S transition of mitotic cell cycle,2/17,139/16992,0.00833703909792567,0.04290754332729414,0.019663139304961216,2,bp,PCR,1956/990,EGFR/CDC6
GO:0072073,kidney epithelium development,2/17,140/16992,0.00845290865510696,0.04334094362861958,0.019861752645155717,2,bp,PCR,8842/6422,PROM1/SFRP1
GO:0046486,glycerolipid metabolic process,3/17,432/16992,0.00851120545745279,0.04345057908936602,0.01991199503076556,3,bp,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0071774,response to fibroblast growth factor,2/17,141/16992,0.008569507928509003,0.04345057908936602,0.01991199503076556,2,bp,PCR,6422/3576,SFRP1/CXCL8
GO:1905475,regulation of protein localization to membrane,2/17,141/16992,0.008569507928509003,0.04345057908936602,0.01991199503076556,2,bp,PCR,2064/1956,ERBB2/EGFR
GO:0006665,sphingolipid metabolic process,2/17,142/16992,0.00868683552108365,0.04388294401610154,0.020110133892273667,2,bp,PCR,3696/7124,ITGB8/TNF
GO:0045619,regulation of lymphocyte differentiation,2/17,143/16992,0.008804890037564564,0.044315788461124585,0.020308492501503406,2,bp,PCR,2064/6422,ERBB2/SFRP1
hsa05133,Pertussis,2/17,76/7430,0.012714831693795062,0.04450191092828272,0.02676806672377908,2,kg,PCR,3576/7124,CXCL8/TNF
hsa05212,Pancreatic cancer,2/17,75/7430,0.012396833175214634,0.04450191092828272,0.02676806672377908,2,kg,PCR,2064/1956,ERBB2/EGFR
GO:0048771,tissue remodeling,2/17,144/16992,0.008923670084465344,0.044749100167154054,0.02050706524133929,2,bp,PCR,1956/6422,EGFR/SFRP1
GO:0001890,placenta development,2/17,145/16992,0.009043174270077763,0.044782659124799035,0.02052244422619678,2,bp,PCR,1956/3696,EGFR/ITGB8
GO:0002695,negative regulation of leukocyte activation,2/17,145/16992,0.009043174270077763,0.044782659124799035,0.02052244422619678,2,bp,PCR,2064/6422,ERBB2/SFRP1
GO:0009991,response to extracellular stimulus,3/17,442/16992,0.00906121006396591,0.044782659124799035,0.02052244422619678,3,bp,PCR,4316/1956/6422,MMP7/EGFR/SFRP1
GO:0051384,response to glucocorticoid,2/17,145/16992,0.009043174270077763,0.044782659124799035,0.02052244422619678,2,bp,PCR,1956/7124,EGFR/TNF
GO:0001660,fever generation,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,7124,TNF
GO:0001886,endothelial cell morphogenesis,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,4233,MET
GO:0006644,phospholipid metabolic process,3/17,448/16992,0.009401121944656202,0.04561385495378816,0.020903354390417704,3,bp,PCR,2064/1956/4233,ERBB2/EGFR/MET
GO:0019058,viral life cycle,3/17,449/16992,0.00945850008709416,0.04561385495378816,0.020903354390417704,3,bp,PCR,3576/7124/7113,CXCL8/TNF/TMPRSS2
GO:0019722,calcium-mediated signaling,2/17,151/16992,0.009775328584607421,0.04561385495378816,0.020903354390417704,2,bp,PCR,1956/3576,EGFR/CXCL8
GO:0031652,positive regulation of heat generation,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,7124,TNF
GO:0032429,regulation of phospholipase A2 activity,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,1956,EGFR
GO:0032844,regulation of homeostatic process,3/17,449/16992,0.00945850008709416,0.04561385495378816,0.020903354390417704,3,bp,PCR,1956/1946/7124,EGFR/EFNA5/TNF
GO:0032930,positive regulation of superoxide anion generation,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,1956,EGFR
GO:0035878,nail development,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,3691,ITGB4
GO:0038127,ERBB signaling pathway,2/17,147/16992,0.009284349499483677,0.04561385495378816,0.020903354390417704,2,bp,PCR,2064/1956,ERBB2/EGFR
GO:0043491,protein kinase B signaling,2/17,149/16992,0.009528404627607906,0.04561385495378816,0.020903354390417704,2,bp,PCR,1956/7124,EGFR/TNF
GO:0045080,positive regulation of chemokine biosynthetic process,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,7124,TNF
GO:0048754,branching morphogenesis of an epithelial tube,2/17,148/16992,0.009406017768734514,0.04561385495378816,0.020903354390417704,2,bp,PCR,4233/7124,MET/TNF
GO:0051533,positive regulation of NFAT protein import into nucleus,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,7124,TNF
GO:0060346,bone trabecula formation,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,6422,SFRP1
GO:0061469,regulation of type B pancreatic cell proliferation,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,6422,SFRP1
GO:0071222,cellular response to lipopolysaccharide,2/17,151/16992,0.009775328584607421,0.04561385495378816,0.020903354390417704,2,bp,PCR,3576/7124,CXCL8/TNF
GO:0071803,positive regulation of podosome assembly,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,7124,TNF
GO:0072567,chemokine (C-X-C motif) ligand 2 production,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,7124,TNF
GO:1901298,regulation of hydrogen peroxide-mediated programmed cell death,1/17,10/16992,0.00996241244060092,0.04561385495378816,0.020903354390417704,1,bp,PCR,4233,MET
GO:1902806,regulation of cell cycle G1/S phase transition,2/17,151/16992,0.009775328584607421,0.04561385495378816,0.020903354390417704,2,bp,PCR,1956/990,EGFR/CDC6
GO:0000185,activation of MAPKKK activity,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,7124,TNF
GO:0002521,leukocyte differentiation,3/17,464/16992,0.010344223093455781,0.0458573110038816,0.02101492242383102,3,bp,PCR,2064/6422/7124,ERBB2/SFRP1/TNF
GO:0002676,regulation of chronic inflammatory response,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,7124,TNF
GO:0002685,regulation of leukocyte migration,2/17,158/16992,0.010661995303246893,0.0458573110038816,0.02101492242383102,2,bp,PCR,3576/7124,CXCL8/TNF
GO:0002863,positive regulation of inflammatory response to antigenic stimulus,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,7124,TNF
GO:0007494,midgut development,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,1956,EGFR
GO:0010608,posttranscriptional regulation of gene expression,3/17,469/16992,0.010649960889408842,0.0458573110038816,0.02101492242383102,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0010960,magnesium ion homeostasis,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,1956,EGFR
GO:0016055,Wnt signaling pathway,3/17,470/16992,0.010711741682334134,0.0458573110038816,0.02101492242383102,3,bp,PCR,83439/898/6422,TCF7L1/CCNE1/SFRP1
GO:0031581,hemidesmosome assembly,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,3691,ITGB4
GO:0035413,positive regulation of catenin import into nucleus,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,1956,EGFR
GO:0039692,single stranded viral RNA replication via double stranded DNA intermediate,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,3576,CXCL8
GO:0042368,vitamin D biosynthetic process,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,7124,TNF
GO:0043112,receptor metabolic process,2/17,155/16992,0.010277738847163397,0.0458573110038816,0.02101492242383102,2,bp,PCR,3576/7124,CXCL8/TNF
GO:0044848,biological phase,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,6422,SFRP1
GO:0045945,positive regulation of transcription from RNA polymerase III promoter,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,2064,ERBB2
GO:0048715,negative regulation of oligodendrocyte differentiation,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,3400,ID4
GO:0051222,positive regulation of protein transport,3/17,460/16992,0.010103422626353359,0.0458573110038816,0.02101492242383102,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0051798,positive regulation of hair follicle development,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,7124,TNF
GO:0060525,prostate glandular acinus development,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,6422,SFRP1
GO:0071219,cellular response to molecule of bacterial origin,2/17,157/16992,0.01053320315416046,0.0458573110038816,0.02101492242383102,2,bp,PCR,3576/7124,CXCL8/TNF
GO:0071372,cellular response to follicle-stimulating hormone stimulus,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,1946,EFNA5
GO:0198738,cell-cell signaling by wnt,3/17,471/16992,0.010773733921756585,0.0458573110038816,0.02101492242383102,3,bp,PCR,83439/898/6422,TCF7L1/CCNE1/SFRP1
GO:1904338,regulation of dopaminergic neuron differentiation,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,6422,SFRP1
GO:1904994,regulation of leukocyte adhesion to vascular endothelial cell,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,7124,TNF
GO:2000121,regulation of removal of superoxide radicals,1/17,11/16992,0.010953499414367629,0.0458573110038816,0.02101492242383102,1,bp,PCR,7124,TNF
GO:2000377,regulation of reactive oxygen species metabolic process,2/17,155/16992,0.010277738847163397,0.0458573110038816,0.02101492242383102,2,bp,PCR,1956/7124,EGFR/TNF
GO:2001236,regulation of extrinsic apoptotic signaling pathway,2/17,154/16992,0.010151069428528385,0.0458573110038816,0.02101492242383102,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0031960,response to corticosteroid,2/17,161/16992,0.011052595334003157,0.04599089061474262,0.021076137638988583,2,bp,PCR,1956/7124,EGFR/TNF
GO:0043410,positive regulation of MAPK cascade,3/17,475/16992,0.011023820452402529,0.04599089061474262,0.021076137638988583,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0010035,response to inorganic substance,3/17,485/16992,0.011663912883445334,0.046231547750429855,0.021186423020457645,3,bp,PCR,1956/4233/7124,EGFR/MET/TNF
GO:0010421,hydrogen peroxide-mediated programmed cell death,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,4233,MET
GO:0014029,neural crest formation,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,6422,SFRP1
GO:0016540,protein autoprocessing,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,7113,TMPRSS2
GO:0021543,pallium development,2/17,162/16992,0.0111841986603885,0.046231547750429855,0.021186423020457645,2,bp,PCR,1956/3400,EGFR/ID4
GO:0030656,regulation of vitamin metabolic process,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,7124,TNF
GO:0031032,actomyosin structure organization,2/17,165/16992,0.011583199547689934,0.046231547750429855,0.021186423020457645,2,bp,PCR,4233/6422,MET/SFRP1
GO:0031650,regulation of heat generation,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,7124,TNF
GO:0033002,muscle cell proliferation,2/17,166/16992,0.01171759229106159,0.046231547750429855,0.021186423020457645,2,bp,PCR,1956/7124,EGFR/TNF
GO:0034116,positive regulation of heterotypic cell-cell adhesion,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,7124,TNF
GO:0042306,regulation of protein import into nucleus,2/17,168/16992,0.011988458328270706,0.046231547750429855,0.021186423020457645,2,bp,PCR,1956/7124,EGFR/TNF
GO:0042635,positive regulation of hair cycle,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,7124,TNF
GO:0045414,regulation of interleukin-8 biosynthetic process,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,7124,TNF
GO:0048712,negative regulation of astrocyte differentiation,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,3400,ID4
GO:0050866,negative regulation of cell activation,2/17,163/16992,0.011316501376690545,0.046231547750429855,0.021186423020457645,2,bp,PCR,2064/6422,ERBB2/SFRP1
GO:0060442,branching involved in prostate gland morphogenesis,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,6422,SFRP1
GO:0060766,negative regulation of androgen receptor signaling pathway,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,6422,SFRP1
GO:0061430,bone trabecula morphogenesis,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,6422,SFRP1
GO:0070493,thrombin-activated receptor signaling pathway,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,4233,MET
GO:0071391,cellular response to estrogen stimulus,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,6422,SFRP1
GO:0097468,programmed cell death in response to reactive oxygen species,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,4233,MET
GO:1901550,regulation of endothelial cell development,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,7124,TNF
GO:1902905,positive regulation of supramolecular fiber organization,2/17,168/16992,0.011988458328270706,0.046231547750429855,0.021186423020457645,2,bp,PCR,4233/6422,MET/SFRP1
GO:1903140,regulation of establishment of endothelial barrier,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,7124,TNF
GO:2000052,positive regulation of non-canonical Wnt signaling pathway,1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,6422,SFRP1
GO:2000095,"regulation of Wnt signaling pathway, planar cell polarity pathway",1/17,12/16992,0.011943652556700823,0.046231547750429855,0.021186423020457645,1,bp,PCR,6422,SFRP1
GO:0048514,blood vessel morphogenesis,3/17,492/16992,0.01212468335328706,0.046625537951264,0.02136697598627761,3,bp,PCR,2064/6422/3576,ERBB2/SFRP1/CXCL8
GO:0007171,activation of transmembrane receptor protein tyrosine kinase activity,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,1946,EFNA5
GO:0007584,response to nutrient,2/17,172/16992,0.012538474828268194,0.0469631371779469,0.021521686792554187,2,bp,PCR,1956/6422,EGFR/SFRP1
GO:0021953,central nervous system neuron differentiation,2/17,173/16992,0.012677697025397764,0.0469631371779469,0.021521686792554187,2,bp,PCR,3400/6422,ID4/SFRP1
GO:0030324,lung development,2/17,172/16992,0.012538474828268194,0.0469631371779469,0.021521686792554187,2,bp,PCR,1956/7124,EGFR/TNF
GO:0032386,regulation of intracellular transport,3/17,498/16992,0.012527999636371627,0.0469631371779469,0.021521686792554187,3,bp,PCR,2064/1956/7124,ERBB2/EGFR/TNF
GO:0032928,regulation of superoxide anion generation,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,1956,EGFR
GO:0042228,interleukin-8 biosynthetic process,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,7124,TNF
GO:0045073,regulation of chemokine biosynthetic process,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,7124,TNF
GO:0045780,positive regulation of bone resorption,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,1956,EGFR
GO:0046325,negative regulation of glucose import,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,7124,TNF
GO:0046852,positive regulation of bone remodeling,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,1956,EGFR
GO:0050920,regulation of chemotaxis,2/17,172/16992,0.012538474828268194,0.0469631371779469,0.021521686792554187,2,bp,PCR,4233/3576,MET/CXCL8
GO:0061029,eyelid development in camera-type eye,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,1956,EGFR
GO:0071481,cellular response to X-ray,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,6422,SFRP1
GO:0072182,regulation of nephron tubule epithelial cell differentiation,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,8842,PROM1
GO:0090179,planar cell polarity pathway involved in neural tube closure,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,6422,SFRP1
GO:1900025,negative regulation of substrate adhesion-dependent cell spreading,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,1946,EFNA5
GO:1903531,negative regulation of secretion by cell,2/17,171/16992,0.012399938516460363,0.0469631371779469,0.021521686792554187,2,bp,PCR,6422/7124,SFRP1/TNF
GO:1904589,regulation of protein import,2/17,171/16992,0.012399938516460363,0.0469631371779469,0.021521686792554187,2,bp,PCR,1956/7124,EGFR/TNF
GO:2000010,positive regulation of protein localization to cell surface,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,7124,TNF
GO:2001028,positive regulation of endothelial cell chemotaxis,1/17,13/16992,0.012932872692539066,0.0469631371779469,0.021521686792554187,1,bp,PCR,4233,MET
GO:0030323,respiratory tube development,2/17,176/16992,0.013099465527915865,0.04744224420030905,0.021741246044661253,2,bp,PCR,1956/7124,EGFR/TNF
GO:0002739,regulation of cytokine secretion involved in immune response,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,7124,TNF
GO:0007369,gastrulation,2/17,180/16992,0.013671344772129768,0.04788459528786112,0.021943961240679117,2,bp,PCR,3691/6422,ITGB4/SFRP1
GO:0010810,regulation of cell-substrate adhesion,2/17,179/16992,0.01352735882773347,0.04788459528786112,0.021943961240679117,2,bp,PCR,1946/6422,EFNA5/SFRP1
GO:0010893,positive regulation of steroid biosynthetic process,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,7124,TNF
GO:0042033,chemokine biosynthetic process,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,7124,TNF
GO:0042362,fat-soluble vitamin biosynthetic process,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,7124,TNF
GO:0042754,negative regulation of circadian rhythm,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,79723,SUV39H2
GO:0043508,negative regulation of JUN kinase activity,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,6422,SFRP1
GO:0044130,negative regulation of growth of symbiont in host,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,7124,TNF
GO:0046851,negative regulation of bone remodeling,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,6422,SFRP1
GO:0050930,induction of positive chemotaxis,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,3576,CXCL8
GO:0070374,positive regulation of ERK1 and ERK2 cascade,2/17,181/16992,0.013816005922466795,0.04788459528786112,0.021943961240679117,2,bp,PCR,1956/7124,EGFR/TNF
GO:0071216,cellular response to biotic stimulus,2/17,179/16992,0.01352735882773347,0.04788459528786112,0.021943961240679117,2,bp,PCR,3576/7124,CXCL8/TNF
GO:0071801,regulation of podosome assembly,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,7124,TNF
GO:0090153,regulation of sphingolipid biosynthetic process,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,7124,TNF
GO:0090178,regulation of establishment of planar polarity involved in neural tube closure,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,6422,SFRP1
GO:1903798,regulation of production of miRNAs involved in gene silencing by miRNA,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,1956,EGFR
GO:1905038,regulation of membrane lipid metabolic process,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,7124,TNF
GO:1905330,regulation of morphogenesis of an epithelium,2/17,179/16992,0.01352735882773347,0.04788459528786112,0.021943961240679117,2,bp,PCR,6422/7124,SFRP1/TNF
GO:2000303,regulation of ceramide biosynthetic process,1/17,14/16992,0.013921160646142239,0.04788459528786112,0.021943961240679117,1,bp,PCR,7124,TNF
GO:0043401,steroid hormone mediated signaling pathway,2/17,183/16992,0.014107348533849843,0.04840340887929934,0.022181716729124144,2,bp,PCR,898/6422,CCNE1/SFRP1
GO:0001573,ganglioside metabolic process,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,3696,ITGB8
GO:0002573,myeloid leukocyte differentiation,2/17,185/16992,0.014401376064734957,0.04871064463735463,0.022322512939804976,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0022010,central nervous system myelination,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,3400,ID4
GO:0030730,sequestering of triglyceride,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,7124,TNF
GO:0032291,axon ensheathment in central nervous system,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,3400,ID4
GO:0044126,regulation of growth of symbiont in host,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,7124,TNF
GO:0044146,negative regulation of growth of symbiont involved in interaction with host,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,7124,TNF
GO:0044849,estrous cycle,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,4316,MMP7
GO:0045637,regulation of myeloid cell differentiation,2/17,185/16992,0.014401376064734957,0.04871064463735463,0.022322512939804976,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0050755,chemokine metabolic process,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,7124,TNF
GO:0051044,positive regulation of membrane protein ectodomain proteolysis,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,7124,TNF
GO:0051532,regulation of NFAT protein import into nucleus,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,7124,TNF
GO:0060026,convergent extension,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,6422,SFRP1
GO:0070920,regulation of production of small RNA involved in gene silencing by RNA,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,1956,EGFR
GO:0071456,cellular response to hypoxia,2/17,186/16992,0.014549393370844625,0.04871064463735463,0.022322512939804976,2,bp,PCR,79723/6422,SUV39H2/SFRP1
GO:0072160,nephron tubule epithelial cell differentiation,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,8842,PROM1
GO:0090177,establishment of planar polarity involved in neural tube closure,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,6422,SFRP1
GO:1900409,positive regulation of cellular response to oxidative stress,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,7124,TNF
GO:1905208,negative regulation of cardiocyte differentiation,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,1956,EGFR
GO:2000269,regulation of fibroblast apoptotic process,1/17,15/16992,0.014908517241089547,0.04871064463735463,0.022322512939804976,1,bp,PCR,6422,SFRP1
hsa04014,Ras signaling pathway,3/17,232/7430,0.014780908889884325,0.048859115497117626,0.029388941652401586,3,kg,PCR,1956/4233/1946,EGFR/MET/EFNA5
hsa04512,ECM-receptor interaction,2/17,82/7430,0.014697500322448605,0.048859115497117626,0.029388941652401586,2,kg,PCR,3691/3696,ITGB4/ITGB8
hsa04012,ErbB signaling pathway,2/17,85/7430,0.015736126658351855,0.049092798854935206,0.029529503070637723,2,kg,PCR,2064/1956,ERBB2/EGFR
hsa04350,TGF-beta signaling pathway,2/17,84/7430,0.015386456854163087,0.049092798854935206,0.029529503070637723,2,kg,PCR,3400/7124,ID4/TNF
hsa05210,Colorectal cancer,2/17,86/7430,0.016089236599516582,0.049092798854935206,0.029529503070637723,2,kg,PCR,83439/1956,TCF7L1/EGFR
GO:0002064,epithelial cell development,2/17,194/16992,0.015757443066274236,0.049732264729667304,0.02279068838482312,2,bp,PCR,4233/7124,MET/TNF
GO:0002922,positive regulation of humoral immune response,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,7124,TNF
GO:0006643,membrane lipid metabolic process,2/17,193/16992,0.015604124394145128,0.049732264729667304,0.02279068838482312,2,bp,PCR,3696/7124,ITGB8/TNF
GO:0009950,dorsal/ventral axis specification,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,6422,SFRP1
GO:0010829,negative regulation of glucose transport,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,7124,TNF
GO:0018027,peptidyl-lysine dimethylation,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,79723,SUV39H2
GO:0032354,response to follicle-stimulating hormone,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,1946,EFNA5
GO:0032515,negative regulation of phosphoprotein phosphatase activity,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,7124,TNF
GO:0036124,histone H3-K9 trimethylation,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,79723,SUV39H2
GO:0036294,cellular response to decreased oxygen levels,2/17,193/16992,0.015604124394145128,0.049732264729667304,0.02279068838482312,2,bp,PCR,79723/6422,SUV39H2/SFRP1
GO:0044144,modulation of growth of symbiont involved in interaction with host,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,7124,TNF
GO:0048012,hepatocyte growth factor receptor signaling pathway,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,4233,MET
GO:0051048,negative regulation of secretion,2/17,195/16992,0.015911418518330372,0.049732264729667304,0.02279068838482312,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0051224,negative regulation of protein transport,2/17,195/16992,0.015911418518330372,0.049732264729667304,0.02279068838482312,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0051495,positive regulation of cytoskeleton organization,2/17,191/16992,0.01529946261186947,0.049732264729667304,0.02279068838482312,2,bp,PCR,4233/6422,MET/SFRP1
GO:0051531,NFAT protein import into nucleus,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,7124,TNF
GO:0060219,camera-type eye photoreceptor cell differentiation,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,8842,PROM1
GO:1904385,cellular response to angiotensin,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,990,CDC6
GO:2000810,regulation of bicellular tight junction assembly,1/17,16/16992,0.015894943300281628,0.049732264729667304,0.02279068838482312,1,bp,PCR,7124,TNF
GO:0005057,"signal transducer activity, downstream of receptor",2/17,143/16982,0.00881483384658947,0.04995072513067367,0.02474339325358448,2,mf,PCR,2064/1956,ERBB2/EGFR
GO:0060541,respiratory system development,2/17,197/16992,0.0162213345501376,0.05058543735566828,0.023181669804296867,2,bp,PCR,1956/7124,EGFR/TNF
GO:0000076,DNA replication checkpoint,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,990,CDC6
GO:0002374,cytokine secretion involved in immune response,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,7124,TNF
GO:0010888,negative regulation of lipid storage,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,7124,TNF
GO:0031649,heat generation,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,7124,TNF
GO:0035024,negative regulation of Rho protein signal transduction,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,4233,MET
GO:0042249,establishment of planar polarity of embryonic epithelium,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,6422,SFRP1
GO:0051023,regulation of immunoglobulin secretion,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,7124,TNF
GO:0060218,hematopoietic stem cell differentiation,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,6422,SFRP1
GO:0071380,cellular response to prostaglandin E stimulus,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,6422,SFRP1
GO:1901032,negative regulation of response to reactive oxygen species,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,4233,MET
GO:1902043,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,6422,SFRP1
GO:1902884,positive regulation of response to oxidative stress,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,7124,TNF
GO:1903206,negative regulation of hydrogen peroxide-induced cell death,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,4233,MET
GO:1904707,positive regulation of vascular smooth muscle cell proliferation,1/17,17/16992,0.016880439645939882,0.051013955574595364,0.02337804584403432,1,bp,PCR,7124,TNF
GO:0001894,tissue homeostasis,2/17,202/16992,0.017007527243470516,0.05117209845343107,0.023450517610430138,2,bp,PCR,8842/1956,PROM1/EGFR
GO:0071453,cellular response to oxygen levels,2/17,202/16992,0.017007527243470516,0.05117209845343107,0.023450517610430138,2,bp,PCR,79723/6422,SUV39H2/SFRP1
hsa05323,Rheumatoid arthritis,2/17,90/7430,0.017535766252788815,0.05216890460204673,0.03137979224183261,2,kg,PCR,3576/7124,CXCL8/TNF
GO:0009612,response to mechanical stimulus,2/17,205/16992,0.01748701000971367,0.05225896307556378,0.0239485925131952,2,bp,PCR,4316/1956,MMP7/EGFR
GO:0032846,positive regulation of homeostatic process,2/17,207/16992,0.017809880006406535,0.05225896307556378,0.0239485925131952,2,bp,PCR,1956/7124,EGFR/TNF
GO:0044117,growth of symbiont in host,1/17,18/16992,0.017865007099608365,0.05225896307556378,0.0239485925131952,1,bp,PCR,7124,TNF
GO:0044346,fibroblast apoptotic process,1/17,18/16992,0.017865007099608365,0.05225896307556378,0.0239485925131952,1,bp,PCR,6422,SFRP1
GO:0048670,regulation of collateral sprouting,1/17,18/16992,0.017865007099608365,0.05225896307556378,0.0239485925131952,1,bp,PCR,1946,EFNA5
GO:0051797,regulation of hair follicle development,1/17,18/16992,0.017865007099608365,0.05225896307556378,0.0239485925131952,1,bp,PCR,7124,TNF
GO:0060560,developmental growth involved in morphogenesis,2/17,205/16992,0.01748701000971367,0.05225896307556378,0.0239485925131952,2,bp,PCR,1946/6422,EFNA5/SFRP1
GO:0071371,cellular response to gonadotropin stimulus,1/17,18/16992,0.017865007099608365,0.05225896307556378,0.0239485925131952,1,bp,PCR,1946,EFNA5
GO:1904950,negative regulation of establishment of protein localization,2/17,207/16992,0.017809880006406535,0.05225896307556378,0.0239485925131952,2,bp,PCR,6422/7124,SFRP1/TNF
GO:1905276,regulation of epithelial tube formation,1/17,18/16992,0.017865007099608365,0.05225896307556378,0.0239485925131952,1,bp,PCR,6422,SFRP1
GO:1905331,negative regulation of morphogenesis of an epithelium,1/17,18/16992,0.017865007099608365,0.05225896307556378,0.0239485925131952,1,bp,PCR,7124,TNF
GO:1990776,response to angiotensin,1/17,18/16992,0.017865007099608365,0.05225896307556378,0.0239485925131952,1,bp,PCR,990,CDC6
GO:2000696,regulation of epithelial cell differentiation involved in kidney development,1/17,18/16992,0.017865007099608365,0.05225896307556378,0.0239485925131952,1,bp,PCR,8842,PROM1
GO:0046822,regulation of nucleocytoplasmic transport,2/17,208/16992,0.017972275595465104,0.05246065093857511,0.024041019537419373,2,bp,PCR,1956/7124,EGFR/TNF
GO:0008201,heparin binding,2/17,152/16982,0.009911012686878402,0.05265225489904151,0.026081612333890534,2,mf,PCR,4316/6422,MMP7/SFRP1
GO:0004175,endopeptidase activity,3/17,474/16982,0.010978470470341423,0.053463430890098716,0.02648343325825324,3,mf,PCR,4316/6422/7113,MMP7/SFRP1/TMPRSS2
GO:0005165,neurotrophin receptor binding,1/17,12/16982,0.011950649257786772,0.053463430890098716,0.02648343325825324,1,mf,PCR,1946,EFNA5
GO:0031994,insulin-like growth factor I binding,1/17,12/16982,0.011950649257786772,0.053463430890098716,0.02648343325825324,1,mf,PCR,3691,ITGB4
GO:0034104,negative regulation of tissue remodeling,1/17,19/16992,0.018848646482152565,0.05387013994585983,0.024686942760933805,1,bp,PCR,6422,SFRP1
GO:0044110,growth involved in symbiotic interaction,1/17,19/16992,0.018848646482152565,0.05387013994585983,0.024686942760933805,1,bp,PCR,7124,TNF
GO:0044116,growth of symbiont involved in interaction with host,1/17,19/16992,0.018848646482152565,0.05387013994585983,0.024686942760933805,1,bp,PCR,7124,TNF
GO:0044342,type B pancreatic cell proliferation,1/17,19/16992,0.018848646482152565,0.05387013994585983,0.024686942760933805,1,bp,PCR,6422,SFRP1
GO:0061318,renal filtration cell differentiation,1/17,19/16992,0.018848646482152565,0.05387013994585983,0.024686942760933805,1,bp,PCR,8842,PROM1
GO:0071305,cellular response to vitamin D,1/17,19/16992,0.018848646482152565,0.05387013994585983,0.024686942760933805,1,bp,PCR,6422,SFRP1
GO:0072112,glomerular visceral epithelial cell differentiation,1/17,19/16992,0.018848646482152565,0.05387013994585983,0.024686942760933805,1,bp,PCR,8842,PROM1
GO:0097191,extrinsic apoptotic signaling pathway,2/17,213/16992,0.01879380823017631,0.05387013994585983,0.024686942760933805,2,bp,PCR,6422/7124,SFRP1/TNF
GO:1904948,midbrain dopaminergic neuron differentiation,1/17,19/16992,0.018848646482152565,0.05387013994585983,0.024686942760933805,1,bp,PCR,6422,SFRP1
GO:2001026,regulation of endothelial cell chemotaxis,1/17,19/16992,0.018848646482152565,0.05387013994585983,0.024686942760933805,1,bp,PCR,4233,MET
GO:0072659,protein localization to plasma membrane,2/17,214/16992,0.018960016758029746,0.054075547795297337,0.024781074534617826,2,bp,PCR,1956/7124,EGFR/TNF
hsa04657,IL-17 signaling pathway,2/17,93/7430,0.01865602469671241,0.054147974119726265,0.03257020999682783,2,kg,PCR,3576/7124,CXCL8/TNF
GO:0050714,positive regulation of protein secretion,2/17,216/16992,0.019294325630753787,0.05480068835788783,0.025113383000500672,2,bp,PCR,1956/7124,EGFR/TNF
GO:1900180,regulation of protein localization to nucleus,2/17,216/16992,0.019294325630753787,0.05480068835788783,0.025113383000500672,2,bp,PCR,1956/7124,EGFR/TNF
hsa04064,NF-kappa B signaling pathway,2/17,95/7430,0.019419471981517427,0.054812319876265884,0.03296981646692685,2,kg,PCR,3576/7124,CXCL8/TNF
hsa05146,Amoebiasis,2/17,96/7430,0.019806132392264142,0.054812319876265884,0.03296981646692685,2,kg,PCR,3576/7124,CXCL8/TNF
GO:0009651,response to salt stress,1/17,20/16992,0.01983135861376173,0.055069229091764316,0.025236446533152535,1,bp,PCR,7124,TNF
GO:0031116,positive regulation of microtubule polymerization,1/17,20/16992,0.01983135861376173,0.055069229091764316,0.025236446533152535,1,bp,PCR,4233,MET
GO:0034114,regulation of heterotypic cell-cell adhesion,1/17,20/16992,0.01983135861376173,0.055069229091764316,0.025236446533152535,1,bp,PCR,7124,TNF
GO:0042359,vitamin D metabolic process,1/17,20/16992,0.01983135861376173,0.055069229091764316,0.025236446533152535,1,bp,PCR,7124,TNF
GO:0043586,tongue development,1/17,20/16992,0.01983135861376173,0.055069229091764316,0.025236446533152535,1,bp,PCR,1956,EGFR
GO:0051497,negative regulation of stress fiber assembly,1/17,20/16992,0.01983135861376173,0.055069229091764316,0.025236446533152535,1,bp,PCR,4233,MET
GO:0051968,"positive regulation of synaptic transmission, glutamatergic",1/17,20/16992,0.01983135861376173,0.055069229091764316,0.025236446533152535,1,bp,PCR,1956,EGFR
GO:0061436,establishment of skin barrier,1/17,20/16992,0.01983135861376173,0.055069229091764316,0.025236446533152535,1,bp,PCR,4233,MET
GO:0072311,glomerular epithelial cell differentiation,1/17,20/16992,0.01983135861376173,0.055069229091764316,0.025236446533152535,1,bp,PCR,8842,PROM1
GO:1901889,negative regulation of cell junction assembly,1/17,20/16992,0.01983135861376173,0.055069229091764316,0.025236446533152535,1,bp,PCR,7124,TNF
GO:2000637,positive regulation of gene silencing by miRNA,1/17,20/16992,0.01983135861376173,0.055069229091764316,0.025236446533152535,1,bp,PCR,1956,EGFR
hsa01522,Endocrine resistance,2/17,98/7430,0.020589250988586383,0.05532292614012041,0.03327694805420777,2,kg,PCR,2064/1956,ERBB2/EGFR
hsa04066,HIF-1 signaling pathway,2/17,100/7430,0.021385332793659992,0.05532292614012041,0.03327694805420777,2,kg,PCR,2064/1956,ERBB2/EGFR
hsa04933,AGE-RAGE signaling pathway in diabetic complications,2/17,99/7430,0.020985679004429658,0.05532292614012041,0.03327694805420777,2,kg,PCR,3576/7124,CXCL8/TNF
GO:0007411,axon guidance,2/17,221/16992,0.020141074256042193,0.055703294255599514,0.02552701808952929,2,bp,PCR,2064/1946,ERBB2/EFNA5
GO:0045926,negative regulation of growth,2/17,221/16992,0.020141074256042193,0.055703294255599514,0.02552701808952929,2,bp,PCR,6422/7124,SFRP1/TNF
hsa05142,Chagas disease (American trypanosomiasis),2/17,102/7430,0.02219425784528494,0.05619397199125336,0.0338008854082727,2,kg,PCR,3576/7124,CXCL8/TNF
GO:0009755,hormone-mediated signaling pathway,2/17,223/16992,0.020484137749799406,0.05619959480433047,0.025754456578663612,2,bp,PCR,898/6422,CCNE1/SFRP1
GO:0031290,retinal ganglion cell axon guidance,1/17,21/16992,0.02081314431394854,0.05619959480433047,0.025754456578663612,1,bp,PCR,1946,EFNA5
GO:0036499,PERK-mediated unfolded protein response,1/17,21/16992,0.02081314431394854,0.05619959480433047,0.025754456578663612,1,bp,PCR,3576,CXCL8
GO:0045662,negative regulation of myoblast differentiation,1/17,21/16992,0.02081314431394854,0.05619959480433047,0.025754456578663612,1,bp,PCR,7124,TNF
GO:0045943,positive regulation of transcription from RNA polymerase I promoter,1/17,21/16992,0.02081314431394854,0.05619959480433047,0.025754456578663612,1,bp,PCR,2064,ERBB2
GO:0048305,immunoglobulin secretion,1/17,21/16992,0.02081314431394854,0.05619959480433047,0.025754456578663612,1,bp,PCR,7124,TNF
GO:0050901,leukocyte tethering or rolling,1/17,21/16992,0.02081314431394854,0.05619959480433047,0.025754456578663612,1,bp,PCR,7124,TNF
GO:0051984,positive regulation of chromosome segregation,1/17,21/16992,0.02081314431394854,0.05619959480433047,0.025754456578663612,1,bp,PCR,990,CDC6
GO:0060148,positive regulation of posttranscriptional gene silencing,1/17,21/16992,0.02081314431394854,0.05619959480433047,0.025754456578663612,1,bp,PCR,1956,EGFR
GO:0097485,neuron projection guidance,2/17,223/16992,0.020484137749799406,0.05619959480433047,0.025754456578663612,2,bp,PCR,2064/1946,ERBB2/EFNA5
GO:1902932,positive regulation of alcohol biosynthetic process,1/17,21/16992,0.02081314431394854,0.05619959480433047,0.025754456578663612,1,bp,PCR,7124,TNF
GO:2000050,regulation of non-canonical Wnt signaling pathway,1/17,21/16992,0.02081314431394854,0.05619959480433047,0.025754456578663612,1,bp,PCR,6422,SFRP1
GO:0007162,negative regulation of cell adhesion,2/17,226/16992,0.02100337728671059,0.05649041946072062,0.025887732112252117,2,bp,PCR,2064/1946,ERBB2/EFNA5
GO:0031334,positive regulation of protein complex assembly,2/17,226/16992,0.02100337728671059,0.05649041946072062,0.025887732112252117,2,bp,PCR,4233/7124,MET/TNF
hsa04620,Toll-like receptor signaling pathway,2/17,104/7430,0.023015906894756667,0.05706026917658424,0.03432196642200556,2,kg,PCR,3576/7124,CXCL8/TNF
GO:0002544,chronic inflammatory response,1/17,22/16992,0.02179400440154844,0.05715707284620654,0.026193237796577673,1,bp,PCR,7124,TNF
GO:0002861,regulation of inflammatory response to antigenic stimulus,1/17,22/16992,0.02179400440154844,0.05715707284620654,0.026193237796577673,1,bp,PCR,7124,TNF
GO:0010842,retina layer formation,1/17,22/16992,0.02179400440154844,0.05715707284620654,0.026193237796577673,1,bp,PCR,8842,PROM1
GO:0019932,second-messenger-mediated signaling,2/17,230/16992,0.021704313401816385,0.05715707284620654,0.026193237796577673,2,bp,PCR,1956/3576,EGFR/CXCL8
GO:0021895,cerebral cortex neuron differentiation,1/17,22/16992,0.02179400440154844,0.05715707284620654,0.026193237796577673,1,bp,PCR,3400,ID4
GO:0033561,regulation of water loss via skin,1/17,22/16992,0.02179400440154844,0.05715707284620654,0.026193237796577673,1,bp,PCR,4233,MET
GO:0050919,negative chemotaxis,1/17,22/16992,0.02179400440154844,0.05715707284620654,0.026193237796577673,1,bp,PCR,1946,EFNA5
GO:0050995,negative regulation of lipid catabolic process,1/17,22/16992,0.02179400440154844,0.05715707284620654,0.026193237796577673,1,bp,PCR,7124,TNF
GO:0051043,regulation of membrane protein ectodomain proteolysis,1/17,22/16992,0.02179400440154844,0.05715707284620654,0.026193237796577673,1,bp,PCR,7124,TNF
GO:0071379,cellular response to prostaglandin stimulus,1/17,22/16992,0.02179400440154844,0.05715707284620654,0.026193237796577673,1,bp,PCR,6422,SFRP1
GO:0071677,positive regulation of mononuclear cell migration,1/17,22/16992,0.02179400440154844,0.05715707284620654,0.026193237796577673,1,bp,PCR,7124,TNF
GO:0071800,podosome assembly,1/17,22/16992,0.02179400440154844,0.05715707284620654,0.026193237796577673,1,bp,PCR,7124,TNF
GO:0097186,amelogenesis,1/17,22/16992,0.02179400440154844,0.05715707284620654,0.026193237796577673,1,bp,PCR,3691,ITGB4
GO:0002719,negative regulation of cytokine production involved in immune response,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,7124,TNF
GO:0002793,positive regulation of peptide secretion,2/17,235/16992,0.02259421962060697,0.057523308622364336,0.026361071807257812,2,bp,PCR,1956/7124,EGFR/TNF
GO:0009110,vitamin biosynthetic process,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,7124,TNF
GO:0019430,removal of superoxide radicals,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,7124,TNF
GO:0021537,telencephalon development,2/17,236/16992,0.022774019922075582,0.057523308622364336,0.026361071807257812,2,bp,PCR,1956/3400,EGFR/ID4
GO:0031112,positive regulation of microtubule polymerization or depolymerization,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,4233,MET
GO:0033688,regulation of osteoblast proliferation,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,6422,SFRP1
GO:0035308,negative regulation of protein dephosphorylation,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,7124,TNF
GO:0045686,negative regulation of glial cell differentiation,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,3400,ID4
GO:0045940,positive regulation of steroid metabolic process,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,7124,TNF
GO:0045948,positive regulation of translational initiation,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,7124,TNF
GO:0046777,protein autophosphorylation,2/17,233/16992,0.022236434358200725,0.057523308622364336,0.026361071807257812,2,bp,PCR,2064/1956,ERBB2/EGFR
GO:0051894,positive regulation of focal adhesion assembly,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,6422,SFRP1
GO:0060445,branching involved in salivary gland morphogenesis,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,7124,TNF
GO:0061448,connective tissue development,2/17,236/16992,0.022774019922075582,0.057523308622364336,0.026361071807257812,2,bp,PCR,3400/3696,ID4/ITGB8
GO:0071526,semaphorin-plexin signaling pathway,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,4233,MET
GO:0072010,glomerular epithelium development,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,8842,PROM1
GO:0072593,reactive oxygen species metabolic process,2/17,236/16992,0.022774019922075582,0.057523308622364336,0.026361071807257812,2,bp,PCR,1956/7124,EGFR/TNF
GO:1903205,regulation of hydrogen peroxide-induced cell death,1/17,23/16992,0.0227739396947233,0.057523308622364336,0.026361071807257812,1,bp,PCR,4233,MET
GO:1990778,protein localization to cell periphery,2/17,232/16992,0.02205845187376509,0.057523308622364336,0.026361071807257812,2,bp,PCR,1956/7124,EGFR/TNF
GO:0014002,astrocyte development,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,1956,EGFR
GO:0032232,negative regulation of actin filament bundle assembly,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,4233,MET
GO:0032800,receptor biosynthetic process,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,7124,TNF
GO:0033081,regulation of T cell differentiation in thymus,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,2064,ERBB2
GO:0034695,response to prostaglandin E,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,6422,SFRP1
GO:0035412,regulation of catenin import into nucleus,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,1956,EGFR
GO:0039694,viral RNA genome replication,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,3576,CXCL8
GO:0039703,RNA replication,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,3576,CXCL8
GO:0042346,positive regulation of NF-kappaB import into nucleus,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,7124,TNF
GO:0042554,superoxide anion generation,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,1956,EGFR
GO:0043243,positive regulation of protein complex disassembly,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,7124,TNF
GO:0045577,regulation of B cell differentiation,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,6422,SFRP1
GO:0045672,positive regulation of osteoclast differentiation,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,7124,TNF
GO:0048668,collateral sprouting,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,1946,EFNA5
GO:0050927,positive regulation of positive chemotaxis,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,3576,CXCL8
GO:0061756,leukocyte adhesion to vascular endothelial cell,1/17,24/16992,0.023752951010957868,0.05827560920071921,0.026705826829901694,1,bp,PCR,7124,TNF
GO:0008045,motor neuron axon guidance,1/17,25/16992,0.024731039167063984,0.059397881788965955,0.027220128058301263,1,bp,PCR,2064,ERBB2
GO:0036474,cell death in response to hydrogen peroxide,1/17,25/16992,0.024731039167063984,0.059397881788965955,0.027220128058301263,1,bp,PCR,4233,MET
GO:0042634,regulation of hair cycle,1/17,25/16992,0.024731039167063984,0.059397881788965955,0.027220128058301263,1,bp,PCR,7124,TNF
GO:0045671,negative regulation of osteoclast differentiation,1/17,25/16992,0.024731039167063984,0.059397881788965955,0.027220128058301263,1,bp,PCR,6422,SFRP1
GO:0048710,regulation of astrocyte differentiation,1/17,25/16992,0.024731039167063984,0.059397881788965955,0.027220128058301263,1,bp,PCR,3400,ID4
GO:0050926,regulation of positive chemotaxis,1/17,25/16992,0.024731039167063984,0.059397881788965955,0.027220128058301263,1,bp,PCR,3576,CXCL8
GO:0060571,morphogenesis of an epithelial fold,1/17,25/16992,0.024731039167063984,0.059397881788965955,0.027220128058301263,1,bp,PCR,1956,EGFR
GO:0071450,cellular response to oxygen radical,1/17,25/16992,0.024731039167063984,0.059397881788965955,0.027220128058301263,1,bp,PCR,7124,TNF
GO:0071451,cellular response to superoxide,1/17,25/16992,0.024731039167063984,0.059397881788965955,0.027220128058301263,1,bp,PCR,7124,TNF
GO:1903393,positive regulation of adherens junction organization,1/17,25/16992,0.024731039167063984,0.059397881788965955,0.027220128058301263,1,bp,PCR,6422,SFRP1
GO:1904705,regulation of vascular smooth muscle cell proliferation,1/17,25/16992,0.024731039167063984,0.059397881788965955,0.027220128058301263,1,bp,PCR,7124,TNF
GO:1990874,vascular smooth muscle cell proliferation,1/17,25/16992,0.024731039167063984,0.059397881788965955,0.027220128058301263,1,bp,PCR,7124,TNF
GO:0019887,protein kinase regulator activity,2/17,182/16982,0.013976921074450315,0.05940191456641384,0.02942509699884277,2,mf,PCR,898/1946,CCNE1/EFNA5
GO:0050808,synapse organization,2/17,248/16992,0.024978341989669434,0.05978208074100954,0.027396194011488743,2,bp,PCR,2064/1946,ERBB2/EFNA5
GO:2000027,regulation of organ morphogenesis,2/17,248/16992,0.024978341989669434,0.05978208074100954,0.027396194011488743,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0060326,cell chemotaxis,2/17,250/16992,0.02535402861504396,0.06057533189178915,0.02775971535696923,2,bp,PCR,4233/3576,MET/CXCL8
GO:0007202,activation of phospholipase C activity,1/17,26/16992,0.025708204979179694,0.06057578763596729,0.027759924209785486,1,bp,PCR,1956,EGFR
GO:0010719,negative regulation of epithelial to mesenchymal transition,1/17,26/16992,0.025708204979179694,0.06057578763596729,0.027759924209785486,1,bp,PCR,6422,SFRP1
GO:0033687,osteoblast proliferation,1/17,26/16992,0.025708204979179694,0.06057578763596729,0.027759924209785486,1,bp,PCR,6422,SFRP1
GO:0034105,positive regulation of tissue remodeling,1/17,26/16992,0.025708204979179694,0.06057578763596729,0.027759924209785486,1,bp,PCR,1956,EGFR
GO:0035411,catenin import into nucleus,1/17,26/16992,0.025708204979179694,0.06057578763596729,0.027759924209785486,1,bp,PCR,1956,EGFR
GO:0035767,endothelial cell chemotaxis,1/17,26/16992,0.025708204979179694,0.06057578763596729,0.027759924209785486,1,bp,PCR,4233,MET
GO:0060343,trabecula formation,1/17,26/16992,0.025708204979179694,0.06057578763596729,0.027759924209785486,1,bp,PCR,6422,SFRP1
GO:0060765,regulation of androgen receptor signaling pathway,1/17,26/16992,0.025708204979179694,0.06057578763596729,0.027759924209785486,1,bp,PCR,6422,SFRP1
GO:0002675,positive regulation of acute inflammatory response,1/17,27/16992,0.026684449262767584,0.06233960928452017,0.028568226622255218,1,bp,PCR,7124,TNF
GO:0006359,regulation of transcription from RNA polymerase III promoter,1/17,27/16992,0.026684449262767584,0.06233960928452017,0.028568226622255218,1,bp,PCR,2064,ERBB2
GO:0045880,positive regulation of smoothened signaling pathway,1/17,27/16992,0.026684449262767584,0.06233960928452017,0.028568226622255218,1,bp,PCR,6422,SFRP1
GO:0090023,positive regulation of neutrophil chemotaxis,1/17,27/16992,0.026684449262767584,0.06233960928452017,0.028568226622255218,1,bp,PCR,3576,CXCL8
GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,1/17,27/16992,0.026684449262767584,0.06233960928452017,0.028568226622255218,1,bp,PCR,990,CDC6
GO:0005539,glycosaminoglycan binding,2/17,201/16982,0.016867683527521066,0.06292361556231825,0.031169592848207184,2,mf,PCR,4316/6422,MMP7/SFRP1
GO:0019207,kinase regulator activity,2/17,202/16982,0.017026390093333173,0.06292361556231825,0.031169592848207184,2,mf,PCR,898/1946,CCNE1/EFNA5
GO:0045236,CXCR chemokine receptor binding,1/17,16/16982,0.015904237108203767,0.06292361556231825,0.031169592848207184,1,mf,PCR,3576,CXCL8
GO:0000303,response to superoxide,1/17,28/16992,0.027659772832619445,0.06407145348198988,0.02936187480317248,1,bp,PCR,7124,TNF
GO:0032770,positive regulation of monooxygenase activity,1/17,28/16992,0.027659772832619445,0.06407145348198988,0.02936187480317248,1,bp,PCR,7124,TNF
GO:0034698,response to gonadotropin,1/17,28/16992,0.027659772832619445,0.06407145348198988,0.02936187480317248,1,bp,PCR,1946,EFNA5
GO:0071295,cellular response to vitamin,1/17,28/16992,0.027659772832619445,0.06407145348198988,0.02936187480317248,1,bp,PCR,6422,SFRP1
GO:0090314,positive regulation of protein targeting to membrane,1/17,28/16992,0.027659772832619445,0.06407145348198988,0.02936187480317248,1,bp,PCR,2064,ERBB2
GO:0001822,kidney development,2/17,265/16992,0.028245769027461037,0.06531834087600365,0.02993328296651276,2,bp,PCR,8842/6422,PROM1/SFRP1
GO:0003382,epithelial cell morphogenesis,1/17,29/16992,0.028634176502852826,0.06566195583317508,0.030090750587499396,1,bp,PCR,4233,MET
GO:0030866,cortical actin cytoskeleton organization,1/17,29/16992,0.028634176502852826,0.06566195583317508,0.030090750587499396,1,bp,PCR,7124,TNF
GO:0060441,epithelial tube branching involved in lung morphogenesis,1/17,29/16992,0.028634176502852826,0.06566195583317508,0.030090750587499396,1,bp,PCR,7124,TNF
GO:0060674,placenta blood vessel development,1/17,29/16992,0.028634176502852826,0.06566195583317508,0.030090750587499396,1,bp,PCR,3696,ITGB8
GO:0060964,regulation of gene silencing by miRNA,1/17,29/16992,0.028634176502852826,0.06566195583317508,0.030090750587499396,1,bp,PCR,1956,EGFR
GO:0002701,negative regulation of production of molecular mediator of immune response,1/17,30/16992,0.02960766108691537,0.06662748654171405,0.030533222082089556,1,bp,PCR,7124,TNF
GO:0006606,protein import into nucleus,2/17,271/16992,0.029438495524470122,0.06662748654171405,0.030533222082089556,2,bp,PCR,1956/7124,EGFR/TNF
GO:0030522,intracellular receptor signaling pathway,2/17,272/16992,0.02963925442213576,0.06662748654171405,0.030533222082089556,2,bp,PCR,898/6422,CCNE1/SFRP1
GO:0034694,response to prostaglandin,1/17,30/16992,0.02960766108691537,0.06662748654171405,0.030533222082089556,1,bp,PCR,6422,SFRP1
GO:0044744,protein targeting to nucleus,2/17,271/16992,0.029438495524470122,0.06662748654171405,0.030533222082089556,2,bp,PCR,1956/7124,EGFR/TNF
GO:0045601,regulation of endothelial cell differentiation,1/17,30/16992,0.02960766108691537,0.06662748654171405,0.030533222082089556,1,bp,PCR,7124,TNF
GO:0046596,regulation of viral entry into host cell,1/17,30/16992,0.02960766108691537,0.06662748654171405,0.030533222082089556,1,bp,PCR,7113,TMPRSS2
GO:0048713,regulation of oligodendrocyte differentiation,1/17,30/16992,0.02960766108691537,0.06662748654171405,0.030533222082089556,1,bp,PCR,3400,ID4
GO:0050869,negative regulation of B cell activation,1/17,30/16992,0.02960766108691537,0.06662748654171405,0.030533222082089556,1,bp,PCR,6422,SFRP1
GO:0071624,positive regulation of granulocyte chemotaxis,1/17,30/16992,0.02960766108691537,0.06662748654171405,0.030533222082089556,1,bp,PCR,3576,CXCL8
GO:1901890,positive regulation of cell junction assembly,1/17,30/16992,0.02960766108691537,0.06662748654171405,0.030533222082089556,1,bp,PCR,6422,SFRP1
GO:1902624,positive regulation of neutrophil migration,1/17,30/16992,0.02960766108691537,0.06662748654171405,0.030533222082089556,1,bp,PCR,3576,CXCL8
GO:0030296,protein tyrosine kinase activator activity,1/17,19/16982,0.01885965169088266,0.06679459973854275,0.03308710822961871,1,mf,PCR,1946,EFNA5
GO:0010721,negative regulation of cell development,2/17,274/16992,0.030042451149616532,0.06720280330690365,0.03079687114752572,2,bp,PCR,3400/1946,ID4/EFNA5
GO:0045930,negative regulation of mitotic cell cycle,2/17,274/16992,0.030042451149616532,0.06720280330690365,0.03079687114752572,2,bp,PCR,1956/7124,EGFR/TNF
GO:1902593,single-organism nuclear import,2/17,274/16992,0.030042451149616532,0.06720280330690365,0.03079687114752572,2,bp,PCR,1956/7124,EGFR/TNF
GO:0005125,cytokine activity,2/17,219/16982,0.01982234467109945,0.06739597188173813,0.03338500155132539,2,mf,PCR,3576/7124,CXCL8/TNF
GO:0000305,response to oxygen radical,1/17,31/16992,0.030580227397581816,0.06774163641956231,0.031043800935034515,1,bp,PCR,7124,TNF
GO:0001937,negative regulation of endothelial cell proliferation,1/17,31/16992,0.030580227397581816,0.06774163641956231,0.031043800935034515,1,bp,PCR,7124,TNF
GO:0003401,axis elongation,1/17,31/16992,0.030580227397581816,0.06774163641956231,0.031043800935034515,1,bp,PCR,6422,SFRP1
GO:0045907,positive regulation of vasoconstriction,1/17,31/16992,0.030580227397581816,0.06774163641956231,0.031043800935034515,1,bp,PCR,1956,EGFR
GO:0048147,negative regulation of fibroblast proliferation,1/17,31/16992,0.030580227397581816,0.06774163641956231,0.031043800935034515,1,bp,PCR,6422,SFRP1
GO:0071276,cellular response to cadmium ion,1/17,31/16992,0.030580227397581816,0.06774163641956231,0.031043800935034515,1,bp,PCR,1956,EGFR
GO:0007009,plasma membrane organization,2/17,277/16992,0.030651425935395025,0.06778966414467817,0.03106581048804597,2,bp,PCR,1956/7124,EGFR/TNF
GO:0002714,positive regulation of B cell mediated immunity,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,7124,TNF
GO:0002891,positive regulation of immunoglobulin mediated immune response,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,7124,TNF
GO:0006356,regulation of transcription from RNA polymerase I promoter,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,2064,ERBB2
GO:0031113,regulation of microtubule polymerization,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,4233,MET
GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,6422,SFRP1
GO:0048333,mesodermal cell differentiation,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,3691,ITGB4
GO:0051567,histone H3-K9 methylation,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,79723,SUV39H2
GO:0060147,regulation of posttranscriptional gene silencing,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,1956,EGFR
GO:0060966,regulation of gene silencing by RNA,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,1956,EGFR
GO:0090022,regulation of neutrophil chemotaxis,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,3576,CXCL8
GO:0097421,liver regeneration,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,1956,EGFR
GO:1902808,positive regulation of cell cycle G1/S phase transition,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,990,CDC6
GO:2000008,regulation of protein localization to cell surface,1/17,32/16992,0.03155187624695632,0.06834575725013166,0.03132064997199528,1,bp,PCR,7124,TNF
GO:1902903,regulation of supramolecular fiber organization,2/17,283/16992,0.03188430647043777,0.06895673863827696,0.03160064298059518,2,bp,PCR,4233/6422,MET/SFRP1
GO:0048638,regulation of developmental growth,2/17,285/16992,0.03229965643333199,0.06963500733422283,0.03191147158601884,2,bp,PCR,1946/6422,EFNA5/SFRP1
GO:0050727,regulation of inflammatory response,2/17,285/16992,0.03229965643333199,0.06963500733422283,0.03191147158601884,2,bp,PCR,1956/7124,EGFR/TNF
GO:0046329,negative regulation of JNK cascade,1/17,33/16992,0.03252260844647248,0.06967676207076812,0.031930606431262,1,bp,PCR,6422,SFRP1
GO:0071549,cellular response to dexamethasone stimulus,1/17,33/16992,0.03252260844647248,0.06967676207076812,0.031930606431262,1,bp,PCR,1956,EGFR
GO:1901099,negative regulation of signal transduction in absence of ligand,1/17,33/16992,0.03252260844647248,0.06967676207076812,0.031930606431262,1,bp,PCR,7124,TNF
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/17,33/16992,0.03252260844647248,0.06967676207076812,0.031930606431262,1,bp,PCR,7124,TNF
GO:0098813,nuclear chromosome segregation,2/17,287/16992,0.03271718580756472,0.06998410526649392,0.032071451877152254,2,bp,PCR,898/990,CCNE1/CDC6
GO:0010165,response to X-ray,1/17,34/16992,0.03349242480689574,0.07075791598864238,0.032426064302972485,1,bp,PCR,6422,SFRP1
GO:0030865,cortical cytoskeleton organization,1/17,34/16992,0.03349242480689574,0.07075791598864238,0.032426064302972485,1,bp,PCR,7124,TNF
GO:0035196,production of miRNAs involved in gene silencing by miRNA,1/17,34/16992,0.03349242480689574,0.07075791598864238,0.032426064302972485,1,bp,PCR,1956,EGFR
GO:0045124,regulation of bone resorption,1/17,34/16992,0.03349242480689574,0.07075791598864238,0.032426064302972485,1,bp,PCR,1956,EGFR
GO:0045581,negative regulation of T cell differentiation,1/17,34/16992,0.03349242480689574,0.07075791598864238,0.032426064302972485,1,bp,PCR,2064,ERBB2
GO:0045684,positive regulation of epidermis development,1/17,34/16992,0.03349242480689574,0.07075791598864238,0.032426064302972485,1,bp,PCR,7124,TNF
GO:0060070,canonical Wnt signaling pathway,2/17,290/16992,0.03334754603359675,0.07075791598864238,0.032426064302972485,2,bp,PCR,83439/6422,TCF7L1/SFRP1
GO:0090313,regulation of protein targeting to membrane,1/17,34/16992,0.03349242480689574,0.07075791598864238,0.032426064302972485,1,bp,PCR,2064,ERBB2
GO:0043010,camera-type eye development,2/17,292/16992,0.03377048351311699,0.07112583373762639,0.032594669107397126,2,bp,PCR,8842/1956,PROM1/EGFR
GO:0051170,nuclear import,2/17,292/16992,0.03377048351311699,0.07112583373762639,0.032594669107397126,2,bp,PCR,1956/7124,EGFR/TNF
GO:0010863,positive regulation of phospholipase C activity,1/17,35/16992,0.03446132613831954,0.07180754259263233,0.03290707422644948,1,bp,PCR,1956,EGFR
GO:0031050,dsRNA fragmentation,1/17,35/16992,0.03446132613831954,0.07180754259263233,0.03290707422644948,1,bp,PCR,1956,EGFR
GO:0033280,response to vitamin D,1/17,35/16992,0.03446132613831954,0.07180754259263233,0.03290707422644948,1,bp,PCR,6422,SFRP1
GO:0045494,photoreceptor cell maintenance,1/17,35/16992,0.03446132613831954,0.07180754259263233,0.03290707422644948,1,bp,PCR,8842,PROM1
GO:0070918,production of small RNA involved in gene silencing by RNA,1/17,35/16992,0.03446132613831954,0.07180754259263233,0.03290707422644948,1,bp,PCR,1956,EGFR
GO:1902622,regulation of neutrophil migration,1/17,35/16992,0.03446132613831954,0.07180754259263233,0.03290707422644948,1,bp,PCR,3576,CXCL8
GO:1902930,regulation of alcohol biosynthetic process,1/17,35/16992,0.03446132613831954,0.07180754259263233,0.03290707422644948,1,bp,PCR,7124,TNF
GO:0008156,negative regulation of DNA replication,1/17,36/16992,0.035429313250169625,0.0737123553791523,0.033779988317230995,1,bp,PCR,990,CDC6
GO:0098802,plasma membrane receptor complex,2/17,169/18122,0.010725181596894943,0.07418250604519003,0.047040270161819935,2,cc,PCR,3691/3696,ITGB4/ITGB8
GO:0004709,MAP kinase kinase kinase activity,1/17,23/16982,0.022787211606265068,0.07449665332817426,0.03690236697370861,1,mf,PCR,1956,EGFR
GO:0001659,temperature homeostasis,1/17,37/16992,0.03639638695120473,0.0748147953996986,0.03428520092131818,1,bp,PCR,7124,TNF
GO:0014003,oligodendrocyte development,1/17,37/16992,0.03639638695120473,0.0748147953996986,0.03428520092131818,1,bp,PCR,3400,ID4
GO:0032467,positive regulation of cytokinesis,1/17,37/16992,0.03639638695120473,0.0748147953996986,0.03428520092131818,1,bp,PCR,990,CDC6
GO:0032496,response to lipopolysaccharide,2/17,304/16992,0.03635287828971974,0.0748147953996986,0.03428520092131818,2,bp,PCR,3576/7124,CXCL8/TNF
GO:0032715,negative regulation of interleukin-6 production,1/17,37/16992,0.03639638695120473,0.0748147953996986,0.03428520092131818,1,bp,PCR,7124,TNF
GO:0046676,negative regulation of insulin secretion,1/17,37/16992,0.03639638695120473,0.0748147953996986,0.03428520092131818,1,bp,PCR,6422,SFRP1
GO:0070266,necroptotic process,1/17,37/16992,0.03639638695120473,0.0748147953996986,0.03428520092131818,1,bp,PCR,7124,TNF
GO:1900274,regulation of phospholipase C activity,1/17,37/16992,0.03639638695120473,0.0748147953996986,0.03428520092131818,1,bp,PCR,1956,EGFR
GO:0004252,serine-type endopeptidase activity,2/17,250/16982,0.0253817321341673,0.07569419066318461,0.037495574322320556,2,mf,PCR,4316/7113,MMP7/TMPRSS2
GO:0005164,tumor necrosis factor receptor binding,1/17,30/16982,0.029624858283087474,0.07569419066318461,0.037495574322320556,1,mf,PCR,7124,TNF
GO:0005520,insulin-like growth factor binding,1/17,28/16982,0.02767585387991045,0.07569419066318461,0.037495574322320556,1,mf,PCR,3691,ITGB4
GO:0008236,serine-type peptidase activity,2/17,272/16982,0.02967141778169898,0.07569419066318461,0.037495574322320556,2,mf,PCR,4316/7113,MMP7/TMPRSS2
GO:0016538,cyclin-dependent protein serine/threonine kinase regulator activity,1/17,30/16982,0.029624858283087474,0.07569419066318461,0.037495574322320556,1,mf,PCR,898,CCNE1
GO:0017147,Wnt-protein binding,1/17,30/16982,0.029624858283087474,0.07569419066318461,0.037495574322320556,1,mf,PCR,6422,SFRP1
GO:0017171,serine hydrolase activity,2/17,275/16982,0.030277676265273848,0.07569419066318461,0.037495574322320556,2,mf,PCR,4316/7113,MMP7/TMPRSS2
GO:0046875,ephrin receptor binding,1/17,25/16982,0.024745437956666394,0.07569419066318461,0.037495574322320556,1,mf,PCR,1946,EFNA5
GO:0014014,negative regulation of gliogenesis,1/17,38/16992,0.03736254804951389,0.07657085071824028,0.035089944275938034,1,bp,PCR,3400,ID4
GO:1905953,negative regulation of lipid localization,1/17,38/16992,0.03736254804951389,0.07657085071824028,0.035089944275938034,1,bp,PCR,7124,TNF
GO:0043175,RNA polymerase core enzyme binding,1/17,32/16982,0.03157018532032896,0.07667045006365604,0.03797917031017018,1,mf,PCR,2064,ERBB2
GO:0030122,AP-2 adaptor complex,1/17,13/18122,0.012130711321713283,0.07741577915595738,0.04909053846287722,1,cc,PCR,1956,EGFR
GO:0030128,clathrin coat of endocytic vesicle,1/17,14/18122,0.01305808323112534,0.07741577915595738,0.04909053846287722,1,cc,PCR,1956,EGFR
hsa04110,Cell cycle,2/17,124/7430,0.03190648586938944,0.0774871799685172,0.04660883005625095,2,kg,PCR,898/990,CCNE1/CDC6
GO:0030111,regulation of Wnt signaling pathway,2/17,311/16992,0.037894189105592745,0.07754431223551042,0.035536050203655536,2,bp,PCR,83439/6422,TCF7L1/SFRP1
GO:0018023,peptidyl-lysine trimethylation,1/17,39/16992,0.03832779735251923,0.07773445122310939,0.03562318475181515,1,bp,PCR,79723,SUV39H2
GO:0031670,cellular response to nutrient,1/17,39/16992,0.03832779735251923,0.07773445122310939,0.03562318475181515,1,bp,PCR,6422,SFRP1
GO:0061028,establishment of endothelial barrier,1/17,39/16992,0.03832779735251923,0.07773445122310939,0.03562318475181515,1,bp,PCR,7124,TNF
GO:0071312,cellular response to alkaloid,1/17,39/16992,0.03832779735251923,0.07773445122310939,0.03562318475181515,1,bp,PCR,7124,TNF
GO:0071542,dopaminergic neuron differentiation,1/17,39/16992,0.03832779735251923,0.07773445122310939,0.03562318475181515,1,bp,PCR,6422,SFRP1
GO:1905207,regulation of cardiocyte differentiation,1/17,39/16992,0.03832779735251923,0.07773445122310939,0.03562318475181515,1,bp,PCR,1956,EGFR
GO:0006509,membrane protein ectodomain proteolysis,1/17,40/16992,0.03929213566697776,0.07875685758139467,0.036091720517097546,1,bp,PCR,7124,TNF
GO:0030098,lymphocyte differentiation,2/17,316/16992,0.03901060563629854,0.07875685758139467,0.036091720517097546,2,bp,PCR,2064/6422,ERBB2/SFRP1
GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,1/17,40/16992,0.03929213566697776,0.07875685758139467,0.036091720517097546,1,bp,PCR,1956,EGFR
GO:0071675,regulation of mononuclear cell migration,1/17,40/16992,0.03929213566697776,0.07875685758139467,0.036091720517097546,1,bp,PCR,7124,TNF
GO:0090184,positive regulation of kidney development,1/17,40/16992,0.03929213566697776,0.07875685758139467,0.036091720517097546,1,bp,PCR,8842,PROM1
GO:1901990,regulation of mitotic cell cycle phase transition,2/17,316/16992,0.03901060563629854,0.07875685758139467,0.036091720517097546,2,bp,PCR,1956/990,EGFR/CDC6
GO:1903078,positive regulation of protein localization to plasma membrane,1/17,40/16992,0.03929213566697776,0.07875685758139467,0.036091720517097546,1,bp,PCR,1956,EGFR
GO:1904377,positive regulation of protein localization to cell periphery,1/17,40/16992,0.03929213566697776,0.07875685758139467,0.036091720517097546,1,bp,PCR,1956,EGFR
GO:0002237,response to molecule of bacterial origin,2/17,319/16992,0.03968658065781483,0.07943118263238085,0.03640074187758947,2,bp,PCR,3576/7124,CXCL8/TNF
GO:0001754,eye photoreceptor cell differentiation,1/17,41/16992,0.04025556379897732,0.07963853589710976,0.036495765172179014,1,bp,PCR,8842,PROM1
GO:0017038,protein import,2/17,321/16992,0.04013976429515754,0.07963853589710976,0.036495765172179014,2,bp,PCR,1956/7124,EGFR/TNF
GO:0043666,regulation of phosphoprotein phosphatase activity,1/17,41/16992,0.04025556379897732,0.07963853589710976,0.036495765172179014,1,bp,PCR,7124,TNF
GO:0071548,response to dexamethasone,1/17,41/16992,0.04025556379897732,0.07963853589710976,0.036495765172179014,1,bp,PCR,1956,EGFR
GO:1900408,negative regulation of cellular response to oxidative stress,1/17,41/16992,0.04025556379897732,0.07963853589710976,0.036495765172179014,1,bp,PCR,4233,MET
GO:1902883,negative regulation of response to oxidative stress,1/17,41/16992,0.04025556379897732,0.07963853589710976,0.036495765172179014,1,bp,PCR,4233,MET
GO:1903037,regulation of leukocyte cell-cell adhesion,2/17,320/16992,0.03991291985209892,0.07963853589710976,0.036495765172179014,2,bp,PCR,2064/7124,ERBB2/TNF
GO:1903202,negative regulation of oxidative stress-induced cell death,1/17,41/16992,0.04025556379897732,0.07963853589710976,0.036495765172179014,1,bp,PCR,4233,MET
GO:0002437,inflammatory response to antigenic stimulus,1/17,42/16992,0.041218082553942326,0.08038113250191888,0.03683607317761227,1,bp,PCR,7124,TNF
GO:0006775,fat-soluble vitamin metabolic process,1/17,42/16992,0.041218082553942326,0.08038113250191888,0.03683607317761227,1,bp,PCR,7124,TNF
GO:0007528,neuromuscular junction development,1/17,42/16992,0.041218082553942326,0.08038113250191888,0.03683607317761227,1,bp,PCR,2064,ERBB2
GO:0010883,regulation of lipid storage,1/17,42/16992,0.041218082553942326,0.08038113250191888,0.03683607317761227,1,bp,PCR,7124,TNF
GO:0032873,negative regulation of stress-activated MAPK cascade,1/17,42/16992,0.041218082553942326,0.08038113250191888,0.03683607317761227,1,bp,PCR,6422,SFRP1
GO:0042743,hydrogen peroxide metabolic process,1/17,42/16992,0.041218082553942326,0.08038113250191888,0.03683607317761227,1,bp,PCR,1956,EGFR
GO:0061647,histone H3-K9 modification,1/17,42/16992,0.041218082553942326,0.08038113250191888,0.03683607317761227,1,bp,PCR,79723,SUV39H2
GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,1/17,42/16992,0.041218082553942326,0.08038113250191888,0.03683607317761227,1,bp,PCR,6422,SFRP1
GO:0090278,negative regulation of peptide hormone secretion,1/17,42/16992,0.041218082553942326,0.08038113250191888,0.03683607317761227,1,bp,PCR,6422,SFRP1
GO:0097300,programmed necrotic cell death,1/17,42/16992,0.041218082553942326,0.08038113250191888,0.03683607317761227,1,bp,PCR,7124,TNF
GO:0005109,frizzled binding,1/17,36/16982,0.0354498333084281,0.08146010141604895,0.040351753023429825,1,mf,PCR,6422,SFRP1
GO:0030546,receptor activator activity,1/17,37/16982,0.03641745710364541,0.08146010141604895,0.040351753023429825,1,mf,PCR,1946,EFNA5
GO:0045296,cadherin binding,2/17,304/16982,0.03639193092492668,0.08146010141604895,0.040351753023429825,2,mf,PCR,8842/1956,PROM1/EGFR
GO:0007059,chromosome segregation,2/17,330/16992,0.042203918695029666,0.0817215907970235,0.0374503618584645,2,bp,PCR,898/990,CCNE1/CDC6
GO:0021795,cerebral cortex cell migration,1/17,43/16992,0.042179692736632024,0.0817215907970235,0.0374503618584645,1,bp,PCR,1956,EGFR
GO:0032757,positive regulation of interleukin-8 production,1/17,43/16992,0.042179692736632024,0.0817215907970235,0.0374503618584645,1,bp,PCR,7124,TNF
GO:0045739,positive regulation of DNA repair,1/17,43/16992,0.042179692736632024,0.0817215907970235,0.0374503618584645,1,bp,PCR,1956,EGFR
GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,1/17,43/16992,0.042179692736632024,0.0817215907970235,0.0374503618584645,1,bp,PCR,6422,SFRP1
GO:1903532,positive regulation of secretion by cell,2/17,331/16992,0.04243575511243807,0.08205444738549113,0.03760289926704295,2,bp,PCR,1956/7124,EGFR/TNF
GO:0001666,response to hypoxia,2/17,332/16992,0.042668084708206766,0.08238731729976737,0.03775544278240848,2,bp,PCR,79723/6422,SUV39H2/SFRP1
GO:0002762,negative regulation of myeloid leukocyte differentiation,1/17,44/16992,0.043140395151138655,0.0824849175445654,0.03780016981781629,1,bp,PCR,6422,SFRP1
GO:0006984,ER-nucleus signaling pathway,1/17,44/16992,0.043140395151138655,0.0824849175445654,0.03780016981781629,1,bp,PCR,3576,CXCL8
GO:0030071,regulation of mitotic metaphase/anaphase transition,1/17,44/16992,0.043140395151138655,0.0824849175445654,0.03780016981781629,1,bp,PCR,990,CDC6
GO:0030099,myeloid cell differentiation,2/17,333/16992,0.042900906393804526,0.0824849175445654,0.03780016981781629,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0046580,negative regulation of Ras protein signal transduction,1/17,44/16992,0.043140395151138655,0.0824849175445654,0.03780016981781629,1,bp,PCR,4233,MET
GO:0051496,positive regulation of stress fiber assembly,1/17,44/16992,0.043140395151138655,0.0824849175445654,0.03780016981781629,1,bp,PCR,6422,SFRP1
GO:1904837,beta-catenin-TCF complex assembly,1/17,44/16992,0.043140395151138655,0.0824849175445654,0.03780016981781629,1,bp,PCR,83439,TCF7L1
GO:0042622,photoreceptor outer segment membrane,1/17,16/18122,0.01491036948645319,0.08250404449170765,0.052317085917379616,1,cc,PCR,8842,PROM1
GO:0001654,eye development,2/17,337/16992,0.04383709231480221,0.08315862387413504,0.03810890763829494,2,bp,PCR,8842/1956,PROM1/EGFR
GO:0001954,positive regulation of cell-matrix adhesion,1/17,45/16992,0.04410019060089265,0.08315862387413504,0.03810890763829494,1,bp,PCR,6422,SFRP1
GO:0002712,regulation of B cell mediated immunity,1/17,45/16992,0.04410019060089265,0.08315862387413504,0.03810890763829494,1,bp,PCR,7124,TNF
GO:0002889,regulation of immunoglobulin mediated immune response,1/17,45/16992,0.04410019060089265,0.08315862387413504,0.03810890763829494,1,bp,PCR,7124,TNF
GO:0042345,regulation of NF-kappaB import into nucleus,1/17,45/16992,0.04410019060089265,0.08315862387413504,0.03810890763829494,1,bp,PCR,7124,TNF
GO:0042348,NF-kappaB import into nucleus,1/17,45/16992,0.04410019060089265,0.08315862387413504,0.03810890763829494,1,bp,PCR,7124,TNF
GO:0050766,positive regulation of phagocytosis,1/17,45/16992,0.04410019060089265,0.08315862387413504,0.03810890763829494,1,bp,PCR,7124,TNF
GO:0051058,negative regulation of small GTPase mediated signal transduction,1/17,45/16992,0.04410019060089265,0.08315862387413504,0.03810890763829494,1,bp,PCR,4233,MET
GO:1901987,regulation of cell cycle phase transition,2/17,337/16992,0.04383709231480221,0.08315862387413504,0.03810890763829494,2,bp,PCR,1956/990,EGFR/CDC6
GO:1902099,regulation of metaphase/anaphase transition of cell cycle,1/17,45/16992,0.04410019060089265,0.08315862387413504,0.03810890763829494,1,bp,PCR,990,CDC6
GO:0006953,acute-phase response,1/17,46/16992,0.04505907988865965,0.08381233745594437,0.038408483429120635,1,bp,PCR,7124,TNF
GO:0007091,metaphase/anaphase transition of mitotic cell cycle,1/17,46/16992,0.04505907988865965,0.08381233745594437,0.038408483429120635,1,bp,PCR,990,CDC6
GO:0007129,synapsis,1/17,46/16992,0.04505907988865965,0.08381233745594437,0.038408483429120635,1,bp,PCR,898,CCNE1
GO:0010965,regulation of mitotic sister chromatid separation,1/17,46/16992,0.04505907988865965,0.08381233745594437,0.038408483429120635,1,bp,PCR,990,CDC6
GO:0030514,negative regulation of BMP signaling pathway,1/17,46/16992,0.04505907988865965,0.08381233745594437,0.038408483429120635,1,bp,PCR,6422,SFRP1
GO:0035850,epithelial cell differentiation involved in kidney development,1/17,46/16992,0.04505907988865965,0.08381233745594437,0.038408483429120635,1,bp,PCR,8842,PROM1
GO:0036293,response to decreased oxygen levels,2/17,340/16992,0.04454434557702962,0.08381233745594437,0.038408483429120635,2,bp,PCR,79723/6422,SUV39H2/SFRP1
GO:0045787,positive regulation of cell cycle,2/17,341/16992,0.04478106496857662,0.08381233745594437,0.038408483429120635,2,bp,PCR,1956/990,EGFR/CDC6
GO:0050999,regulation of nitric-oxide synthase activity,1/17,46/16992,0.04505907988865965,0.08381233745594437,0.038408483429120635,1,bp,PCR,1956,EGFR
GO:1900024,regulation of substrate adhesion-dependent cell spreading,1/17,46/16992,0.04505907988865965,0.08381233745594437,0.038408483429120635,1,bp,PCR,1946,EFNA5
GO:0006898,receptor-mediated endocytosis,2/17,343/16992,0.04525594975283165,0.0839504000157541,0.03847175303478485,2,bp,PCR,3576/7113,CXCL8/TMPRSS2
GO:0007015,actin filament organization,2/17,343/16992,0.04525594975283165,0.0839504000157541,0.03847175303478485,2,bp,PCR,4233/6422,MET/SFRP1
GO:0000060,"protein import into nucleus, translocation",1/17,47/16992,0.04601706381654158,0.08410862532022086,0.03854426257418141,1,bp,PCR,7124,TNF
GO:0035094,response to nicotine,1/17,47/16992,0.04601706381654158,0.08410862532022086,0.03854426257418141,1,bp,PCR,7124,TNF
GO:0042993,positive regulation of transcription factor import into nucleus,1/17,47/16992,0.04601706381654158,0.08410862532022086,0.03854426257418141,1,bp,PCR,7124,TNF
GO:0044784,metaphase/anaphase transition of cell cycle,1/17,47/16992,0.04601706381654158,0.08410862532022086,0.03854426257418141,1,bp,PCR,990,CDC6
GO:0045123,cellular extravasation,1/17,47/16992,0.04601706381654158,0.08410862532022086,0.03854426257418141,1,bp,PCR,7124,TNF
GO:0051205,protein insertion into membrane,1/17,47/16992,0.04601706381654158,0.08410862532022086,0.03854426257418141,1,bp,PCR,1956,EGFR
GO:0060042,retina morphogenesis in camera-type eye,1/17,47/16992,0.04601706381654158,0.08410862532022086,0.03854426257418141,1,bp,PCR,8842,PROM1
GO:0070830,bicellular tight junction assembly,1/17,47/16992,0.04601706381654158,0.08410862532022086,0.03854426257418141,1,bp,PCR,7124,TNF
GO:0072577,endothelial cell apoptotic process,1/17,47/16992,0.04601706381654158,0.08410862532022086,0.03854426257418141,1,bp,PCR,7124,TNF
GO:1905818,regulation of chromosome separation,1/17,47/16992,0.04601706381654158,0.08410862532022086,0.03854426257418141,1,bp,PCR,990,CDC6
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,1/17,47/16992,0.04601706381654158,0.08410862532022086,0.03854426257418141,1,bp,PCR,7124,TNF
GO:0007159,leukocyte cell-cell adhesion,2/17,349/16992,0.04669209496556746,0.08495059712233337,0.03893011101834661,2,bp,PCR,2064/7124,ERBB2/TNF
GO:0045661,regulation of myoblast differentiation,1/17,48/16992,0.04697414318597981,0.08495059712233337,0.03893011101834661,1,bp,PCR,7124,TNF
GO:0046513,ceramide biosynthetic process,1/17,48/16992,0.04697414318597981,0.08495059712233337,0.03893011101834661,1,bp,PCR,7124,TNF
GO:0050710,negative regulation of cytokine secretion,1/17,48/16992,0.04697414318597981,0.08495059712233337,0.03893011101834661,1,bp,PCR,7124,TNF
GO:0051306,mitotic sister chromatid separation,1/17,48/16992,0.04697414318597981,0.08495059712233337,0.03893011101834661,1,bp,PCR,990,CDC6
GO:0051353,positive regulation of oxidoreductase activity,1/17,48/16992,0.04697414318597981,0.08495059712233337,0.03893011101834661,1,bp,PCR,7124,TNF
GO:0061383,trabecula morphogenesis,1/17,48/16992,0.04697414318597981,0.08495059712233337,0.03893011101834661,1,bp,PCR,6422,SFRP1
GO:0071622,regulation of granulocyte chemotaxis,1/17,48/16992,0.04697414318597981,0.08495059712233337,0.03893011101834661,1,bp,PCR,3576,CXCL8
GO:0042805,actinin binding,1/17,40/16982,0.039314849759714776,0.08568621101476297,0.04244518192681757,1,mf,PCR,8842,PROM1
GO:0001891,phagocytic cup,1/17,19/18122,0.01768266513498673,0.0863330121296411,0.05474509329717254,1,cc,PCR,7124,TNF
GO:0030132,clathrin coat of coated pit,1/17,18/18122,0.016759383513230475,0.0863330121296411,0.05474509329717254,1,cc,PCR,1956,EGFR
GO:0034113,heterotypic cell-cell adhesion,1/17,49/16992,0.047930318797750227,0.08645139187631103,0.039617876712376585,1,bp,PCR,7124,TNF
GO:0070265,necrotic cell death,1/17,49/16992,0.047930318797750227,0.08645139187631103,0.039617876712376585,1,bp,PCR,7124,TNF
GO:0070482,response to oxygen levels,2/17,355/16992,0.0481452973574418,0.08672488431886556,0.0397432094529575,2,bp,PCR,79723/6422,SUV39H2/SFRP1
GO:0005044,scavenger receptor activity,1/17,46/16982,0.04508505344872449,0.08709612598049049,0.04314359181696124,1,mf,PCR,7113,TMPRSS2
GO:0018024,histone-lysine N-methyltransferase activity,1/17,45/16982,0.04412562353788729,0.08709612598049049,0.04314359181696124,1,mf,PCR,79723,SUV39H2
GO:0032813,tumor necrosis factor receptor superfamily binding,1/17,45/16982,0.04412562353788729,0.08709612598049049,0.04314359181696124,1,mf,PCR,7124,TNF
GO:0050681,androgen receptor binding,1/17,42/16982,0.04124188733578038,0.08709612598049049,0.04314359181696124,1,mf,PCR,898,CCNE1
GO:0070063,RNA polymerase binding,1/17,46/16982,0.04508505344872449,0.08709612598049049,0.04314359181696124,1,mf,PCR,2064,ERBB2
GO:0002763,positive regulation of myeloid leukocyte differentiation,1/17,50/16992,0.048885591451969135,0.0873686353756472,0.04003821974079099,1,bp,PCR,7124,TNF
GO:0002920,regulation of humoral immune response,1/17,50/16992,0.048885591451969135,0.0873686353756472,0.04003821974079099,1,bp,PCR,7124,TNF
GO:0010518,positive regulation of phospholipase activity,1/17,50/16992,0.048885591451969135,0.0873686353756472,0.04003821974079099,1,bp,PCR,1956,EGFR
GO:0031663,lipopolysaccharide-mediated signaling pathway,1/17,50/16992,0.048885591451969135,0.0873686353756472,0.04003821974079099,1,bp,PCR,7124,TNF
GO:0032722,positive regulation of chemokine production,1/17,50/16992,0.048885591451969135,0.0873686353756472,0.04003821974079099,1,bp,PCR,7124,TNF
GO:0061178,regulation of insulin secretion involved in cellular response to glucose stimulus,1/17,50/16992,0.048885591451969135,0.0873686353756472,0.04003821974079099,1,bp,PCR,1946,EFNA5
GO:0034504,protein localization to nucleus,2/17,359/16992,0.04912346212765715,0.08767929550555754,0.04018058523033508,2,bp,PCR,1956/7124,EGFR/TNF
GO:0010812,negative regulation of cell-substrate adhesion,1/17,51/16992,0.04983996194809237,0.08830661615996808,0.04046806599618698,1,bp,PCR,1946,EFNA5
GO:0030900,forebrain development,2/17,361/16992,0.04961532818630208,0.08830661615996808,0.04046806599618698,2,bp,PCR,1956/3400,EGFR/ID4
GO:0042130,negative regulation of T cell proliferation,1/17,51/16992,0.04983996194809237,0.08830661615996808,0.04046806599618698,1,bp,PCR,2064,ERBB2
GO:0045071,negative regulation of viral genome replication,1/17,51/16992,0.04983996194809237,0.08830661615996808,0.04046806599618698,1,bp,PCR,7124,TNF
GO:0045453,bone resorption,1/17,51/16992,0.04983996194809237,0.08830661615996808,0.04046806599618698,1,bp,PCR,1956,EGFR
GO:0051047,positive regulation of secretion,2/17,362/16992,0.04986195346359045,0.08830661615996808,0.04046806599618698,2,bp,PCR,1956/7124,EGFR/TNF
GO:0008009,chemokine activity,1/17,48/16982,0.047001194857619666,0.08878003473105936,0.04397772618256811,1,mf,PCR,3576,CXCL8
GO:0000186,activation of MAPKK activity,1/17,52/16992,0.0507934310849133,0.08892098101693902,0.04074960953911472,1,bp,PCR,1956,EGFR
GO:0002637,regulation of immunoglobulin production,1/17,52/16992,0.0507934310849133,0.08892098101693902,0.04074960953911472,1,bp,PCR,7124,TNF
GO:0032233,positive regulation of actin filament bundle assembly,1/17,52/16992,0.0507934310849133,0.08892098101693902,0.04074960953911472,1,bp,PCR,6422,SFRP1
GO:0038083,peptidyl-tyrosine autophosphorylation,1/17,52/16992,0.0507934310849133,0.08892098101693902,0.04074960953911472,1,bp,PCR,1956,EGFR
GO:0050810,regulation of steroid biosynthetic process,1/17,52/16992,0.0507934310849133,0.08892098101693902,0.04074960953911472,1,bp,PCR,7124,TNF
GO:0060425,lung morphogenesis,1/17,52/16992,0.0507934310849133,0.08892098101693902,0.04074960953911472,1,bp,PCR,7124,TNF
GO:0071359,cellular response to dsRNA,1/17,52/16992,0.0507934310849133,0.08892098101693902,0.04074960953911472,1,bp,PCR,1956,EGFR
GO:0071398,cellular response to fatty acid,1/17,52/16992,0.0507934310849133,0.08892098101693902,0.04074960953911472,1,bp,PCR,6422,SFRP1
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,1/17,52/16992,0.0507934310849133,0.08892098101693902,0.04074960953911472,1,bp,PCR,6422,SFRP1
GO:0006383,transcription from RNA polymerase III promoter,1/17,53/16992,0.05174599966056548,0.09012757447240985,0.04130255229368826,1,bp,PCR,2064,ERBB2
GO:0007405,neuroblast proliferation,1/17,53/16992,0.05174599966056548,0.09012757447240985,0.04130255229368826,1,bp,PCR,3400,ID4
GO:0033047,regulation of mitotic sister chromatid segregation,1/17,53/16992,0.05174599966056548,0.09012757447240985,0.04130255229368826,1,bp,PCR,990,CDC6
GO:0034394,protein localization to cell surface,1/17,53/16992,0.05174599966056548,0.09012757447240985,0.04130255229368826,1,bp,PCR,7124,TNF
GO:2001233,regulation of apoptotic signaling pathway,2/17,371/16992,0.052102160649605066,0.09063260219734351,0.04153399016540442,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,1/17,54/16992,0.05269766847252422,0.09143613198844823,0.04190222187929349,1,bp,PCR,7124,TNF
GO:0031110,regulation of microtubule polymerization or depolymerization,1/17,54/16992,0.05269766847252422,0.09143613198844823,0.04190222187929349,1,bp,PCR,4233,MET
GO:0030858,positive regulation of epithelial cell differentiation,1/17,55/16992,0.05364843831760502,0.09215145803864651,0.04223003267158765,1,bp,PCR,8842,PROM1
GO:0043254,regulation of protein complex assembly,2/17,377/16992,0.0536159629824875,0.09215145803864651,0.04223003267158765,2,bp,PCR,4233/7124,MET/TNF
GO:0045600,positive regulation of fat cell differentiation,1/17,55/16992,0.05364843831760502,0.09215145803864651,0.04223003267158765,1,bp,PCR,6422,SFRP1
GO:0045740,positive regulation of DNA replication,1/17,55/16992,0.05364843831760502,0.09215145803864651,0.04223003267158765,1,bp,PCR,1956,EGFR
GO:0046530,photoreceptor cell differentiation,1/17,55/16992,0.05364843831760502,0.09215145803864651,0.04223003267158765,1,bp,PCR,8842,PROM1
GO:0046686,response to cadmium ion,1/17,55/16992,0.05364843831760502,0.09215145803864651,0.04223003267158765,1,bp,PCR,1956,EGFR
GO:0090183,regulation of kidney development,1/17,55/16992,0.05364843831760502,0.09215145803864651,0.04223003267158765,1,bp,PCR,8842,PROM1
GO:0097306,cellular response to alcohol,1/17,55/16992,0.05364843831760502,0.09215145803864651,0.04223003267158765,1,bp,PCR,6422,SFRP1
GO:0009897,external side of plasma membrane,2/17,258/18122,0.023853791727718322,0.09224637864185747,0.05849485012165978,2,cc,PCR,1946/7124,EFNA5/TNF
GO:0009925,basal plasma membrane,1/17,30/18122,0.027785053807788396,0.09224637864185747,0.05849485012165978,1,cc,PCR,4233,MET
GO:0030125,clathrin vesicle coat,1/17,24/18122,0.022286846380260128,0.09224637864185747,0.05849485012165978,1,cc,PCR,1956,EGFR
GO:0030131,clathrin adaptor complex,1/17,30/18122,0.027785053807788396,0.09224637864185747,0.05849485012165978,1,cc,PCR,1956,EGFR
GO:0031233,intrinsic component of external side of plasma membrane,1/17,29/18122,0.026870711360052812,0.09224637864185747,0.05849485012165978,1,cc,PCR,1946,EFNA5
GO:0031362,anchored component of external side of plasma membrane,1/17,24/18122,0.022286846380260128,0.09224637864185747,0.05849485012165978,1,cc,PCR,1946,EFNA5
GO:0031528,microvillus membrane,1/17,22/18122,0.02044761655270899,0.09224637864185747,0.05849485012165978,1,cc,PCR,8842,PROM1
GO:0051233,spindle midzone,1/17,28/18122,0.025955559625424285,0.09224637864185747,0.05849485012165978,1,cc,PCR,990,CDC6
GO:0022029,telencephalon cell migration,1/17,56/16992,0.0545983099919628,0.09296652534701129,0.04260355165646744,1,bp,PCR,1956,EGFR
GO:0033619,membrane protein proteolysis,1/17,56/16992,0.0545983099919628,0.09296652534701129,0.04260355165646744,1,bp,PCR,7124,TNF
GO:0043297,apical junction assembly,1/17,56/16992,0.0545983099919628,0.09296652534701129,0.04260355165646744,1,bp,PCR,7124,TNF
GO:0045685,regulation of glial cell differentiation,1/17,56/16992,0.0545983099919628,0.09296652534701129,0.04260355165646744,1,bp,PCR,3400,ID4
GO:0050994,regulation of lipid catabolic process,1/17,56/16992,0.0545983099919628,0.09296652534701129,0.04260355165646744,1,bp,PCR,7124,TNF
GO:0061005,cell differentiation involved in kidney development,1/17,56/16992,0.0545983099919628,0.09296652534701129,0.04260355165646744,1,bp,PCR,8842,PROM1
GO:0097755,positive regulation of blood vessel diameter,1/17,56/16992,0.0545983099919628,0.09296652534701129,0.04260355165646744,1,bp,PCR,1956,EGFR
GO:0042176,regulation of protein catabolic process,2/17,382/16992,0.05488970062843353,0.09334658405009379,0.042777720267468296,2,bp,PCR,1956/7124,EGFR/TNF
GO:0003407,neural retina development,1/17,57/16992,0.05554728429109668,0.09388176814137204,0.043022977826502426,1,bp,PCR,8842,PROM1
GO:0035773,insulin secretion involved in cellular response to glucose stimulus,1/17,57/16992,0.05554728429109668,0.09388176814137204,0.043022977826502426,1,bp,PCR,1946,EFNA5
GO:0045669,positive regulation of osteoblast differentiation,1/17,57/16992,0.05554728429109668,0.09388176814137204,0.043022977826502426,1,bp,PCR,3400,ID4
GO:0046785,microtubule polymerization,1/17,57/16992,0.05554728429109668,0.09388176814137204,0.043022977826502426,1,bp,PCR,4233,MET
GO:1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,1/17,57/16992,0.05554728429109668,0.09388176814137204,0.043022977826502426,1,bp,PCR,6422,SFRP1
GO:0019229,regulation of vasoconstriction,1/17,58/16992,0.05649536200984817,0.09501492701656283,0.0435422678881023,1,bp,PCR,1956,EGFR
GO:0051966,"regulation of synaptic transmission, glutamatergic",1/17,58/16992,0.05649536200984817,0.09501492701656283,0.0435422678881023,1,bp,PCR,1956,EGFR
GO:0071385,cellular response to glucocorticoid stimulus,1/17,58/16992,0.05649536200984817,0.09501492701656283,0.0435422678881023,1,bp,PCR,1956,EGFR
GO:1903201,regulation of oxidative stress-induced cell death,1/17,58/16992,0.05649536200984817,0.09501492701656283,0.0435422678881023,1,bp,PCR,4233,MET
GO:0030545,receptor regulator activity,1/17,53/16982,0.051775728391361686,0.09567254159273356,0.04739197106760796,1,mf,PCR,1946,EFNA5
GO:0016278,lysine N-methyltransferase activity,1/17,58/16982,0.0565277419107163,0.09609716124821771,0.04760230897744531,1,mf,PCR,79723,SUV39H2
GO:0016279,protein-lysine N-methyltransferase activity,1/17,57/16982,0.05557913602075171,0.09609716124821771,0.04760230897744531,1,mf,PCR,79723,SUV39H2
GO:0042054,histone methyltransferase activity,1/17,58/16982,0.0565277419107163,0.09609716124821771,0.04760230897744531,1,mf,PCR,79723,SUV39H2
GO:0042379,chemokine receptor binding,1/17,58/16982,0.0565277419107163,0.09609716124821771,0.04760230897744531,1,mf,PCR,3576,CXCL8
GO:0021885,forebrain cell migration,1/17,59/16992,0.057442543942400226,0.09625317338695949,0.044109716149804204,1,bp,PCR,1956,EGFR
GO:1901992,positive regulation of mitotic cell cycle phase transition,1/17,59/16992,0.057442543942400226,0.09625317338695949,0.044109716149804204,1,bp,PCR,990,CDC6
GO:1902117,positive regulation of organelle assembly,1/17,59/16992,0.057442543942400226,0.09625317338695949,0.044109716149804204,1,bp,PCR,7124,TNF
GO:0010517,regulation of phospholipase activity,1/17,60/16992,0.05838883088227931,0.09689007209435196,0.044401586227545094,1,bp,PCR,1956,EGFR
GO:0032677,regulation of interleukin-8 production,1/17,60/16992,0.05838883088227931,0.09689007209435196,0.044401586227545094,1,bp,PCR,7124,TNF
GO:0035195,gene silencing by miRNA,1/17,60/16992,0.05838883088227931,0.09689007209435196,0.044401586227545094,1,bp,PCR,1956,EGFR
GO:0042108,positive regulation of cytokine biosynthetic process,1/17,60/16992,0.05838883088227931,0.09689007209435196,0.044401586227545094,1,bp,PCR,7124,TNF
GO:0043242,negative regulation of protein complex disassembly,1/17,60/16992,0.05838883088227931,0.09689007209435196,0.044401586227545094,1,bp,PCR,7124,TNF
GO:0045143,homologous chromosome segregation,1/17,60/16992,0.05838883088227931,0.09689007209435196,0.044401586227545094,1,bp,PCR,898,CCNE1
GO:0051148,negative regulation of muscle cell differentiation,1/17,60/16992,0.05838883088227931,0.09689007209435196,0.044401586227545094,1,bp,PCR,7124,TNF
GO:0060135,maternal process involved in female pregnancy,1/17,60/16992,0.05838883088227931,0.09689007209435196,0.044401586227545094,1,bp,PCR,4316,MMP7
GO:0006360,transcription from RNA polymerase I promoter,1/17,61/16992,0.059334223622357296,0.09833965150000865,0.04506588158394921,1,bp,PCR,2064,ERBB2
GO:0010507,negative regulation of autophagy,1/17,62/16992,0.06027872295484893,0.09930393709408927,0.04550778248285511,1,bp,PCR,4233,MET
GO:0010975,regulation of neuron projection development,2/17,402/16992,0.060093261378565126,0.09930393709408927,0.04550778248285511,2,bp,PCR,1946/6422,EFNA5/SFRP1
GO:0046889,positive regulation of lipid biosynthetic process,1/17,62/16992,0.06027872295484893,0.09930393709408927,0.04550778248285511,1,bp,PCR,7124,TNF
GO:0051965,positive regulation of synapse assembly,1/17,62/16992,0.06027872295484893,0.09930393709408927,0.04550778248285511,1,bp,PCR,1946,EFNA5
GO:0071384,cellular response to corticosteroid stimulus,1/17,62/16992,0.06027872295484893,0.09930393709408927,0.04550778248285511,1,bp,PCR,1956,EGFR
GO:0002718,regulation of cytokine production involved in immune response,1/17,63/16992,0.061222329671315134,0.09989674531588846,0.04577944731711163,1,bp,PCR,7124,TNF
GO:0019915,lipid storage,1/17,63/16992,0.061222329671315134,0.09989674531588846,0.04577944731711163,1,bp,PCR,7124,TNF
GO:0032729,positive regulation of interferon-gamma production,1/17,63/16992,0.061222329671315134,0.09989674531588846,0.04577944731711163,1,bp,PCR,7124,TNF
GO:0032835,glomerulus development,1/17,63/16992,0.061222329671315134,0.09989674531588846,0.04577944731711163,1,bp,PCR,8842,PROM1
GO:0046324,regulation of glucose import,1/17,63/16992,0.061222329671315134,0.09989674531588846,0.04577944731711163,1,bp,PCR,7124,TNF
GO:0050891,multicellular organismal water homeostasis,1/17,63/16992,0.061222329671315134,0.09989674531588846,0.04577944731711163,1,bp,PCR,4233,MET
GO:0060193,positive regulation of lipase activity,1/17,63/16992,0.061222329671315134,0.09989674531588846,0.04577944731711163,1,bp,PCR,1956,EGFR
GO:1903524,positive regulation of blood circulation,1/17,63/16992,0.061222329671315134,0.09989674531588846,0.04577944731711163,1,bp,PCR,1956,EGFR
GO:0042493,response to drug,2/17,408/16992,0.06168740767112697,0.10053578702592003,0.046072299463648714,2,bp,PCR,1956/6422,EGFR/SFRP1
GO:0032945,negative regulation of mononuclear cell proliferation,1/17,64/16992,0.06216504456266059,0.10059568085848977,0.04609974686990881,1,bp,PCR,2064,ERBB2
GO:0033045,regulation of sister chromatid segregation,1/17,64/16992,0.06216504456266059,0.10059568085848977,0.04609974686990881,1,bp,PCR,990,CDC6
GO:0035194,posttranscriptional gene silencing by RNA,1/17,64/16992,0.06216504456266059,0.10059568085848977,0.04609974686990881,1,bp,PCR,1956,EGFR
GO:0046888,negative regulation of hormone secretion,1/17,64/16992,0.06216504456266059,0.10059568085848977,0.04609974686990881,1,bp,PCR,6422,SFRP1
GO:0050672,negative regulation of lymphocyte proliferation,1/17,64/16992,0.06216504456266059,0.10059568085848977,0.04609974686990881,1,bp,PCR,2064,ERBB2
GO:0060968,regulation of gene silencing,1/17,64/16992,0.06216504456266059,0.10059568085848977,0.04609974686990881,1,bp,PCR,1956,EGFR
GO:0016441,posttranscriptional gene silencing,1/17,65/16992,0.06310686841913715,0.10163917984211619,0.046577948703165,1,bp,PCR,1956,EGFR
GO:0035304,regulation of protein dephosphorylation,1/17,65/16992,0.06310686841913715,0.10163917984211619,0.046577948703165,1,bp,PCR,7124,TNF
GO:0050764,regulation of phagocytosis,1/17,65/16992,0.06310686841913715,0.10163917984211619,0.046577948703165,1,bp,PCR,7124,TNF
GO:0071479,cellular response to ionizing radiation,1/17,65/16992,0.06310686841913715,0.10163917984211619,0.046577948703165,1,bp,PCR,6422,SFRP1
GO:0001756,somitogenesis,1/17,66/16992,0.06404780203034244,0.1018367491051554,0.04666848830623399,1,bp,PCR,6422,SFRP1
GO:0006687,glycosphingolipid metabolic process,1/17,66/16992,0.06404780203034244,0.1018367491051554,0.04666848830623399,1,bp,PCR,3696,ITGB8
GO:0008589,regulation of smoothened signaling pathway,1/17,66/16992,0.06404780203034244,0.1018367491051554,0.04666848830623399,1,bp,PCR,6422,SFRP1
GO:0014033,neural crest cell differentiation,1/17,66/16992,0.06404780203034244,0.1018367491051554,0.04666848830623399,1,bp,PCR,6422,SFRP1
GO:0032465,regulation of cytokinesis,1/17,66/16992,0.06404780203034244,0.1018367491051554,0.04666848830623399,1,bp,PCR,990,CDC6
GO:0032637,interleukin-8 production,1/17,66/16992,0.06404780203034244,0.1018367491051554,0.04666848830623399,1,bp,PCR,7124,TNF
GO:0032755,positive regulation of interleukin-6 production,1/17,66/16992,0.06404780203034244,0.1018367491051554,0.04666848830623399,1,bp,PCR,7124,TNF
GO:0035690,cellular response to drug,1/17,66/16992,0.06404780203034244,0.1018367491051554,0.04666848830623399,1,bp,PCR,1956,EGFR
GO:0043507,positive regulation of JUN kinase activity,1/17,66/16992,0.06404780203034244,0.1018367491051554,0.04666848830623399,1,bp,PCR,7124,TNF
GO:0050830,defense response to Gram-positive bacterium,1/17,66/16992,0.06404780203034244,0.1018367491051554,0.04666848830623399,1,bp,PCR,7124,TNF
GO:1901989,positive regulation of cell cycle phase transition,1/17,66/16992,0.06404780203034244,0.1018367491051554,0.04666848830623399,1,bp,PCR,990,CDC6
hsa04072,Phospholipase D signaling pathway,2/17,146/7430,0.043005992533047495,0.10235426222865303,0.06156647352099431,2,kg,PCR,1956/3576,EGFR/CXCL8
GO:0030104,water homeostasis,1/17,67/16992,0.06498784618522169,0.1027348284383008,0.047080049017129116,1,bp,PCR,4233,MET
GO:0031349,positive regulation of defense response,2/17,420/16992,0.06492014869985087,0.1027348284383008,0.047080049017129116,2,bp,PCR,1956/7124,EGFR/TNF
GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,1/17,67/16992,0.06498784618522169,0.1027348284383008,0.047080049017129116,1,bp,PCR,6422,SFRP1
GO:0070192,chromosome organization involved in meiotic cell cycle,1/17,67/16992,0.06498784618522169,0.1027348284383008,0.047080049017129116,1,bp,PCR,898,CCNE1
GO:0070664,negative regulation of leukocyte proliferation,1/17,67/16992,0.06498784618522169,0.1027348284383008,0.047080049017129116,1,bp,PCR,2064,ERBB2
GO:0007409,axonogenesis,2/17,422/16992,0.06546460972185217,0.10336914730013334,0.04737073683509244,2,bp,PCR,2064/1946,ERBB2/EFNA5
GO:0030574,collagen catabolic process,1/17,68/16992,0.06592700167206678,0.10350236845075622,0.04743178777951689,1,bp,PCR,4316,MMP7
GO:0032642,regulation of chemokine production,1/17,68/16992,0.06592700167206678,0.10350236845075622,0.04743178777951689,1,bp,PCR,7124,TNF
GO:0033077,T cell differentiation in thymus,1/17,68/16992,0.06592700167206678,0.10350236845075622,0.04743178777951689,1,bp,PCR,2064,ERBB2
GO:0051304,chromosome separation,1/17,68/16992,0.06592700167206678,0.10350236845075622,0.04743178777951689,1,bp,PCR,990,CDC6
GO:1903076,regulation of protein localization to plasma membrane,1/17,68/16992,0.06592700167206678,0.10350236845075622,0.04743178777951689,1,bp,PCR,1956,EGFR
GO:0042562,hormone binding,1/17,64/16982,0.06220057193776407,0.10366761989627346,0.051352381372767035,1,mf,PCR,1956,EGFR
hsa04932,Non-alcoholic fatty liver disease (NAFLD),2/17,149/7430,0.04461902563933083,0.10411105982510528,0.06262319387976258,2,kg,PCR,3576/7124,CXCL8/TNF
GO:0030295,protein kinase activator activity,1/17,67/16982,0.06502493350383765,0.10428527071370189,0.0516583384340319,1,mf,PCR,1946,EFNA5
GO:0038024,cargo receptor activity,1/17,66/16982,0.06408437038587533,0.10428527071370189,0.0516583384340319,1,mf,PCR,7113,TMPRSS2
GO:0001707,mesoderm formation,1/17,69/16992,0.06686526927851788,0.10449606580170204,0.0478871671353,1,bp,PCR,3691,ITGB4
GO:0038034,signal transduction in absence of ligand,1/17,69/16992,0.06686526927851788,0.10449606580170204,0.0478871671353,1,bp,PCR,7124,TNF
GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,1/17,69/16992,0.06686526927851788,0.10449606580170204,0.0478871671353,1,bp,PCR,7124,TNF
GO:1904375,regulation of protein localization to cell periphery,1/17,69/16992,0.06686526927851788,0.10449606580170204,0.0478871671353,1,bp,PCR,1956,EGFR
GO:0001895,retina homeostasis,1/17,70/16992,0.06780264979156281,0.105599348765244,0.04839276603289795,1,bp,PCR,8842,PROM1
GO:0010923,negative regulation of phosphatase activity,1/17,70/16992,0.06780264979156281,0.105599348765244,0.04839276603289795,1,bp,PCR,7124,TNF
GO:0051249,regulation of lymphocyte activation,2/17,430/16992,0.06765837301835971,0.105599348765244,0.04839276603289795,2,bp,PCR,2064/6422,ERBB2/SFRP1
GO:0009314,response to radiation,2/17,432/16992,0.0682107553405432,0.10611423188773142,0.048628720314549935,2,bp,PCR,1956/6422,EGFR/SFRP1
GO:0002673,regulation of acute inflammatory response,1/17,71/16992,0.06873914399753966,0.1062120633551149,0.04867355331178999,1,bp,PCR,7124,TNF
GO:0006446,regulation of translational initiation,1/17,71/16992,0.06873914399753966,0.1062120633551149,0.04867355331178999,1,bp,PCR,7124,TNF
GO:0010595,positive regulation of endothelial cell migration,1/17,71/16992,0.06873914399753966,0.1062120633551149,0.04867355331178999,1,bp,PCR,4233,MET
GO:0043407,negative regulation of MAP kinase activity,1/17,71/16992,0.06873914399753966,0.1062120633551149,0.04867355331178999,1,bp,PCR,6422,SFRP1
GO:0045682,regulation of epidermis development,1/17,71/16992,0.06873914399753966,0.1062120633551149,0.04867355331178999,1,bp,PCR,7124,TNF
GO:0048332,mesoderm morphogenesis,1/17,71/16992,0.06873914399753966,0.1062120633551149,0.04867355331178999,1,bp,PCR,3691,ITGB4
GO:0007422,peripheral nervous system development,1/17,72/16992,0.06967475268213563,0.10741524371829243,0.0492249319565586,1,bp,PCR,2064,ERBB2
GO:0035019,somatic stem cell population maintenance,1/17,72/16992,0.06967475268213563,0.10741524371829243,0.0492249319565586,1,bp,PCR,6422,SFRP1
GO:0036473,cell death in response to oxidative stress,1/17,73/16992,0.0706094766303863,0.10861165562584141,0.04977320883703162,1,bp,PCR,4233,MET
GO:2001022,positive regulation of response to DNA damage stimulus,1/17,73/16992,0.0706094766303863,0.10861165562584141,0.04977320883703162,1,bp,PCR,1956,EGFR
GO:0000226,microtubule cytoskeleton organization,2/17,443/16992,0.07127656431711679,0.10931116122982626,0.05009376963052281,2,bp,PCR,4233/1946,MET/EFNA5
GO:0010717,regulation of epithelial to mesenchymal transition,1/17,74/16992,0.07154331662667957,0.10931116122982626,0.05009376963052281,1,bp,PCR,6422,SFRP1
GO:0042310,vasoconstriction,1/17,74/16992,0.07154331662667957,0.10931116122982626,0.05009376963052281,1,bp,PCR,1956,EGFR
GO:0043627,response to estrogen,1/17,74/16992,0.07154331662667957,0.10931116122982626,0.05009376963052281,1,bp,PCR,6422,SFRP1
GO:0048640,negative regulation of developmental growth,1/17,74/16992,0.07154331662667957,0.10931116122982626,0.05009376963052281,1,bp,PCR,6422,SFRP1
GO:0050772,positive regulation of axonogenesis,1/17,74/16992,0.07154331662667957,0.10931116122982626,0.05009376963052281,1,bp,PCR,1946,EFNA5
GO:0008544,epidermis development,2/17,445/16992,0.07183896035603934,0.10964050917214922,0.05024469914005685,2,bp,PCR,1956/7124,EGFR/TNF
GO:0002708,positive regulation of lymphocyte mediated immunity,1/17,75/16992,0.07247627345475305,0.11024446484395213,0.050521472490096864,1,bp,PCR,7124,TNF
GO:0032602,chemokine production,1/17,75/16992,0.07247627345475305,0.11024446484395213,0.050521472490096864,1,bp,PCR,7124,TNF
GO:0035249,"synaptic transmission, glutamatergic",1/17,75/16992,0.07247627345475305,0.11024446484395213,0.050521472490096864,1,bp,PCR,1956,EGFR
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/17,76/16992,0.07340834789769568,0.11080047218516581,0.050776272671069024,1,bp,PCR,7124,TNF
GO:0006914,autophagy,2/17,449/16992,0.0729682821966219,0.11080047218516581,0.050776272671069024,2,bp,PCR,3691/4233,ITGB4/MET
GO:0010771,negative regulation of cell morphogenesis involved in differentiation,1/17,76/16992,0.07340834789769568,0.11080047218516581,0.050776272671069024,1,bp,PCR,1946,EFNA5
GO:0019218,regulation of steroid metabolic process,1/17,76/16992,0.07340834789769568,0.11080047218516581,0.050776272671069024,1,bp,PCR,7124,TNF
GO:0021766,hippocampus development,1/17,76/16992,0.07340834789769568,0.11080047218516581,0.050776272671069024,1,bp,PCR,3400,ID4
GO:0044243,multicellular organismal catabolic process,1/17,76/16992,0.07340834789769568,0.11080047218516581,0.050776272671069024,1,bp,PCR,4316,MMP7
GO:0046323,glucose import,1/17,76/16992,0.07340834789769568,0.11080047218516581,0.050776272671069024,1,bp,PCR,7124,TNF
GO:0090066,regulation of anatomical structure size,2/17,451/16992,0.07353519311382871,0.11086969093924173,0.05080799338725007,2,bp,PCR,1956/1946,EGFR/EFNA5
GO:0051051,negative regulation of transport,2/17,453/16992,0.07410359414026366,0.11160376279210225,0.05114439477458994,2,bp,PCR,6422/7124,SFRP1/TNF
GO:0031100,animal organ regeneration,1/17,77/16992,0.07433954073795024,0.1116640928754618,0.0511720421004769,1,bp,PCR,1956,EGFR
GO:0045833,negative regulation of lipid metabolic process,1/17,77/16992,0.07433954073795024,0.1116640928754618,0.0511720421004769,1,bp,PCR,7124,TNF
GO:0050900,leukocyte migration,2/17,454/16992,0.07438835113398186,0.1116640928754618,0.0511720421004769,2,bp,PCR,3576/7124,CXCL8/TNF
GO:0005771,multivesicular body,1/17,38/18122,0.035070739469735934,0.11195659138415703,0.07099339973630757,1,cc,PCR,1956,EGFR
GO:0002367,cytokine production involved in immune response,1/17,78/16992,0.0752698527573088,0.11249391749427483,0.051552323883424546,1,bp,PCR,7124,TNF
GO:0070542,response to fatty acid,1/17,78/16992,0.0752698527573088,0.11249391749427483,0.051552323883424546,1,bp,PCR,6422,SFRP1
GO:0071674,mononuclear cell migration,1/17,78/16992,0.0752698527573088,0.11249391749427483,0.051552323883424546,1,bp,PCR,7124,TNF
GO:1903729,regulation of plasma membrane organization,1/17,78/16992,0.0752698527573088,0.11249391749427483,0.051552323883424546,1,bp,PCR,1956,EGFR
GO:0019209,kinase activator activity,1/17,74/16982,0.07158400830794942,0.11267853159584632,0.05581599088339137,1,mf,PCR,1946,EFNA5
GO:0061564,axon development,2/17,458/16992,0.0755310674816521,0.11276121197642501,0.051674816299219016,2,bp,PCR,2064/1946,ERBB2/EFNA5
GO:0000307,cyclin-dependent protein kinase holoenzyme complex,1/17,40/18122,0.03688411486408871,0.1133845012488653,0.07189885938418852,1,cc,PCR,898,CCNE1
GO:0035305,negative regulation of dephosphorylation,1/17,79/16992,0.07619928473691906,0.11338784870091542,0.05196198364210956,1,bp,PCR,7124,TNF
GO:0045445,myoblast differentiation,1/17,79/16992,0.07619928473691906,0.11338784870091542,0.05196198364210956,1,bp,PCR,7124,TNF
GO:0060191,regulation of lipase activity,1/17,79/16992,0.07619928473691906,0.11338784870091542,0.05196198364210956,1,bp,PCR,1956,EGFR
GO:0050839,cell adhesion molecule binding,2/17,451/16982,0.07361053592824422,0.11376173734365017,0.05635256339004342,2,mf,PCR,8842/1956,PROM1/EGFR
GO:0002821,positive regulation of adaptive immune response,1/17,80/16992,0.07712783745728058,0.1142727375314038,0.0523674995722707,1,bp,PCR,7124,TNF
GO:0042058,regulation of epidermal growth factor receptor signaling pathway,1/17,80/16992,0.07712783745728058,0.1142727375314038,0.0523674995722707,1,bp,PCR,1956,EGFR
GO:0045639,positive regulation of myeloid cell differentiation,1/17,80/16992,0.07712783745728058,0.1142727375314038,0.0523674995722707,1,bp,PCR,7124,TNF
GO:0097756,negative regulation of blood vessel diameter,1/17,80/16992,0.07712783745728058,0.1142727375314038,0.0523674995722707,1,bp,PCR,1956,EGFR
GO:0006913,nucleocytoplasmic transport,2/17,464/16992,0.07725610623288415,0.11433903722466854,0.0523978825772961,2,bp,PCR,1956/7124,EGFR/TNF
GO:0051963,regulation of synapse assembly,1/17,81/16992,0.07805551169824732,0.11527291857055079,0.05282585019264793,1,bp,PCR,1946,EFNA5
GO:0070098,chemokine-mediated signaling pathway,1/17,81/16992,0.07805551169824732,0.11527291857055079,0.05282585019264793,1,bp,PCR,3576,CXCL8
GO:0030118,clathrin coat,1/17,48/18122,0.04410559221135901,0.11545295480279118,0.07321049765554291,1,cc,PCR,1956,EGFR
GO:0030119,AP-type membrane coat adaptor complex,1/17,43/18122,0.03959816510766212,0.11545295480279118,0.07321049765554291,1,cc,PCR,1956,EGFR
GO:0030120,vesicle coat,1/17,49/18122,0.04500468510349198,0.11545295480279118,0.07321049765554291,1,cc,PCR,1956,EGFR
GO:0030669,clathrin-coated endocytic vesicle membrane,1/17,50/18122,0.04590298203002541,0.11545295480279118,0.07321049765554291,1,cc,PCR,1956,EGFR
GO:0045178,basal part of cell,1/17,48/18122,0.04410559221135901,0.11545295480279118,0.07321049765554291,1,cc,PCR,4233,MET
GO:0046658,anchored component of plasma membrane,1/17,49/18122,0.04500468510349198,0.11545295480279118,0.07321049765554291,1,cc,PCR,1946,EFNA5
GO:1902532,negative regulation of intracellular signal transduction,2/17,468/16992,0.07841335639512759,0.11567660011307075,0.05301084438690567,2,bp,PCR,4233/6422,MET/SFRP1
GO:0008013,beta-catenin binding,1/17,79/16982,0.07624252073386761,0.11572525468533476,0.057325203559298966,1,mf,PCR,83439,TCF7L1
GO:0006919,activation of cysteine-type endopeptidase activity involved in apoptotic process,1/17,82/16992,0.07898230823902697,0.11576743038461233,0.05305246896253812,1,bp,PCR,7124,TNF
GO:0030510,regulation of BMP signaling pathway,1/17,82/16992,0.07898230823902697,0.11576743038461233,0.05305246896253812,1,bp,PCR,6422,SFRP1
GO:0034446,substrate adhesion-dependent cell spreading,1/17,82/16992,0.07898230823902697,0.11576743038461233,0.05305246896253812,1,bp,PCR,1946,EFNA5
GO:0042475,odontogenesis of dentin-containing tooth,1/17,82/16992,0.07898230823902697,0.11576743038461233,0.05305246896253812,1,bp,PCR,3691,ITGB4
GO:0045778,positive regulation of ossification,1/17,82/16992,0.07898230823902697,0.11576743038461233,0.05305246896253812,1,bp,PCR,3400,ID4
GO:0070301,cellular response to hydrogen peroxide,1/17,82/16992,0.07898230823902697,0.11576743038461233,0.05305246896253812,1,bp,PCR,4233,MET
hsa04218,Cellular senescence,2/17,160/7430,0.05072564462509841,0.11608368673820597,0.06982477397786827,2,kg,PCR,898/3576,CCNE1/CXCL8
GO:0006282,regulation of DNA repair,1/17,83/16992,0.07990822785818319,0.11650092006161107,0.05338860355751043,1,bp,PCR,1956,EGFR
GO:0030148,sphingolipid biosynthetic process,1/17,83/16992,0.07990822785818319,0.11650092006161107,0.05338860355751043,1,bp,PCR,7124,TNF
GO:0031623,receptor internalization,1/17,83/16992,0.07990822785818319,0.11650092006161107,0.05338860355751043,1,bp,PCR,3576,CXCL8
GO:0051169,nuclear transport,2/17,472/16992,0.07957631831770265,0.11650092006161107,0.05338860355751043,2,bp,PCR,1956/7124,EGFR/TNF
GO:0051983,regulation of chromosome segregation,1/17,83/16992,0.07990822785818319,0.11650092006161107,0.05338860355751043,1,bp,PCR,990,CDC6
GO:0004197,cysteine-type endopeptidase activity,1/17,83/16982,0.07995348130025948,0.11656204343458079,0.05773971191805861,1,mf,PCR,6422,SFRP1
GO:0008170,N-methyltransferase activity,1/17,87/16982,0.0836504076412874,0.11656204343458079,0.05773971191805861,1,mf,PCR,79723,SUV39H2
GO:0008276,protein methyltransferase activity,1/17,84/16982,0.08087902664719693,0.11656204343458079,0.05773971191805861,1,mf,PCR,79723,SUV39H2
GO:0035258,steroid hormone receptor binding,1/17,86/16982,0.08272748904006111,0.11656204343458079,0.05773971191805861,1,mf,PCR,898,CCNE1
GO:0046982,protein heterodimerization activity,2/17,480/16982,0.08200228319258866,0.11656204343458079,0.05773971191805861,2,mf,PCR,2064/1956,ERBB2/EGFR
GO:0031109,microtubule polymerization or depolymerization,1/17,84/16992,0.08083327133363505,0.11747425526087726,0.05383465159777236,1,bp,PCR,4233,MET
GO:0043244,regulation of protein complex disassembly,1/17,84/16992,0.08083327133363505,0.11747425526087726,0.05383465159777236,1,bp,PCR,7124,TNF
GO:0051781,positive regulation of cell division,1/17,84/16992,0.08083327133363505,0.11747425526087726,0.05383465159777236,1,bp,PCR,990,CDC6
GO:0001843,neural tube closure,1/17,85/16992,0.08175743944265634,0.11831494143445723,0.05421991087996348,1,bp,PCR,6422,SFRP1
GO:0043331,response to dsRNA,1/17,85/16992,0.08175743944265634,0.11831494143445723,0.05421991087996348,1,bp,PCR,1956,EGFR
GO:0045638,negative regulation of myeloid cell differentiation,1/17,85/16992,0.08175743944265634,0.11831494143445723,0.05421991087996348,1,bp,PCR,6422,SFRP1
GO:0061053,somite development,1/17,85/16992,0.08175743944265634,0.11831494143445723,0.05421991087996348,1,bp,PCR,6422,SFRP1
GO:0002690,positive regulation of leukocyte chemotaxis,1/17,86/16992,0.08268073296187739,0.11927283817155969,0.05465888397235752,1,bp,PCR,3576,CXCL8
GO:0060606,tube closure,1/17,86/16992,0.08268073296187739,0.11927283817155969,0.05465888397235752,1,bp,PCR,6422,SFRP1
GO:0090277,positive regulation of peptide hormone secretion,1/17,86/16992,0.08268073296187739,0.11927283817155969,0.05465888397235752,1,bp,PCR,1956,EGFR
GO:0001501,skeletal system development,2/17,485/16992,0.08339469661194536,0.12009728856402431,0.05503670292119371,2,bp,PCR,6422/3696,SFRP1/ITGB8
GO:0045132,meiotic chromosome segregation,1/17,87/16992,0.08360315266728646,0.12009728856402431,0.05503670292119371,1,bp,PCR,898,CCNE1
GO:0048013,ephrin receptor signaling pathway,1/17,87/16992,0.08360315266728646,0.12009728856402431,0.05503670292119371,1,bp,PCR,1946,EFNA5
GO:1903901,negative regulation of viral life cycle,1/17,87/16992,0.08360315266728646,0.12009728856402431,0.05503670292119371,1,bp,PCR,7124,TNF
GO:0004702,"signal transducer, downstream of receptor, with serine/threonine kinase activity",1/17,92/16982,0.08825190574339903,0.12099051593853091,0.059933382508250616,1,mf,PCR,1956,EGFR
GO:0001892,embryonic placenta development,1/17,88/16992,0.08452469933422868,0.12112112082614883,0.05550589213208619,1,bp,PCR,1956,EGFR
GO:0002694,regulation of leukocyte activation,2/17,489/16992,0.08458129401738369,0.12112112082614883,0.05550589213208619,2,bp,PCR,2064/6422,ERBB2/SFRP1
GO:0030593,neutrophil chemotaxis,1/17,88/16992,0.08452469933422868,0.12112112082614883,0.05550589213208619,1,bp,PCR,3576,CXCL8
GO:0002705,positive regulation of leukocyte mediated immunity,1/17,89/16992,0.08544537373740668,0.12184866317344765,0.055839301258217525,1,bp,PCR,7124,TNF
GO:0009798,axis specification,1/17,89/16992,0.08544537373740668,0.12184866317344765,0.055839301258217525,1,bp,PCR,6422,SFRP1
GO:0042990,regulation of transcription factor import into nucleus,1/17,89/16992,0.08544537373740668,0.12184866317344765,0.055839301258217525,1,bp,PCR,7124,TNF
GO:1904019,epithelial cell apoptotic process,1/17,89/16992,0.08544537373740668,0.12184866317344765,0.055839301258217525,1,bp,PCR,7124,TNF
GO:0022617,extracellular matrix disassembly,1/17,90/16992,0.08636517665088128,0.12277666338012094,0.056264573737689505,1,bp,PCR,4316,MMP7
GO:0042991,transcription factor import into nucleus,1/17,90/16992,0.08636517665088128,0.12277666338012094,0.056264573737689505,1,bp,PCR,7124,TNF
GO:0061387,regulation of extent of cell growth,1/17,90/16992,0.08636517665088128,0.12277666338012094,0.056264573737689505,1,bp,PCR,1946,EFNA5
GO:0014020,primary neural tube formation,1/17,91/16992,0.08728410884807303,0.12382584975441656,0.05674538191813638,1,bp,PCR,6422,SFRP1
GO:0050868,negative regulation of T cell activation,1/17,91/16992,0.08728410884807303,0.12382584975441656,0.05674538191813638,1,bp,PCR,2064,ERBB2
GO:0007507,heart development,2/17,499/16992,0.08757134506069827,0.12410473228581359,0.056873184762096726,2,bp,PCR,2064/1956,ERBB2/EGFR
hsa04621,NOD-like receptor signaling pathway,2/17,168/7430,0.055349453713863295,0.12427518852735345,0.07475199309915996,2,kg,PCR,3576/7124,CXCL8/TNF
GO:0007043,cell-cell junction assembly,1/17,92/16992,0.08820217110176132,0.12435506924645855,0.05698790609425957,1,bp,PCR,7124,TNF
GO:0014013,regulation of gliogenesis,1/17,92/16992,0.08820217110176132,0.12435506924645855,0.05698790609425957,1,bp,PCR,3400,ID4
GO:0032649,regulation of interferon-gamma production,1/17,92/16992,0.08820217110176132,0.12435506924645855,0.05698790609425957,1,bp,PCR,7124,TNF
GO:0033138,positive regulation of peptidyl-serine phosphorylation,1/17,92/16992,0.08820217110176132,0.12435506924645855,0.05698790609425957,1,bp,PCR,7124,TNF
GO:0072080,nephron tubule development,1/17,92/16992,0.08820217110176132,0.12435506924645855,0.05698790609425957,1,bp,PCR,8842,PROM1
GO:0008585,female gonad development,1/17,93/16992,0.08911936418408506,0.12551893988478646,0.05752127036356367,1,bp,PCR,6422,SFRP1
GO:0008144,drug binding,1/17,98/16982,0.09374499683880644,0.1264813449412468,0.06265329780371358,1,mf,PCR,6422,SFRP1
GO:0061326,renal tubule development,1/17,94/16992,0.09003568886654378,0.12654913558346864,0.05799337573161147,1,bp,PCR,8842,PROM1
GO:0098869,cellular oxidant detoxification,1/17,94/16992,0.09003568886654378,0.12654913558346864,0.05799337573161147,1,bp,PCR,7124,TNF
GO:0009953,dorsal/ventral pattern formation,1/17,95/16992,0.09095114591999798,0.12731300487165362,0.058343432319792055,1,bp,PCR,6422,SFRP1
GO:0030901,midbrain development,1/17,95/16992,0.09095114591999798,0.12731300487165362,0.058343432319792055,1,bp,PCR,6422,SFRP1
GO:1903902,positive regulation of viral life cycle,1/17,95/16992,0.09095114591999798,0.12731300487165362,0.058343432319792055,1,bp,PCR,7113,TMPRSS2
GO:1990266,neutrophil migration,1/17,95/16992,0.09095114591999798,0.12731300487165362,0.058343432319792055,1,bp,PCR,3576,CXCL8
GO:0002244,hematopoietic progenitor cell differentiation,1/17,96/16992,0.09186573611466908,0.12819999260038936,0.05874991010713319,1,bp,PCR,6422,SFRP1
GO:0035282,segmentation,1/17,96/16992,0.09186573611466908,0.12819999260038936,0.05874991010713319,1,bp,PCR,6422,SFRP1
GO:1990748,cellular detoxification,1/17,96/16992,0.09186573611466908,0.12819999260038936,0.05874991010713319,1,bp,PCR,7124,TNF
GO:0030055,cell-substrate junction,2/17,398/18122,0.052656085578883766,0.12854279714845154,0.08151096838836497,2,cc,PCR,3691/1956,ITGB4/EGFR
GO:0001948,glycoprotein binding,1/17,102/16982,0.0973897367522153,0.12854453711490338,0.06367531250273852,1,mf,PCR,1956,EGFR
GO:0005178,integrin binding,1/17,103/16982,0.09829876367610257,0.12854453711490338,0.06367531250273852,1,mf,PCR,1956,EGFR
GO:0001657,ureteric bud development,1/17,97/16992,0.09277946022014116,0.12868802537119883,0.058973559741059174,1,bp,PCR,6422,SFRP1
GO:0001936,regulation of endothelial cell proliferation,1/17,97/16992,0.09277946022014116,0.12868802537119883,0.058973559741059174,1,bp,PCR,7124,TNF
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,1/17,97/16992,0.09277946022014116,0.12868802537119883,0.058973559741059174,1,bp,PCR,7124,TNF
GO:0016101,diterpenoid metabolic process,1/17,97/16992,0.09277946022014116,0.12868802537119883,0.058973559741059174,1,bp,PCR,1956,EGFR
GO:0042035,regulation of cytokine biosynthetic process,1/17,97/16992,0.09277946022014116,0.12868802537119883,0.058973559741059174,1,bp,PCR,7124,TNF
GO:0046545,development of primary female sexual characteristics,1/17,97/16992,0.09277946022014116,0.12868802537119883,0.058973559741059174,1,bp,PCR,6422,SFRP1
GO:0072163,mesonephric epithelium development,1/17,98/16992,0.09369231900535901,0.1295603886043803,0.05937333559510258,1,bp,PCR,6422,SFRP1
GO:0072164,mesonephric tubule development,1/17,98/16992,0.09369231900535901,0.1295603886043803,0.05937333559510258,1,bp,PCR,6422,SFRP1
GO:1903038,negative regulation of leukocyte cell-cell adhesion,1/17,98/16992,0.09369231900535901,0.1295603886043803,0.05937333559510258,1,bp,PCR,2064,ERBB2
hsa04360,Axon guidance,2/17,175/7430,0.05951582899842367,0.13115525279282253,0.07889037761974288,2,kg,PCR,4233/1946,MET/EFNA5
GO:0001841,neural tube formation,1/17,100/16992,0.09551544368763087,0.1316824193437731,0.06034579364798643,1,bp,PCR,6422,SFRP1
GO:0042752,regulation of circadian rhythm,1/17,100/16992,0.09551544368763087,0.1316824193437731,0.06034579364798643,1,bp,PCR,79723,SUV39H2
GO:0098754,detoxification,1/17,100/16992,0.09551544368763087,0.1316824193437731,0.06034579364798643,1,bp,PCR,7124,TNF
GO:0032609,interferon-gamma production,1/17,101/16992,0.09642571111939191,0.13253694630767823,0.06073739571671695,1,bp,PCR,7124,TNF
GO:0050715,positive regulation of cytokine secretion,1/17,101/16992,0.09642571111939191,0.13253694630767823,0.06073739571671695,1,bp,PCR,7124,TNF
GO:2001237,negative regulation of extrinsic apoptotic signaling pathway,1/17,101/16992,0.09642571111939191,0.13253694630767823,0.06073739571671695,1,bp,PCR,7124,TNF
GO:0001823,mesonephros development,1/17,102/16992,0.09733511630031488,0.1335188118388087,0.06118735293216714,1,bp,PCR,6422,SFRP1
GO:0021761,limbic system development,1/17,102/16992,0.09733511630031488,0.1335188118388087,0.06118735293216714,1,bp,PCR,3400,ID4
GO:0002688,regulation of leukocyte chemotaxis,1/17,103/16992,0.09824365999616436,0.1340932906627607,0.06145061799623651,1,bp,PCR,3576,CXCL8
GO:0010827,regulation of glucose transport,1/17,103/16992,0.09824365999616436,0.1340932906627607,0.06145061799623651,1,bp,PCR,7124,TNF
GO:0032675,regulation of interleukin-6 production,1/17,103/16992,0.09824365999616436,0.1340932906627607,0.06145061799623651,1,bp,PCR,7124,TNF
GO:0042177,negative regulation of protein catabolic process,1/17,103/16992,0.09824365999616436,0.1340932906627607,0.06145061799623651,1,bp,PCR,1956,EGFR
GO:0090101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1/17,103/16992,0.09824365999616436,0.1340932906627607,0.06145061799623651,1,bp,PCR,6422,SFRP1
GO:0002698,negative regulation of immune effector process,1/17,104/16992,0.0991513429720694,0.13519739893303087,0.06195659510521426,1,bp,PCR,7124,TNF
GO:0002020,protease binding,1/17,111/16982,0.10554002254921568,0.13592275631338382,0.0673301579261344,1,mf,PCR,7124,TNF
GO:0046165,alcohol biosynthetic process,1/17,105/16992,0.10005816599252626,0.1361626533238255,0.0623989399723194,1,bp,PCR,7124,TNF
GO:0048593,camera-type eye morphogenesis,1/17,105/16992,0.10005816599252626,0.1361626533238255,0.0623989399723194,1,bp,PCR,8842,PROM1
GO:0001085,RNA polymerase II transcription factor binding,1/17,114/16982,0.10824135659849654,0.13642511708866364,0.06757900536899747,1,mf,PCR,3400,ID4
GO:0004222,metalloendopeptidase activity,1/17,115/16982,0.10914009367093092,0.13642511708866364,0.06757900536899747,1,mf,PCR,4316,MMP7
GO:0010811,positive regulation of cell-substrate adhesion,1/17,106/16992,0.10096412982139669,0.13712291044195643,0.0628389947509946,1,bp,PCR,6422,SFRP1
GO:0034968,histone lysine methylation,1/17,106/16992,0.10096412982139669,0.13712291044195643,0.0628389947509946,1,bp,PCR,79723,SUV39H2
GO:0006721,terpenoid metabolic process,1/17,107/16992,0.10186923522190783,0.13794162514222733,0.06321418521761368,1,bp,PCR,1956,EGFR
GO:0007127,meiosis I,1/17,107/16992,0.10186923522190783,0.13794162514222733,0.06321418521761368,1,bp,PCR,898,CCNE1
GO:0072089,stem cell proliferation,1/17,107/16992,0.10186923522190783,0.13794162514222733,0.06321418521761368,1,bp,PCR,3400,ID4
GO:0010008,endosome membrane,2/17,421/18122,0.05819190262748796,0.13799794051661432,0.0875066204924631,2,cc,PCR,2064/1956,ERBB2/EGFR
hsa04020,Calcium signaling pathway,2/17,182/7430,0.063790386241682,0.13801919932291196,0.08301906726190193,2,kg,PCR,2064/1956,ERBB2/EGFR
GO:0021987,cerebral cortex development,1/17,108/16992,0.10277348295665623,0.13861763366272156,0.063523978057731,1,bp,PCR,1956,EGFR
GO:0042089,cytokine biosynthetic process,1/17,108/16992,0.10277348295665623,0.13861763366272156,0.063523978057731,1,bp,PCR,7124,TNF
GO:0048524,positive regulation of viral process,1/17,108/16992,0.10277348295665623,0.13861763366272156,0.063523978057731,1,bp,PCR,7113,TMPRSS2
GO:0071621,granulocyte chemotaxis,1/17,108/16992,0.10277348295665623,0.13861763366272156,0.063523978057731,1,bp,PCR,3576,CXCL8
GO:0001750,photoreceptor outer segment,1/17,78/18122,0.07073480225313244,0.13865874595640465,0.08792564740418811,1,cc,PCR,8842,PROM1
GO:0005901,caveola,1/17,72/18122,0.06546546687401267,0.13865874595640465,0.08792564740418811,1,cc,PCR,1946,EFNA5
GO:0005902,microvillus,1/17,79/18122,0.07161030149729652,0.13865874595640465,0.08792564740418811,1,cc,PCR,8842,PROM1
GO:0005905,clathrin-coated pit,1/17,69/18122,0.06282026579498179,0.13865874595640465,0.08792564740418811,1,cc,PCR,1956,EGFR
GO:0005912,adherens junction,2/17,490/18122,0.07595068502552087,0.13865874595640465,0.08792564740418811,2,cc,PCR,1956/1946,EGFR/EFNA5
GO:0044440,endosomal part,2/17,455/18122,0.06673585664436274,0.13865874595640465,0.08792564740418811,2,cc,PCR,2064/1956,ERBB2/EGFR
GO:0044853,plasma membrane raft,1/17,85/18122,0.07684701583126041,0.13865874595640465,0.08792564740418811,1,cc,PCR,1946,EFNA5
GO:0045334,clathrin-coated endocytic vesicle,1/17,66/18122,0.06016801907023195,0.13865874595640465,0.08792564740418811,1,cc,PCR,1956,EGFR
GO:0060170,ciliary membrane,1/17,81/18122,0.07335897153040294,0.13865874595640465,0.08792564740418811,1,cc,PCR,8842,PROM1
GO:0098552,side of membrane,2/17,462/18122,0.06854582292512007,0.13865874595640465,0.08792564740418811,2,cc,PCR,1946/7124,EFNA5/TNF
GO:1902554,serine/threonine protein kinase complex,1/17,82/18122,0.07423214360977626,0.13865874595640465,0.08792564740418811,1,cc,PCR,898,CCNE1
GO:0010921,regulation of phosphatase activity,1/17,109/16992,0.10367687378760493,0.13942400806997166,0.06389351336719319,1,bp,PCR,7124,TNF
GO:0032635,interleukin-6 production,1/17,109/16992,0.10367687378760493,0.13942400806997166,0.06389351336719319,1,bp,PCR,7124,TNF
GO:0048525,negative regulation of viral process,1/17,109/16992,0.10367687378760493,0.13942400806997166,0.06389351336719319,1,bp,PCR,7124,TNF
GO:0042107,cytokine metabolic process,1/17,110/16992,0.10457940847608527,0.14022449579212606,0.06426035099927503,1,bp,PCR,7124,TNF
GO:0060071,"Wnt signaling pathway, planar cell polarity pathway",1/17,110/16992,0.10457940847608527,0.14022449579212606,0.06426035099927503,1,bp,PCR,6422,SFRP1
GO:0072009,nephron epithelium development,1/17,110/16992,0.10457940847608527,0.14022449579212606,0.06426035099927503,1,bp,PCR,8842,PROM1
GO:0002700,regulation of production of molecular mediator of immune response,1/17,111/16992,0.10548108778279708,0.14060721438622123,0.06443573855229545,1,bp,PCR,7124,TNF
GO:0010634,positive regulation of epithelial cell migration,1/17,111/16992,0.10548108778279708,0.14060721438622123,0.06443573855229545,1,bp,PCR,4233,MET
GO:0032963,collagen metabolic process,1/17,111/16992,0.10548108778279708,0.14060721438622123,0.06443573855229545,1,bp,PCR,4316,MMP7
GO:0046660,female sex differentiation,1/17,111/16992,0.10548108778279708,0.14060721438622123,0.06443573855229545,1,bp,PCR,6422,SFRP1
GO:0090175,regulation of establishment of planar polarity,1/17,111/16992,0.10548108778279708,0.14060721438622123,0.06443573855229545,1,bp,PCR,6422,SFRP1
GO:1902904,negative regulation of supramolecular fiber organization,1/17,111/16992,0.10548108778279708,0.14060721438622123,0.06443573855229545,1,bp,PCR,4233,MET
GO:0032273,positive regulation of protein polymerization,1/17,112/16992,0.10638191246780926,0.14153239860877637,0.06485972055732629,1,bp,PCR,4233,MET
GO:0045807,positive regulation of endocytosis,1/17,112/16992,0.10638191246780926,0.14153239860877637,0.06485972055732629,1,bp,PCR,7124,TNF
GO:0030117,membrane coat,1/17,91/18122,0.08205592005506657,0.14188836176188593,0.08997359655160808,1,cc,PCR,1956,EGFR
GO:0048475,coated membrane,1/17,91/18122,0.08205592005506657,0.14188836176188593,0.08997359655160808,1,cc,PCR,1956,EGFR
GO:0005604,basement membrane,1/17,93/18122,0.08378606539604971,0.14192333526269646,0.08999577378737886,1,cc,PCR,1946,EFNA5
GO:0001935,endothelial cell proliferation,1/17,113/16992,0.10728188329056099,0.1424528595778642,0.06528153804806201,1,bp,PCR,7124,TNF
GO:0046718,viral entry into host cell,1/17,113/16992,0.10728188329056099,0.1424528595778642,0.06528153804806201,1,bp,PCR,7113,TMPRSS2
GO:0097731,9+0 non-motile cilium,1/17,100/18122,0.08981743523536867,0.1433624447026077,0.09090833525847032,1,cc,PCR,8842,PROM1
GO:0097733,photoreceptor cell cilium,1/17,100/18122,0.08981743523536867,0.1433624447026077,0.09090833525847032,1,cc,PCR,8842,PROM1
GO:1902911,protein kinase complex,1/17,96/18122,0.08637552968387108,0.1433624447026077,0.09090833525847032,1,cc,PCR,898,CCNE1
hsa01523,Antifolate resistance,1/17,31/7430,0.06868140350621421,0.14338749153051739,0.08624811520632625,1,kg,PCR,7124,TNF
hsa05310,Asthma,1/17,31/7430,0.06868140350621421,0.14338749153051739,0.08624811520632625,1,kg,PCR,7124,TNF
GO:0006664,glycolipid metabolic process,1/17,114/16992,0.1081810010098605,0.143507548820251,0.06576486801497028,1,bp,PCR,3696,ITGB8
GO:0030183,B cell differentiation,1/17,115/16992,0.10907926638388754,0.14400146160032984,0.06599121226696135,1,bp,PCR,6422,SFRP1
GO:0046887,positive regulation of hormone secretion,1/17,115/16992,0.10907926638388754,0.14400146160032984,0.06599121226696135,1,bp,PCR,1956,EGFR
GO:0051592,response to calcium ion,1/17,115/16992,0.10907926638388754,0.14400146160032984,0.06599121226696135,1,bp,PCR,1956,EGFR
GO:0071333,cellular response to glucose stimulus,1/17,115/16992,0.10907926638388754,0.14400146160032984,0.06599121226696135,1,bp,PCR,1946,EFNA5
GO:1903509,liposaccharide metabolic process,1/17,115/16992,0.10907926638388754,0.14400146160032984,0.06599121226696135,1,bp,PCR,3696,ITGB8
GO:0042476,odontogenesis,1/17,116/16992,0.10997668017019313,0.14490671333300711,0.0664060598565778,1,bp,PCR,3691,ITGB4
GO:0044259,multicellular organismal macromolecule metabolic process,1/17,116/16992,0.10997668017019313,0.14490671333300711,0.0664060598565778,1,bp,PCR,4316,MMP7
GO:0018022,peptidyl-lysine methylation,1/17,117/16992,0.11087324312569835,0.14580736776088477,0.06681880065009982,1,bp,PCR,79723,SUV39H2
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,1/17,117/16992,0.11087324312569835,0.14580736776088477,0.06681880065009982,1,bp,PCR,7124,TNF
GO:0002706,regulation of lymphocyte mediated immunity,1/17,118/16992,0.11176895600669734,0.1462826967238706,0.06703662853979231,1,bp,PCR,7124,TNF
GO:0010594,regulation of endothelial cell migration,1/17,118/16992,0.11176895600669734,0.1462826967238706,0.06703662853979231,1,bp,PCR,4233,MET
GO:0045580,regulation of T cell differentiation,1/17,118/16992,0.11176895600669734,0.1462826967238706,0.06703662853979231,1,bp,PCR,2064,ERBB2
GO:0071331,cellular response to hexose stimulus,1/17,118/16992,0.11176895600669734,0.1462826967238706,0.06703662853979231,1,bp,PCR,1946,EFNA5
GO:0097530,granulocyte migration,1/17,118/16992,0.11176895600669734,0.1462826967238706,0.06703662853979231,1,bp,PCR,3576,CXCL8
GO:0001704,formation of primary germ layer,1/17,119/16992,0.11266381956885707,0.14675239675524768,0.0672518768721907,1,bp,PCR,3691,ITGB4
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/17,119/16992,0.11266381956885707,0.14675239675524768,0.0672518768721907,1,bp,PCR,7124,TNF
GO:0046330,positive regulation of JNK cascade,1/17,119/16992,0.11266381956885707,0.14675239675524768,0.0672518768721907,1,bp,PCR,7124,TNF
GO:0051494,negative regulation of cytoskeleton organization,1/17,119/16992,0.11266381956885707,0.14675239675524768,0.0672518768721907,1,bp,PCR,4233,MET
GO:0071326,cellular response to monosaccharide stimulus,1/17,119/16992,0.11266381956885707,0.14675239675524768,0.0672518768721907,1,bp,PCR,1946,EFNA5
GO:0001838,embryonic epithelial tube formation,1/17,120/16992,0.11355783456721724,0.14749589708019015,0.06759259902333115,1,bp,PCR,6422,SFRP1
GO:0045995,regulation of embryonic development,1/17,120/16992,0.11355783456721724,0.14749589708019015,0.06759259902333115,1,bp,PCR,6422,SFRP1
GO:0050807,regulation of synapse organization,1/17,120/16992,0.11355783456721724,0.14749589708019015,0.06759259902333115,1,bp,PCR,1946,EFNA5
GO:0001736,establishment of planar polarity,1/17,121/16992,0.11445100175619072,0.1480939710814982,0.06786667699402017,1,bp,PCR,6422,SFRP1
GO:0007164,establishment of tissue polarity,1/17,121/16992,0.11445100175619072,0.1480939710814982,0.06786667699402017,1,bp,PCR,6422,SFRP1
GO:0007224,smoothened signaling pathway,1/17,121/16992,0.11445100175619072,0.1480939710814982,0.06786667699402017,1,bp,PCR,6422,SFRP1
GO:0035051,cardiocyte differentiation,1/17,121/16992,0.11445100175619072,0.1480939710814982,0.06786667699402017,1,bp,PCR,1956,EGFR
GO:0031503,protein complex localization,1/17,122/16992,0.11534332188956431,0.14854657353416137,0.0680740900590982,1,bp,PCR,7124,TNF
GO:0045766,positive regulation of angiogenesis,1/17,122/16992,0.11534332188956431,0.14854657353416137,0.0680740900590982,1,bp,PCR,3576,CXCL8
GO:0050777,negative regulation of immune response,1/17,122/16992,0.11534332188956431,0.14854657353416137,0.0680740900590982,1,bp,PCR,7124,TNF
GO:0050806,positive regulation of synaptic transmission,1/17,122/16992,0.11534332188956431,0.14854657353416137,0.0680740900590982,1,bp,PCR,1956,EGFR
GO:0090263,positive regulation of canonical Wnt signaling pathway,1/17,122/16992,0.11534332188956431,0.14854657353416137,0.0680740900590982,1,bp,PCR,6422,SFRP1
GO:0030665,clathrin-coated vesicle membrane,1/17,106/18122,0.09495741873036956,0.14870690103057876,0.09429733736878804,1,cc,PCR,1956,EGFR
GO:0046467,membrane lipid biosynthetic process,1/17,123/16992,0.11623479572049955,0.14927339150221752,0.06840716722565195,1,bp,PCR,7124,TNF
GO:0051053,negative regulation of DNA metabolic process,1/17,123/16992,0.11623479572049955,0.14927339150221752,0.06840716722565195,1,bp,PCR,990,CDC6
GO:0071901,negative regulation of protein serine/threonine kinase activity,1/17,123/16992,0.11623479572049955,0.14927339150221752,0.06840716722565195,1,bp,PCR,6422,SFRP1
GO:0001837,epithelial to mesenchymal transition,1/17,125/16992,0.11801520748457617,0.1500119025500323,0.06874560295245799,1,bp,PCR,6422,SFRP1
GO:0007173,epidermal growth factor receptor signaling pathway,1/17,125/16992,0.11801520748457617,0.1500119025500323,0.06874560295245799,1,bp,PCR,1956,EGFR
GO:0009267,cellular response to starvation,1/17,125/16992,0.11801520748457617,0.1500119025500323,0.06874560295245799,1,bp,PCR,6422,SFRP1
GO:0030968,endoplasmic reticulum unfolded protein response,1/17,125/16992,0.11801520748457617,0.1500119025500323,0.06874560295245799,1,bp,PCR,3576,CXCL8
GO:0033135,regulation of peptidyl-serine phosphorylation,1/17,124/16992,0.11712542400153314,0.1500119025500323,0.06874560295245799,1,bp,PCR,7124,TNF
GO:0035023,regulation of Rho protein signal transduction,1/17,125/16992,0.11801520748457617,0.1500119025500323,0.06874560295245799,1,bp,PCR,4233,MET
GO:0035296,regulation of tube diameter,1/17,125/16992,0.11801520748457617,0.1500119025500323,0.06874560295245799,1,bp,PCR,1956,EGFR
GO:0042542,response to hydrogen peroxide,1/17,125/16992,0.11801520748457617,0.1500119025500323,0.06874560295245799,1,bp,PCR,4233,MET
GO:0050803,regulation of synapse structure or activity,1/17,124/16992,0.11712542400153314,0.1500119025500323,0.06874560295245799,1,bp,PCR,1946,EFNA5
GO:0097746,regulation of blood vessel diameter,1/17,125/16992,0.11801520748457617,0.1500119025500323,0.06874560295245799,1,bp,PCR,1956,EGFR
GO:2000241,regulation of reproductive process,1/17,125/16992,0.11801520748457617,0.1500119025500323,0.06874560295245799,1,bp,PCR,6422,SFRP1
GO:0045834,positive regulation of lipid metabolic process,1/17,126/16992,0.11890414692091689,0.15058258754369586,0.06900712942681383,1,bp,PCR,7124,TNF
GO:0071322,cellular response to carbohydrate stimulus,1/17,126/16992,0.11890414692091689,0.15058258754369586,0.06900712942681383,1,bp,PCR,1946,EFNA5
GO:0090288,negative regulation of cellular response to growth factor stimulus,1/17,126/16992,0.11890414692091689,0.15058258754369586,0.06900712942681383,1,bp,PCR,6422,SFRP1
GO:2001056,positive regulation of cysteine-type endopeptidase activity,1/17,126/16992,0.11890414692091689,0.15058258754369586,0.06900712942681383,1,bp,PCR,7124,TNF
GO:0007498,mesoderm development,1/17,127/16992,0.11979224306121983,0.15142712904045239,0.06939415547892017,1,bp,PCR,3691,ITGB4
GO:1905952,regulation of lipid localization,1/17,127/16992,0.11979224306121983,0.15142712904045239,0.06939415547892017,1,bp,PCR,7124,TNF
GO:0002455,humoral immune response mediated by circulating immunoglobulin,1/17,128/16992,0.12067949665552491,0.15184763871453455,0.06958686146158363,1,bp,PCR,7124,TNF
GO:0006720,isoprenoid metabolic process,1/17,128/16992,0.12067949665552491,0.15184763871453455,0.06958686146158363,1,bp,PCR,1956,EGFR
GO:0009411,response to UV,1/17,128/16992,0.12067949665552491,0.15184763871453455,0.06958686146158363,1,bp,PCR,1956,EGFR
GO:0045931,positive regulation of mitotic cell cycle,1/17,128/16992,0.12067949665552491,0.15184763871453455,0.06958686146158363,1,bp,PCR,990,CDC6
GO:0072175,epithelial tube formation,1/17,128/16992,0.12067949665552491,0.15184763871453455,0.06958686146158363,1,bp,PCR,6422,SFRP1
GO:0001678,cellular glucose homeostasis,1/17,129/16992,0.12156590845325133,0.15254237275206328,0.06990523560049958,1,bp,PCR,1946,EFNA5
GO:0006766,vitamin metabolic process,1/17,129/16992,0.12156590845325133,0.15254237275206328,0.06990523560049958,1,bp,PCR,7124,TNF
GO:0061351,neural precursor cell proliferation,1/17,129/16992,0.12156590845325133,0.15254237275206328,0.06990523560049958,1,bp,PCR,3400,ID4
GO:0001889,liver development,1/17,130/16992,0.12245147920319477,0.15323224408516786,0.07022138131925726,1,bp,PCR,1956,EGFR
GO:0002819,regulation of adaptive immune response,1/17,130/16992,0.12245147920319477,0.15323224408516786,0.07022138131925726,1,bp,PCR,7124,TNF
GO:0034620,cellular response to unfolded protein,1/17,130/16992,0.12245147920319477,0.15323224408516786,0.07022138131925726,1,bp,PCR,3576,CXCL8
GO:0001738,morphogenesis of a polarized epithelium,1/17,132/16992,0.12422010055180932,0.15473823262550224,0.07091152715758665,1,bp,PCR,6422,SFRP1
GO:0002377,immunoglobulin production,1/17,132/16992,0.12422010055180932,0.15473823262550224,0.07091152715758665,1,bp,PCR,7124,TNF
GO:0002526,acute inflammatory response,1/17,132/16992,0.12422010055180932,0.15473823262550224,0.07091152715758665,1,bp,PCR,7124,TNF
GO:0016571,histone methylation,1/17,132/16992,0.12422010055180932,0.15473823262550224,0.07091152715758665,1,bp,PCR,79723,SUV39H2
GO:1902107,positive regulation of leukocyte differentiation,1/17,132/16992,0.12422010055180932,0.15473823262550224,0.07091152715758665,1,bp,PCR,7124,TNF
GO:0010770,positive regulation of cell morphogenesis involved in differentiation,1/17,133/16992,0.1251031526449653,0.15527308791564598,0.07115663403769559,1,bp,PCR,1946,EFNA5
GO:0046890,regulation of lipid biosynthetic process,1/17,133/16992,0.1251031526449653,0.15527308791564598,0.07115663403769559,1,bp,PCR,7124,TNF
GO:0050880,regulation of blood vessel size,1/17,133/16992,0.1251031526449653,0.15527308791564598,0.07115663403769559,1,bp,PCR,1956,EGFR
GO:0061008,hepaticobiliary system development,1/17,133/16992,0.1251031526449653,0.15527308791564598,0.07115663403769559,1,bp,PCR,1956,EGFR
GO:0000070,mitotic sister chromatid segregation,1/17,134/16992,0.12598536667931104,0.15580304153927446,0.07139949464258011,1,bp,PCR,990,CDC6
GO:0007270,neuron-neuron synaptic transmission,1/17,134/16992,0.12598536667931104,0.15580304153927446,0.07139949464258011,1,bp,PCR,1956,EGFR
GO:0035150,regulation of tube size,1/17,134/16992,0.12598536667931104,0.15580304153927446,0.07139949464258011,1,bp,PCR,1956,EGFR
GO:0051092,positive regulation of NF-kappaB transcription factor activity,1/17,134/16992,0.12598536667931104,0.15580304153927446,0.07139949464258011,1,bp,PCR,7124,TNF
GO:0035257,nuclear hormone receptor binding,1/17,135/16982,0.12693680637988258,0.15637142814913071,0.07745953097170562,1,mf,PCR,898,CCNE1
GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,1/17,114/18122,0.10176824315882405,0.15642155892930362,0.0991893208175673,1,cc,PCR,8842,PROM1
GO:0051302,regulation of cell division,1/17,135/16992,0.12686674340053883,0.1567514185156477,0.07183410513653918,1,bp,PCR,990,CDC6
GO:0044236,multicellular organism metabolic process,1/17,136/16992,0.1277472835537209,0.15769705246622534,0.07226745859049656,1,bp,PCR,4316,MMP7
GO:0008584,male gonad development,1/17,137/16992,0.12862698788331184,0.15835462806857367,0.07256880422042204,1,bp,PCR,6422,SFRP1
GO:0022408,negative regulation of cell-cell adhesion,1/17,137/16992,0.12862698788331184,0.15835462806857367,0.07256880422042204,1,bp,PCR,2064,ERBB2
GO:0046546,development of primary male sexual characteristics,1/17,137/16992,0.12862698788331184,0.15835462806857367,0.07256880422042204,1,bp,PCR,6422,SFRP1
hsa05143,African trypanosomiasis,1/17,35/7430,0.0772128933214754,0.15841955698716506,0.0952899590900241,1,kg,PCR,7124,TNF
GO:0060041,retina development in camera-type eye,1/17,138/16992,0.12950585713314777,0.15915037559719863,0.07293346957512621,1,bp,PCR,8842,PROM1
GO:0090002,establishment of protein localization to plasma membrane,1/17,138/16992,0.12950585713314777,0.15915037559719863,0.07293346957512621,1,bp,PCR,7124,TNF
GO:0051015,actin filament binding,1/17,140/16982,0.13133340695124085,0.15947627986936389,0.07899753801578398,1,mf,PCR,1956,EGFR
GO:0000910,cytokinesis,1/17,139/16992,0.13038389204644674,0.15965612541286725,0.07316523835767089,1,bp,PCR,990,CDC6
GO:0035303,regulation of dephosphorylation,1/17,139/16992,0.13038389204644674,0.15965612541286725,0.07316523835767089,1,bp,PCR,7124,TNF
GO:0072006,nephron development,1/17,139/16992,0.13038389204644674,0.15965612541286725,0.07316523835767089,1,bp,PCR,8842,PROM1
GO:1904018,positive regulation of vasculature development,1/17,139/16992,0.13038389204644674,0.15965612541286725,0.07316523835767089,1,bp,PCR,3576,CXCL8
GO:0044420,extracellular matrix component,1/17,119/18122,0.10600048062451861,0.15996436166972808,0.10143586662633361,1,cc,PCR,1946,EFNA5
GO:0010950,positive regulation of endopeptidase activity,1/17,140/16992,0.1312610933658086,0.16030012204976982,0.07346036118693078,1,bp,PCR,7124,TNF
GO:0032874,positive regulation of stress-activated MAPK cascade,1/17,140/16992,0.1312610933658086,0.16030012204976982,0.07346036118693078,1,bp,PCR,7124,TNF
GO:0043279,response to alkaloid,1/17,140/16992,0.1312610933658086,0.16030012204976982,0.07346036118693078,1,bp,PCR,7124,TNF
GO:0031901,early endosome membrane,1/17,122/18122,0.10853080686283711,0.160858160171705,0.10200263802898225,1,cc,PCR,1956,EGFR
GO:0048592,eye morphogenesis,1/17,141/16992,0.13213746183321817,0.16108297885100237,0.07381911913820878,1,bp,PCR,8842,PROM1
GO:0070304,positive regulation of stress-activated protein kinase signaling cascade,1/17,141/16992,0.13213746183321817,0.16108297885100237,0.07381911913820878,1,bp,PCR,7124,TNF
GO:0035148,tube formation,1/17,142/16992,0.1330129981900411,0.16200604494854648,0.0742421304750557,1,bp,PCR,6422,SFRP1
GO:0008757,S-adenosylmethionine-dependent methyltransferase activity,1/17,145/16982,0.13570916318355397,0.16246871648735334,0.08047985956029888,1,mf,PCR,79723,SUV39H2
GO:0007416,synapse assembly,1/17,144/16992,0.13476157753432128,0.16384422703773163,0.0750845098723525,1,bp,PCR,1946,EFNA5
GO:0050864,regulation of B cell activation,1/17,144/16992,0.13476157753432128,0.16384422703773163,0.0750845098723525,1,bp,PCR,6422,SFRP1
hsa05216,Thyroid cancer,1/17,37/7430,0.08145100223857027,0.1642825299388112,0.09881655936169095,1,kg,PCR,83439,TCF7L1
GO:0001959,regulation of cytokine-mediated signaling pathway,1/17,145/16992,0.13563462200143406,0.16461329567372626,0.07543694915346649,1,bp,PCR,7124,TNF
GO:1902115,regulation of organelle assembly,1/17,145/16992,0.13563462200143406,0.16461329567372626,0.07543694915346649,1,bp,PCR,7124,TNF
GO:0097730,non-motile cilium,1/17,128/18122,0.11357125155992731,0.1653756820960345,0.10486726829171497,1,cc,PCR,8842,PROM1
GO:0016331,morphogenesis of embryonic epithelium,1/17,146/16992,0.1365068373172751,0.16537863742243325,0.07578768052267904,1,bp,PCR,6422,SFRP1
GO:0035967,cellular response to topologically incorrect protein,1/17,146/16992,0.1365068373172751,0.16537863742243325,0.07578768052267904,1,bp,PCR,3576,CXCL8
GO:0000187,activation of MAPK activity,1/17,147/16992,0.1373782242201369,0.16570113564525762,0.07593547102731425,1,bp,PCR,7124,TNF
GO:0010212,response to ionizing radiation,1/17,147/16992,0.1373782242201369,0.16570113564525762,0.07593547102731425,1,bp,PCR,6422,SFRP1
GO:0042129,regulation of T cell proliferation,1/17,147/16992,0.1373782242201369,0.16570113564525762,0.07593547102731425,1,bp,PCR,2064,ERBB2
GO:0043409,negative regulation of MAPK cascade,1/17,147/16992,0.1373782242201369,0.16570113564525762,0.07593547102731425,1,bp,PCR,6422,SFRP1
GO:0071248,cellular response to metal ion,1/17,147/16992,0.1373782242201369,0.16570113564525762,0.07593547102731425,1,bp,PCR,1956,EGFR
hsa05330,Allograft rejection,1/17,38/7430,0.08356318037490795,0.16573364107690078,0.09968940816655686,1,kg,PCR,7124,TNF
GO:0019827,stem cell population maintenance,1/17,148/16992,0.13824878344769775,0.1663115857116856,0.07621522054835617,1,bp,PCR,6422,SFRP1
GO:0030509,BMP signaling pathway,1/17,148/16992,0.13824878344769775,0.1663115857116856,0.07621522054835617,1,bp,PCR,6422,SFRP1
GO:0031330,negative regulation of cellular catabolic process,1/17,148/16992,0.13824878344769775,0.1663115857116856,0.07621522054835617,1,bp,PCR,4233,MET
GO:0000723,telomere maintenance,1/17,149/16992,0.13911851573702272,0.16721092892360326,0.07662736045401371,1,bp,PCR,898,CCNE1
GO:0008361,regulation of cell size,1/17,150/16992,0.13998742182456414,0.1679603685169398,0.07697080437975942,1,bp,PCR,1946,EFNA5
GO:0050770,regulation of axonogenesis,1/17,150/16992,0.13998742182456414,0.1679603685169398,0.07697080437975942,1,bp,PCR,1946,EFNA5
GO:0007088,regulation of mitotic nuclear division,1/17,151/16992,0.1408555024461643,0.1682645574596849,0.07711020433352982,1,bp,PCR,990,CDC6
GO:0035567,non-canonical Wnt signaling pathway,1/17,151/16992,0.1408555024461643,0.1682645574596849,0.07711020433352982,1,bp,PCR,6422,SFRP1
GO:0050707,regulation of cytokine secretion,1/17,151/16992,0.1408555024461643,0.1682645574596849,0.07711020433352982,1,bp,PCR,7124,TNF
GO:0060759,regulation of response to cytokine stimulus,1/17,151/16992,0.1408555024461643,0.1682645574596849,0.07711020433352982,1,bp,PCR,7124,TNF
GO:0098727,maintenance of cell number,1/17,151/16992,0.1408555024461643,0.1682645574596849,0.07711020433352982,1,bp,PCR,6422,SFRP1
GO:0000922,spindle pole,1/17,135/18122,0.11941786759567996,0.17089108638692133,0.1083646711394555,1,cc,PCR,990,CDC6
GO:0003018,vascular process in circulatory system,1/17,154/16992,0.14345479886454238,0.1709222103094504,0.0783281206754315,1,bp,PCR,1956,EGFR
GO:0015758,glucose transport,1/17,154/16992,0.14345479886454238,0.1709222103094504,0.0783281206754315,1,bp,PCR,7124,TNF
GO:0030177,positive regulation of Wnt signaling pathway,1/17,154/16992,0.14345479886454238,0.1709222103094504,0.0783281206754315,1,bp,PCR,6422,SFRP1
GO:0002703,regulation of leukocyte mediated immunity,1/17,155/16992,0.14431958496855124,0.17150478456766202,0.07859509561518324,1,bp,PCR,7124,TNF
GO:0017148,negative regulation of translation,1/17,155/16992,0.14431958496855124,0.17150478456766202,0.07859509561518324,1,bp,PCR,1956,EGFR
GO:0051099,positive regulation of binding,1/17,155/16992,0.14431958496855124,0.17150478456766202,0.07859509561518324,1,bp,PCR,4233,MET
GO:0008645,hexose transport,1/17,156/16992,0.14518354927665456,0.17208335840670136,0.07886023729221792,1,bp,PCR,7124,TNF
GO:0021915,neural tube development,1/17,156/16992,0.14518354927665456,0.17208335840670136,0.07886023729221792,1,bp,PCR,6422,SFRP1
GO:0043542,endothelial cell migration,1/17,156/16992,0.14518354927665456,0.17208335840670136,0.07886023729221792,1,bp,PCR,4233,MET
GO:0010952,positive regulation of peptidase activity,1/17,158/16992,0.14690901543324464,0.17322863232395513,0.07938507928574623,1,bp,PCR,7124,TNF
GO:0015749,monosaccharide transport,1/17,158/16992,0.14690901543324464,0.17322863232395513,0.07938507928574623,1,bp,PCR,7124,TNF
GO:0030308,negative regulation of cell growth,1/17,158/16992,0.14690901543324464,0.17322863232395513,0.07938507928574623,1,bp,PCR,6422,SFRP1
GO:0043901,negative regulation of multi-organism process,1/17,158/16992,0.14690901543324464,0.17322863232395513,0.07938507928574623,1,bp,PCR,7124,TNF
GO:0071772,response to BMP,1/17,158/16992,0.14690901543324464,0.17322863232395513,0.07938507928574623,1,bp,PCR,6422,SFRP1
GO:0071773,cellular response to BMP stimulus,1/17,158/16992,0.14690901543324464,0.17322863232395513,0.07938507928574623,1,bp,PCR,6422,SFRP1
GO:0051427,hormone receptor binding,1/17,158/16982,0.1469892418078934,0.1735289660232075,0.08595862094028855,1,mf,PCR,898,CCNE1
GO:0006338,chromatin remodeling,1/17,159/16992,0.14777051874426006,0.17379539532722682,0.07964480843875836,1,bp,PCR,79723,SUV39H2
GO:0046661,male sex differentiation,1/17,159/16992,0.14777051874426006,0.17379539532722682,0.07964480843875836,1,bp,PCR,6422,SFRP1
GO:0048639,positive regulation of developmental growth,1/17,159/16992,0.14777051874426006,0.17379539532722682,0.07964480843875836,1,bp,PCR,1946,EFNA5
hsa05332,Graft-versus-host disease,1/17,41/7430,0.0898723209953578,0.17532469177782914,0.10545846121974686,1,kg,PCR,7124,TNF
GO:0031047,gene silencing by RNA,1/17,161/16992,0.14949106948349333,0.17536698725184438,0.08036501818622832,1,bp,PCR,1956,EGFR
GO:0031570,DNA integrity checkpoint,1/17,161/16992,0.14949106948349333,0.17536698725184438,0.08036501818622832,1,bp,PCR,990,CDC6
GO:0042594,response to starvation,1/17,161/16992,0.14949106948349333,0.17536698725184438,0.08036501818622832,1,bp,PCR,6422,SFRP1
GO:0032200,telomere organization,1/17,162/16992,0.15035011837059364,0.17607297865640947,0.08068855121234866,1,bp,PCR,898,CCNE1
GO:0043902,positive regulation of multi-organism process,1/17,162/16992,0.15035011837059364,0.17607297865640947,0.08068855121234866,1,bp,PCR,7113,TMPRSS2
GO:0048863,stem cell differentiation,1/17,163/16992,0.1512083505742594,0.17677560370295572,0.08101054154547045,1,bp,PCR,6422,SFRP1
GO:1903708,positive regulation of hemopoiesis,1/17,163/16992,0.1512083505742594,0.17677560370295572,0.08101054154547045,1,bp,PCR,7124,TNF
GO:0002699,positive regulation of immune effector process,1/17,164/16992,0.15206576682241668,0.17747488046026297,0.08133099746593112,1,bp,PCR,7124,TNF
GO:0090090,negative regulation of canonical Wnt signaling pathway,1/17,164/16992,0.15206576682241668,0.17747488046026297,0.08133099746593112,1,bp,PCR,6422,SFRP1
GO:0006694,steroid biosynthetic process,1/17,165/16992,0.15292236784238444,0.17801932106821794,0.08158049698716535,1,bp,PCR,7124,TNF
GO:0051147,regulation of muscle cell differentiation,1/17,165/16992,0.15292236784238444,0.17801932106821794,0.08158049698716535,1,bp,PCR,7124,TNF
GO:2001020,regulation of response to DNA damage stimulus,1/17,165/16992,0.15292236784238444,0.17801932106821794,0.08158049698716535,1,bp,PCR,1956,EGFR
GO:0097529,myeloid leukocyte migration,1/17,166/16992,0.15377815436087694,0.17886346076469034,0.08196733890719729,1,bp,PCR,3576,CXCL8
GO:0033209,tumor necrosis factor-mediated signaling pathway,1/17,167/16992,0.154633127104005,0.17924873074122172,0.0821438956762663,1,bp,PCR,7124,TNF
GO:0034249,negative regulation of cellular amide metabolic process,1/17,167/16992,0.154633127104005,0.17924873074122172,0.0821438956762663,1,bp,PCR,1956,EGFR
GO:0050731,positive regulation of peptidyl-tyrosine phosphorylation,1/17,167/16992,0.154633127104005,0.17924873074122172,0.0821438956762663,1,bp,PCR,1946,EFNA5
GO:0071478,cellular response to radiation,1/17,167/16992,0.154633127104005,0.17924873074122172,0.0821438956762663,1,bp,PCR,6422,SFRP1
GO:0006986,response to unfolded protein,1/17,168/16992,0.15548728679727264,0.18008637531765334,0.08252776109286178,1,bp,PCR,3576,CXCL8
hsa04940,Type I diabetes mellitus,1/17,43/7430,0.09405567915040791,0.18052622288546036,0.10858720173561526,1,kg,PCR,7124,TNF
GO:0007266,Rho protein signal transduction,1/17,169/16992,0.15634063416558286,0.18061631069424722,0.08277061333572051,1,bp,PCR,4233,MET
GO:0048736,appendage development,1/17,169/16992,0.15634063416558286,0.18061631069424722,0.08277061333572051,1,bp,PCR,3691,ITGB4
GO:0060173,limb development,1/17,169/16992,0.15634063416558286,0.18061631069424722,0.08277061333572051,1,bp,PCR,3691,ITGB4
GO:0071241,cellular response to inorganic substance,1/17,172/16992,0.1588958095607368,0.18341345977120463,0.08405245628667714,1,bp,PCR,1956,EGFR
GO:0031099,regeneration,1/17,173/16992,0.15974591486617495,0.1839294848206842,0.08428893387653513,1,bp,PCR,1956,EGFR
GO:0042098,T cell proliferation,1/17,173/16992,0.15974591486617495,0.1839294848206842,0.08428893387653513,1,bp,PCR,2064,ERBB2
GO:0051783,regulation of nuclear division,1/17,173/16992,0.15974591486617495,0.1839294848206842,0.08428893387653513,1,bp,PCR,990,CDC6
GO:0031669,cellular response to nutrient levels,1/17,174/16992,0.16059521146212408,0.1845968467604096,0.08459476426835119,1,bp,PCR,6422,SFRP1
GO:0050663,cytokine secretion,1/17,174/16992,0.16059521146212408,0.1845968467604096,0.08459476426835119,1,bp,PCR,7124,TNF
GO:0010632,regulation of epithelial cell migration,1/17,176/16992,0.16229138141011445,0.18607780665866558,0.08527344028954265,1,bp,PCR,4233,MET
GO:0032271,regulation of protein polymerization,1/17,176/16992,0.16229138141011445,0.18607780665866558,0.08527344028954265,1,bp,PCR,4233,MET
GO:2001235,positive regulation of apoptotic signaling pathway,1/17,176/16992,0.16229138141011445,0.18607780665866558,0.08527344028954265,1,bp,PCR,6422,SFRP1
GO:0006479,protein methylation,1/17,177/16992,0.16313825620293254,0.18658001064479085,0.08550358413309396,1,bp,PCR,79723,SUV39H2
GO:0008213,protein alkylation,1/17,177/16992,0.16313825620293254,0.18658001064479085,0.08550358413309396,1,bp,PCR,79723,SUV39H2
GO:0009749,response to glucose,1/17,177/16992,0.16313825620293254,0.18658001064479085,0.08550358413309396,1,bp,PCR,1946,EFNA5
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,1/17,179/16992,0.16482958902366107,0.18835701784089484,0.0863179290555329,1,bp,PCR,7124,TNF
GO:0055037,recycling endosome,1/17,153/18122,0.13428580991919448,0.18891054615751088,0.11979108824192193,1,cc,PCR,7124,TNF
hsa04930,Type II diabetes mellitus,1/17,46/7430,0.10029679733733521,0.18944950608163316,0.11395459012429063,1,kg,PCR,7124,TNF
GO:0009746,response to hexose,1/17,182/16992,0.16736055711686182,0.1907715259725094,0.08742442003738081,1,bp,PCR,1946,EFNA5
GO:0048762,mesenchymal cell differentiation,1/17,182/16992,0.16736055711686182,0.1907715259725094,0.08742442003738081,1,bp,PCR,6422,SFRP1
GO:0051216,cartilage development,1/17,182/16992,0.16736055711686182,0.1907715259725094,0.08742442003738081,1,bp,PCR,3696,ITGB8
GO:0008022,protein C-terminus binding,1/17,178/16982,0.16407300262216062,0.19104390716278977,0.09463475277413735,1,mf,PCR,2064,ERBB2
GO:0030662,coated vesicle membrane,1/17,166/18122,0.14487648014845766,0.19193562369637585,0.12170933652274944,1,cc,PCR,1956,EGFR
GO:0030666,endocytic vesicle membrane,1/17,167/18122,0.14568607581773108,0.19193562369637585,0.12170933652274944,1,cc,PCR,1956,EGFR
GO:0031225,anchored component of membrane,1/17,161/18122,0.14081765901002885,0.19193562369637585,0.12170933652274944,1,cc,PCR,1946,EFNA5
GO:0043209,myelin sheath,1/17,167/18122,0.14568607581773108,0.19193562369637585,0.12170933652274944,1,cc,PCR,2064,ERBB2
GO:0007126,meiotic nuclear division,1/17,184/16992,0.16904385678651979,0.19221016606374217,0.08808370225980572,1,bp,PCR,898,CCNE1
GO:0007565,female pregnancy,1/17,184/16992,0.16904385678651979,0.19221016606374217,0.08808370225980572,1,bp,PCR,4316,MMP7
GO:0045665,negative regulation of neuron differentiation,1/17,184/16992,0.16904385678651979,0.19221016606374217,0.08808370225980572,1,bp,PCR,3400,ID4
GO:0006333,chromatin assembly or disassembly,1/17,186/16992,0.1707239532225583,0.19347772513384295,0.08866458358369182,1,bp,PCR,79723,SUV39H2
GO:0016064,immunoglobulin mediated immune response,1/17,186/16992,0.1707239532225583,0.19347772513384295,0.08866458358369182,1,bp,PCR,7124,TNF
GO:0035966,response to topologically incorrect protein,1/17,186/16992,0.1707239532225583,0.19347772513384295,0.08866458358369182,1,bp,PCR,3576,CXCL8
GO:0048588,developmental cell growth,1/17,186/16992,0.1707239532225583,0.19347772513384295,0.08866458358369182,1,bp,PCR,1946,EFNA5
GO:0006612,protein targeting to membrane,1/17,187/16992,0.17156280201437146,0.19394671837958258,0.08887950801909286,1,bp,PCR,2064,ERBB2
GO:0008643,carbohydrate transport,1/17,187/16992,0.17156280201437146,0.19394671837958258,0.08887950801909286,1,bp,PCR,7124,TNF
GO:0034284,response to monosaccharide,1/17,187/16992,0.17156280201437146,0.19394671837958258,0.08887950801909286,1,bp,PCR,1946,EFNA5
GO:0019724,B cell mediated immunity,1/17,188/16992,0.17240085214027168,0.19457276717232638,0.08916640593188,1,bp,PCR,7124,TNF
GO:0097305,response to alcohol,1/17,188/16992,0.17240085214027168,0.19457276717232638,0.08916640593188,1,bp,PCR,6422,SFRP1
GO:0006413,translational initiation,1/17,190/16992,0.1740745592454387,0.19629989423970803,0.0899578924046488,1,bp,PCR,7124,TNF
GO:0030595,leukocyte chemotaxis,1/17,191/16992,0.17491021764877324,0.19707990778697165,0.09031534738459505,1,bp,PCR,3576,CXCL8
GO:0005516,calmodulin binding,1/17,190/16982,0.1741681390150991,0.19739055755044563,0.09777860435935387,1,mf,PCR,1956,EGFR
GO:0008237,metallopeptidase activity,1/17,188/16982,0.17249362350397202,0.19739055755044563,0.09777860435935387,1,mf,PCR,4316,MMP7
GO:0008234,cysteine-type peptidase activity,1/17,194/16982,0.17750760707588642,0.19852824475592562,0.09834216458497863,1,mf,PCR,6422,SFRP1
GO:0030136,clathrin-coated vesicle,1/17,177/18122,0.15374245237695183,0.1993847429263594,0.1264329378099933,1,cc,PCR,1956,EGFR
GO:0006006,glucose metabolic process,1/17,194/16992,0.17741242079373554,0.19957075108186026,0.09145682030278629,1,bp,PCR,7124,TNF
GO:0050670,regulation of lymphocyte proliferation,1/17,194/16992,0.17741242079373554,0.19957075108186026,0.09145682030278629,1,bp,PCR,2064,ERBB2
GO:0032944,regulation of mononuclear cell proliferation,1/17,195/16992,0.17824490018690753,0.20017823491048106,0.0917352104929812,1,bp,PCR,2064,ERBB2
GO:1903046,meiotic cell cycle process,1/17,195/16992,0.17824490018690753,0.20017823491048106,0.0917352104929812,1,bp,PCR,898,CCNE1
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,1/17,196/16992,0.17907658660095915,0.20094741562025664,0.09208770113388408,1,bp,PCR,7124,TNF
GO:0030178,negative regulation of Wnt signaling pathway,1/17,198/16992,0.18073758332385215,0.20264516918128875,0.09286572667874984,1,bp,PCR,6422,SFRP1
GO:0000775,"chromosome, centromeric region",1/17,188/18122,0.16252185605724356,0.2043835462538063,0.12960275602651003,1,cc,PCR,79723,SUV39H2
GO:0098858,actin-based cell projection,1/17,186/18122,0.1609320039908697,0.2043835462538063,0.12960275602651003,1,cc,PCR,8842,PROM1
hsa05014,Amyotrophic lateral sclerosis (ALS),1/17,51/7430,0.11060882089146773,0.2056632763450728,0.12370723389177313,1,kg,PCR,7124,TNF
GO:0009952,anterior/posterior pattern specification,1/17,202/16992,0.184050092140834,0.20602173028683707,0.0944130954219022,1,bp,PCR,6422,SFRP1
GO:0070663,regulation of leukocyte proliferation,1/17,202/16992,0.184050092140834,0.20602173028683707,0.0944130954219022,1,bp,PCR,2064,ERBB2
GO:0031668,cellular response to extracellular stimulus,1/17,203/16992,0.1848762474972131,0.20627186864195984,0.09452772573957792,1,bp,PCR,6422,SFRP1
GO:0046578,regulation of Ras protein signal transduction,1/17,203/16992,0.1848762474972131,0.20627186864195984,0.09452772573957792,1,bp,PCR,4233,MET
GO:1901617,organic hydroxy compound biosynthetic process,1/17,203/16992,0.1848762474972131,0.20627186864195984,0.09452772573957792,1,bp,PCR,7124,TNF
GO:2001234,negative regulation of apoptotic signaling pathway,1/17,203/16992,0.1848762474972131,0.20627186864195984,0.09452772573957792,1,bp,PCR,7124,TNF
GO:0002440,production of molecular mediator of immune response,1/17,204/16992,0.1857016155234532,0.2070240322895826,0.09487241801129616,1,bp,PCR,7124,TNF
GO:0030100,regulation of endocytosis,1/17,206/16992,0.18734999239883343,0.2086917327860073,0.09563667120868889,1,bp,PCR,7124,TNF
GO:0009743,response to carbohydrate,1/17,207/16992,0.18817300265316572,0.20926794527391054,0.09590073075487346,1,bp,PCR,1946,EFNA5
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1/17,207/16992,0.18817300265316572,0.20926794527391054,0.09590073075487346,1,bp,PCR,6422,SFRP1
GO:0008168,methyltransferase activity,1/17,209/16982,0.18991775988360138,0.20964947519618335,0.10385113322411559,1,mf,PCR,79723,SUV39H2
GO:0048705,skeletal system morphogenesis,1/17,209/16992,0.18981667030370042,0.21092453055662813,0.0966598902093348,1,bp,PCR,6422,SFRP1
GO:0051054,positive regulation of DNA metabolic process,1/17,210/16992,0.19063732910158127,0.21149311470021456,0.09692045393205018,1,bp,PCR,1956,EGFR
GO:2000116,regulation of cysteine-type endopeptidase activity,1/17,210/16992,0.19063732910158127,0.21149311470021456,0.09692045393205018,1,bp,PCR,7124,TNF
GO:0044706,multi-multicellular organism process,1/17,212/16992,0.19227630014238384,0.21313866793111214,0.09767455775398318,1,bp,PCR,4316,MMP7
GO:0033500,carbohydrate homeostasis,1/17,213/16992,0.19309461378347947,0.21352708099320145,0.09785255489750341,1,bp,PCR,1946,EFNA5
GO:0042593,glucose homeostasis,1/17,213/16992,0.19309461378347947,0.21352708099320145,0.09785255489750341,1,bp,PCR,1946,EFNA5
GO:0044033,multi-organism metabolic process,1/17,213/16992,0.19309461378347947,0.21352708099320145,0.09785255489750341,1,bp,PCR,3576,CXCL8
GO:0008406,gonad development,1/17,214/16992,0.19391214710284765,0.21391275534552653,0.09802929697891954,1,bp,PCR,6422,SFRP1
GO:0030336,negative regulation of cell migration,1/17,214/16992,0.19391214710284765,0.21391275534552653,0.09802929697891954,1,bp,PCR,6422,SFRP1
GO:0071560,cellular response to transforming growth factor beta stimulus,1/17,214/16992,0.19391214710284765,0.21391275534552653,0.09802929697891954,1,bp,PCR,6422,SFRP1
GO:0030217,T cell differentiation,1/17,216/16992,0.1955448755663387,0.21536680181039233,0.09869563944407661,1,bp,PCR,2064,ERBB2
GO:0071559,response to transforming growth factor beta,1/17,216/16992,0.1955448755663387,0.21536680181039233,0.09869563944407661,1,bp,PCR,6422,SFRP1
GO:0003714,transcription corepressor activity,1/17,222/16982,0.20053045901915567,0.2157606204636485,0.10687832592626552,1,mf,PCR,3400,ID4
GO:0016741,"transferase activity, transferring one-carbon groups",1/17,220/16982,0.1989062980838585,0.2157606204636485,0.10687832592626552,1,mf,PCR,79723,SUV39H2
GO:0000819,sister chromatid segregation,1/17,218/16992,0.19717449110690877,0.21698704045446793,0.09943814240964428,1,bp,PCR,990,CDC6
GO:0045137,development of primary sexual characteristics,1/17,219/16992,0.19798813327044684,0.2177074332909572,0.09976827514621545,1,bp,PCR,6422,SFRP1
GO:0009636,response to toxic substance,1/17,220/16992,0.1988009992893105,0.21825065599604337,0.10001721654195674,1,bp,PCR,7124,TNF
GO:1903039,positive regulation of leukocyte cell-cell adhesion,1/17,220/16992,0.1988009992893105,0.21825065599604337,0.10001721654195674,1,bp,PCR,7124,TNF
GO:0000075,cell cycle checkpoint,1/17,221/16992,0.19961308985764326,0.21896660257621284,0.10034531170306628,1,bp,PCR,990,CDC6
GO:0001818,negative regulation of cytokine production,1/17,222/16992,0.20042440566900943,0.21950480908869913,0.10059195433998284,1,bp,PCR,7124,TNF
GO:0007611,learning or memory,1/17,222/16992,0.20042440566900943,0.21950480908869913,0.10059195433998284,1,bp,PCR,1956,EGFR
GO:0016485,protein processing,1/17,228/16992,0.20527606940757226,0.22445921646882303,0.10286239899690018,1,bp,PCR,7113,TMPRSS2
GO:2000146,negative regulation of cell motility,1/17,228/16992,0.20527606940757226,0.22445921646882303,0.10286239899690018,1,bp,PCR,6422,SFRP1
GO:0010631,epithelial cell migration,1/17,230/16992,0.2068871239459148,0.22604028147003777,0.10358694994897737,1,bp,PCR,4233,MET
GO:0019318,hexose metabolic process,1/17,233/16992,0.20929794341476782,0.2281280927824977,0.10454372634529133,1,bp,PCR,7124,TNF
GO:0051321,meiotic cell cycle,1/17,233/16992,0.20929794341476782,0.2281280927824977,0.10454372634529133,1,bp,PCR,898,CCNE1
GO:0090132,epithelium migration,1/17,233/16992,0.20929794341476782,0.2281280927824977,0.10454372634529133,1,bp,PCR,4233,MET
GO:0051091,positive regulation of sequence-specific DNA binding transcription factor activity,1/17,234/16992,0.21010001603019535,0.22882014474569407,0.10486087137628977,1,bp,PCR,7124,TNF
GO:0005770,late endosome,1/17,217/18122,0.18525845339562885,0.2294992780871223,0.14552902859043904,1,cc,PCR,1956,EGFR
GO:0043241,protein complex disassembly,1/17,235/16992,0.21090132285245844,0.22951026310414593,0.10517713029877436,1,bp,PCR,7124,TNF
GO:0010976,positive regulation of neuron projection development,1/17,236/16992,0.21170186456705564,0.2298333486061056,0.10532518993444231,1,bp,PCR,1946,EFNA5
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,1/17,236/16992,0.21170186456705564,0.2298333486061056,0.10532518993444231,1,bp,PCR,7124,TNF
GO:0090287,regulation of cellular response to growth factor stimulus,1/17,236/16992,0.21170186456705564,0.2298333486061056,0.10532518993444231,1,bp,PCR,6422,SFRP1
GO:0050768,negative regulation of neurogenesis,1/17,237/16992,0.21250164185891307,0.23051881751573058,0.10563931816491133,1,bp,PCR,3400,ID4
GO:0060485,mesenchyme development,1/17,238/16992,0.21330065541238352,0.2312023731271204,0.10595256959268289,1,bp,PCR,6422,SFRP1
GO:0060828,regulation of canonical Wnt signaling pathway,1/17,239/16992,0.21409890591124892,0.23170071319565197,0.10618094272777562,1,bp,PCR,6422,SFRP1
GO:0090130,tissue migration,1/17,239/16992,0.21409890591124892,0.23170071319565197,0.10618094272777562,1,bp,PCR,4233,MET
hsa00310,Lysine degradation,1/17,59/7430,0.12687699325238244,0.23228249533897707,0.13971879418885838,1,kg,PCR,79723,SUV39H2
GO:0006469,negative regulation of protein kinase activity,1/17,240/16992,0.21489639403871919,0.23238006590758814,0.1064922681026662,1,bp,PCR,6422,SFRP1
GO:0045165,cell fate commitment,1/17,241/16992,0.2156931204774334,0.23287372392240244,0.10671849560397667,1,bp,PCR,6422,SFRP1
GO:0051258,protein polymerization,1/17,241/16992,0.2156931204774334,0.23287372392240244,0.10671849560397667,1,bp,PCR,4233,MET
GO:0051271,negative regulation of cellular component movement,1/17,243/16992,0.21728429101629876,0.2344067725778668,0.10742104221783755,1,bp,PCR,6422,SFRP1
GO:0007050,cell cycle arrest,1/17,246/16992,0.21966535119212338,0.2367888706945015,0.10851268073808995,1,bp,PCR,3576,CXCL8
GO:0090596,sensory organ morphogenesis,1/17,248/16992,0.22124893548525526,0.23830825545186032,0.10920896562939428,1,bp,PCR,8842,PROM1
hsa01524,Platinum drug resistance,1/17,73/7430,0.15467439669982974,0.23895766205817043,0.14373393206506493,1,kg,PCR,2064,ERBB2
hsa04060,Cytokine-cytokine receptor interaction,2/17,294/7430,0.14385876190828797,0.23895766205817043,0.14373393206506493,2,kg,PCR,3576/7124,CXCL8/TNF
hsa04115,p53 signaling pathway,1/17,72/7430,0.15271682480824755,0.23895766205817043,0.14373393206506493,1,kg,PCR,898,CCNE1
hsa04664,Fc epsilon RI signaling pathway,1/17,68/7430,0.14484378977131052,0.23895766205817043,0.14373393206506493,1,kg,PCR,7124,TNF
hsa04920,Adipocytokine signaling pathway,1/17,69/7430,0.14681847811332183,0.23895766205817043,0.14373393206506493,1,kg,PCR,7124,TNF
hsa05100,Bacterial invasion of epithelial cells,1/17,74/7430,0.1566277112650193,0.23895766205817043,0.14373393206506493,1,kg,PCR,4233,MET
hsa05131,Shigellosis,1/17,65/7430,0.13889388371239797,0.23895766205817043,0.14373393206506493,1,kg,PCR,3576,CXCL8
hsa05140,Leishmaniasis,1/17,74/7430,0.1566277112650193,0.23895766205817043,0.14373393206506493,1,kg,PCR,7124,TNF
hsa05211,Renal cell carcinoma,1/17,69/7430,0.14681847811332183,0.23895766205817043,0.14373393206506493,1,kg,PCR,4233,MET
hsa05214,Glioma,1/17,71/7430,0.15075498689238553,0.23895766205817043,0.14373393206506493,1,kg,PCR,1956,EGFR
hsa05217,Basal cell carcinoma,1/17,63/7430,0.13490565745876493,0.23895766205817043,0.14373393206506493,1,kg,PCR,83439,TCF7L1
hsa05221,Acute myeloid leukemia,1/17,66/7430,0.14088150136031186,0.23895766205817043,0.14373393206506493,1,kg,PCR,83439,TCF7L1
hsa05321,Inflammatory bowel disease (IBD),1/17,65/7430,0.13889388371239797,0.23895766205817043,0.14373393206506493,1,kg,PCR,7124,TNF
GO:0022409,positive regulation of cell-cell adhesion,1/17,249/16992,0.22203959292056075,0.23897185747503746,0.10951307297306703,1,bp,PCR,7124,TNF
GO:0010769,regulation of cell morphogenesis involved in differentiation,1/17,250/16992,0.2228294947852416,0.2394455089175791,0.10973013210939767,1,bp,PCR,1946,EFNA5
GO:0090068,positive regulation of cell cycle process,1/17,250/16992,0.2228294947852416,0.2394455089175791,0.10973013210939767,1,bp,PCR,990,CDC6
GO:0006470,protein dephosphorylation,1/17,252/16992,0.22440703450997834,0.24095155313267477,0.11042030346166941,1,bp,PCR,7124,TNF
GO:0046651,lymphocyte proliferation,1/17,255/16992,0.2267676942228546,0.24329543369207518,0.11149442811155036,1,bp,PCR,2064,ERBB2
GO:0016458,gene silencing,1/17,256/16992,0.22755307686001858,0.24356541221373373,0.1116181505358389,1,bp,PCR,1956,EGFR
GO:0050890,cognition,1/17,256/16992,0.22755307686001858,0.24356541221373373,0.1116181505358389,1,bp,PCR,1956,EGFR
GO:0051961,negative regulation of nervous system development,1/17,256/16992,0.22755307686001858,0.24356541221373373,0.1116181505358389,1,bp,PCR,3400,ID4
GO:0032943,mononuclear cell proliferation,1/17,257/16992,0.2283377086533609,0.24364327602996966,0.11165383300439193,1,bp,PCR,2064,ERBB2
GO:0033673,negative regulation of kinase activity,1/17,257/16992,0.2283377086533609,0.24364327602996966,0.11165383300439193,1,bp,PCR,6422,SFRP1
GO:0040013,negative regulation of locomotion,1/17,257/16992,0.2283377086533609,0.24364327602996966,0.11165383300439193,1,bp,PCR,6422,SFRP1
GO:0045732,positive regulation of protein catabolic process,1/17,257/16992,0.2283377086533609,0.24364327602996966,0.11165383300439193,1,bp,PCR,7124,TNF
GO:0042113,B cell activation,1/17,258/16992,0.22912159027588186,0.24409918839508346,0.11186276289529026,1,bp,PCR,6422,SFRP1
GO:0051604,protein maturation,1/17,258/16992,0.22912159027588186,0.24409918839508346,0.11186276289529026,1,bp,PCR,7113,TMPRSS2
hsa04612,Antigen processing and presentation,1/17,77/7430,0.1624621977329881,0.24472153835728586,0.14720092532769075,1,kg,PCR,7124,TNF
GO:0007249,I-kappaB kinase/NF-kappaB signaling,1/17,263/16992,0.23302976934178588,0.24787704291290197,0.11359403142984859,1,bp,PCR,7124,TNF
GO:0034976,response to endoplasmic reticulum stress,1/17,263/16992,0.23302976934178588,0.24787704291290197,0.11359403142984859,1,bp,PCR,3576,CXCL8
GO:0042742,defense response to bacterium,1/17,264/16992,0.23380916404088248,0.24851300122047215,0.11388547055276721,1,bp,PCR,7124,TNF
GO:0007548,sex differentiation,1/17,266/16992,0.23536571768090075,0.24977958721329702,0.11446590594681097,1,bp,PCR,6422,SFRP1
GO:0032984,macromolecular complex disassembly,1/17,266/16992,0.23536571768090075,0.24977958721329702,0.11446590594681097,1,bp,PCR,7124,TNF
GO:0040029,"regulation of gene expression, epigenetic",1/17,267/16992,0.23614287795827882,0.2504102245738836,0.11475490665182778,1,bp,PCR,1956,EGFR
GO:0070661,leukocyte proliferation,1/17,270/16992,0.23846990062688522,0.2526821160667228,0.11579604104091867,1,bp,PCR,2064,ERBB2
GO:0010506,regulation of autophagy,1/17,272/16992,0.24001754059768177,0.25412530013783935,0.11645740562235382,1,bp,PCR,4233,MET
GO:0005996,monosaccharide metabolic process,1/17,273/16992,0.24079025003606902,0.25435328109519945,0.11656188192129398,1,bp,PCR,7124,TNF
GO:0022412,cellular process involved in reproduction in multicellular organism,1/17,273/16992,0.24079025003606902,0.25435328109519945,0.11656188192129398,1,bp,PCR,6422,SFRP1
GO:1903522,regulation of blood circulation,1/17,273/16992,0.24079025003606902,0.25435328109519945,0.11656188192129398,1,bp,PCR,1956,EGFR
GO:0018105,peptidyl-serine phosphorylation,1/17,277/16992,0.243873699630753,0.2574117924398619,0.11796349874603644,1,bp,PCR,7124,TNF
GO:0043414,macromolecule methylation,1/17,279/16992,0.24541100080799683,0.25883486911105363,0.11861564875643994,1,bp,PCR,79723,SUV39H2
GO:0007568,aging,1/17,280/16992,0.24617854780651693,0.25944452035960097,0.11889503220508414,1,bp,PCR,4316,MMP7
GO:0097193,intrinsic apoptotic signaling pathway,1/17,281/16992,0.24694535995870015,0.26005245983343117,0.11917363120274112,1,bp,PCR,7124,TNF
GO:0061695,"transferase complex, transferring phosphorus-containing groups",1/17,254/18122,0.2134242704834507,0.26050315367832955,0.1651890638416801,1,cc,PCR,898,CCNE1
GO:0019216,regulation of lipid metabolic process,1/17,282/16992,0.24771143792415418,0.26065869217384097,0.11945144787636708,1,bp,PCR,7124,TNF
GO:0030135,coated vesicle,1/17,260/18122,0.2179044197833654,0.2621169107539033,0.1662123720696914,1,cc,PCR,1956,EGFR
GO:0006959,humoral immune response,1/17,288/16992,0.25229252466398355,0.2650717315924739,0.12147380110654296,1,bp,PCR,7124,TNF
GO:0033044,regulation of chromosome organization,1/17,288/16992,0.25229252466398355,0.2650717315924739,0.12147380110654296,1,bp,PCR,990,CDC6
hsa05132,Salmonella infection,1/17,86/7430,0.1797385581116332,0.2673611051910544,0.16081870988935604,1,kg,PCR,3576,CXCL8
GO:0008202,steroid metabolic process,1/17,292/16992,0.25533198202757046,0.2678540102649379,0.12274882943208873,1,bp,PCR,7124,TNF
GO:0051235,maintenance of location,1/17,292/16992,0.25533198202757046,0.2678540102649379,0.12274882943208873,1,bp,PCR,7124,TNF
GO:0003713,transcription coactivator activity,1/17,297/16982,0.2592470076246829,0.26873165424509815,0.13311784730407336,1,mf,PCR,898,CCNE1
GO:0031625,ubiquitin protein ligase binding,1/17,291/16982,0.25470334436141817,0.26873165424509815,0.13311784730407336,1,mf,PCR,1956,EGFR
GO:0044389,ubiquitin-like protein ligase binding,1/17,296/16982,0.25849154533718033,0.26873165424509815,0.13311784730407336,1,mf,PCR,1956,EGFR
GO:0018209,peptidyl-serine modification,1/17,294/16992,0.2568473462886568,0.26923737907287226,0.12338278261307281,1,bp,PCR,7124,TNF
hsa04540,Gap junction,1/17,88/7430,0.18353192750617575,0.2696333255954928,0.16218545900480769,1,kg,PCR,1956,EGFR
GO:0030139,endocytic vesicle,1/17,273/18122,0.22752915243017713,0.2697845664529243,0.1710745506993813,1,cc,PCR,1956,EGFR
GO:0006066,alcohol metabolic process,1/17,295/16992,0.25760393960001704,0.26982386634462385,0.12365155076036738,1,bp,PCR,7124,TNF
GO:0009416,response to light stimulus,1/17,296/16992,0.25835980790131674,0.2704086980251549,0.12391956020375404,1,bp,PCR,1956,EGFR
GO:0050804,modulation of synaptic transmission,1/17,297/16992,0.2591149518439183,0.2709918785900108,0.12418681299423047,1,bp,PCR,1956,EGFR
GO:0006909,phagocytosis,1/17,298/16992,0.25986937207863825,0.27136626268165964,0.12435838111435095,1,bp,PCR,7124,TNF
GO:0071375,cellular response to peptide hormone stimulus,1/17,298/16992,0.25986937207863825,0.27136626268165964,0.12435838111435095,1,bp,PCR,990,CDC6
GO:0016042,lipid catabolic process,1/17,299/16992,0.26062306925574785,0.27194587028286493,0.12462399653115029,1,bp,PCR,7124,TNF
GO:0002449,lymphocyte mediated immunity,1/17,300/16992,0.2613760440249716,0.2723164416059255,0.124793817382747,1,bp,PCR,7124,TNF
GO:0051056,regulation of small GTPase mediated signal transduction,1/17,300/16992,0.2613760440249716,0.2723164416059255,0.124793817382747,1,bp,PCR,4233,MET
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,1/17,301/16992,0.26212829703549,0.2728925008681261,0.12505780671054795,1,bp,PCR,7124,TNF
GO:0050863,regulation of T cell activation,1/17,305/16992,0.26513010445506957,0.2758078366253725,0.12639381079445006,1,bp,PCR,2064,ERBB2
hsa04912,GnRH signaling pathway,1/17,93/7430,0.1929432438558336,0.27662947010655664,0.16639366622950774,1,kg,PCR,1956,EGFR
hsa05222,Small cell lung cancer,1/17,93/7430,0.1929432438558336,0.27662947010655664,0.16639366622950774,1,kg,PCR,898,CCNE1
GO:0001701,in utero embryonic development,1/17,311/16992,0.26961127284277964,0.2802565167211582,0.12843249699420267,1,bp,PCR,1956,EGFR
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,1/17,312/16992,0.2703556291980147,0.28081703821857523,0.12868936586695692,1,bp,PCR,6422,SFRP1
GO:0009615,response to virus,1/17,313/16992,0.27109927154235713,0.2813759687198536,0.12894550563764004,1,bp,PCR,7124,TNF
GO:0005667,transcription factor complex,1/17,307/18122,0.25217718521191923,0.2814431476195409,0.17846743666426185,1,cc,PCR,83439,TCF7L1
GO:0005769,early endosome,1/17,310/18122,0.2543160972465731,0.2814431476195409,0.17846743666426185,1,cc,PCR,1956,EGFR
GO:0005819,spindle,1/17,301/18122,0.24788202644569357,0.2814431476195409,0.17846743666426185,1,cc,PCR,990,CDC6
GO:0031253,cell projection membrane,1/17,299/18122,0.24644515476544704,0.2814431476195409,0.17846743666426185,1,cc,PCR,8842,PROM1
GO:0031965,nuclear membrane,1/17,300/18122,0.24716391324432196,0.2814431476195409,0.17846743666426185,1,cc,PCR,1956,EGFR
GO:0010038,response to metal ion,1/17,315/16992,0.2725844167663648,0.28270308072208594,0.12955367814414148,1,bp,PCR,1956,EGFR
GO:0001667,ameboidal-type cell migration,1/17,316/16992,0.27332592092868235,0.2832575213863483,0.1298077603677395,1,bp,PCR,4233,MET
hsa04640,Hematopoietic cell lineage,1/17,97/7430,0.20039868375632408,0.28389813532145913,0.17076579568208067,1,kg,PCR,7124,TNF
hsa04660,T cell receptor signaling pathway,1/17,101/7430,0.20778926771480122,0.28421750411564767,0.17095789721241963,1,kg,PCR,7124,TNF
hsa04916,Melanogenesis,1/17,101/7430,0.20778926771480122,0.28421750411564767,0.17095789721241963,1,kg,PCR,83439,TCF7L1
hsa05231,Choline metabolism in cancer,1/17,99/7430,0.20410204955739064,0.28421750411564767,0.17095789721241963,1,kg,PCR,1956,EGFR
GO:0031346,positive regulation of cell projection organization,1/17,318/16992,0.2748067955565401,0.2843616803604712,0.13031376071265297,1,bp,PCR,1946,EFNA5
GO:0045666,positive regulation of neuron differentiation,1/17,318/16992,0.2748067955565401,0.2843616803604712,0.13031376071265297,1,bp,PCR,1946,EFNA5
GO:1901653,cellular response to peptide,1/17,320/16992,0.27628482951921396,0.2856751749333867,0.13091569279174076,1,bp,PCR,990,CDC6
GO:0051098,regulation of binding,1/17,321/16992,0.2770227828480395,0.28622202997657814,0.13116629877055136,1,bp,PCR,4233,MET
GO:0010639,negative regulation of organelle organization,1/17,323/16992,0.27849656538983714,0.2873110761256119,0.13166537339653586,1,bp,PCR,4233,MET
GO:0032535,regulation of cellular component size,1/17,323/16992,0.27849656538983714,0.2873110761256119,0.13166537339653586,1,bp,PCR,1946,EFNA5
GO:0007265,Ras protein signal transduction,1/17,324/16992,0.2792323958768711,0.2878532755688528,0.13191384586446986,1,bp,PCR,4233,MET
hsa04625,C-type lectin receptor signaling pathway,1/17,104/7430,0.21328996248079657,0.2884261992638045,0.17348944316619816,1,kg,PCR,7124,TNF
hsa04668,TNF signaling pathway,1/17,108/7430,0.22056831954256406,0.28843549478642994,0.17349503445800296,1,kg,PCR,7124,TNF
hsa04928,"Parathyroid hormone synthesis, secretion and action",1/17,106/7430,0.21693709983932696,0.28843549478642994,0.17349503445800296,1,kg,PCR,1956,EGFR
hsa04931,Insulin resistance,1/17,107/7430,0.21875469532031122,0.28843549478642994,0.17349503445800296,1,kg,PCR,7124,TNF
GO:0002697,regulation of immune effector process,1/17,328/16992,0.28216866077167524,0.29066132174298226,0.1332006826026046,1,bp,PCR,7124,TNF
GO:0003002,regionalization,1/17,331/16992,0.28436346730632733,0.29270194491906926,0.13413583420227232,1,bp,PCR,6422,SFRP1
hsa05145,Toxoplasmosis,1/17,113/7430,0.2295771559749865,0.29695306044590647,0.17861838222310164,1,kg,PCR,7124,TNF
GO:0031983,vesicle lumen,1/17,337/18122,0.27330889740146624,0.29848208532002235,0.18927208961320377,1,cc,PCR,1956,EGFR
GO:0098687,chromosomal region,1/17,349/18122,0.28160316154934784,0.3035462650466996,0.19248336401185773,1,cc,PCR,79723,SUV39H2
GO:0031252,cell leading edge,1/17,355/18122,0.28571680231619656,0.30403198195185016,0.19279136458582766,1,cc,PCR,3691,ITGB4
GO:0032259,methylation,1/17,347/16992,0.29596282801674856,0.30441255563856406,0.13950242832692644,1,bp,PCR,79723,SUV39H2
hsa04071,Sphingolipid signaling pathway,1/17,118/7430,0.23848792468809776,0.30516196814928637,0.18355607106723995,1,kg,PCR,7124,TNF
GO:0010876,lipid localization,1/17,351/16992,0.29883489385994,0.3071358631338272,0.1407504320693253,1,bp,PCR,7124,TNF
GO:0051348,negative regulation of transferase activity,1/17,353/16992,0.30026678811245255,0.30837601869913545,0.14131875525330415,1,bp,PCR,6422,SFRP1
GO:0031331,positive regulation of cellular catabolic process,1/17,358/16992,0.30383449247497596,0.3118061620676478,0.14289067901450775,1,bp,PCR,7124,TNF
GO:0042692,muscle cell differentiation,1/17,362/16992,0.30667632180446636,0.31448680490660263,0.1441191309248665,1,bp,PCR,7124,TNF
hsa04068,FoxO signaling pathway,1/17,132/7430,0.2629248450417332,0.3145086286152582,0.18917812247534327,1,kg,PCR,1956,EGFR
hsa04114,Oocyte meiosis,1/17,124/7430,0.24905280719172662,0.3145086286152582,0.18917812247534327,1,kg,PCR,898,CCNE1
hsa04210,Apoptosis,1/17,136/7430,0.2697700748162106,0.3145086286152582,0.18917812247534327,1,kg,PCR,7124,TNF
hsa04380,Osteoclast differentiation,1/17,128/7430,0.25601925540074577,0.3145086286152582,0.18917812247534327,1,kg,PCR,7124,TNF
hsa04550,Signaling pathways regulating pluripotency of stem cells,1/17,139/7430,0.2748646838318223,0.3145086286152582,0.18917812247534327,1,kg,PCR,3400,ID4
hsa04650,Natural killer cell mediated cytotoxicity,1/17,131/7430,0.26120412578407193,0.3145086286152582,0.18917812247534327,1,kg,PCR,7124,TNF
hsa04915,Estrogen signaling pathway,1/17,137/7430,0.27147200910852254,0.3145086286152582,0.18917812247534327,1,kg,PCR,1956,EGFR
hsa04926,Relaxin signaling pathway,1/17,130/7430,0.25947962628363663,0.3145086286152582,0.18917812247534327,1,kg,PCR,1956,EGFR
hsa05162,Measles,1/17,132/7430,0.2629248450417332,0.3145086286152582,0.18917812247534327,1,kg,PCR,898,CCNE1
hsa05322,Systemic lupus erythematosus,1/17,133/7430,0.2646417918263715,0.3145086286152582,0.18917812247534327,1,kg,PCR,7124,TNF
hsa05418,Fluid shear stress and atherosclerosis,1/17,139/7430,0.2748646838318223,0.3145086286152582,0.18917812247534327,1,kg,PCR,7124,TNF
GO:0018205,peptidyl-lysine modification,1/17,366/16992,0.30950723022274385,0.3171522441429164,0.14534061551588034,1,bp,PCR,79723,SUV39H2
GO:0045862,positive regulation of proteolysis,1/17,367/16992,0.31021325554971435,0.3176379557573365,0.14556320143890858,1,bp,PCR,7124,TNF
GO:0005924,cell-substrate adherens junction,1/17,393/18122,0.3112594631391682,0.31894488198211063,0.20224786428795855,1,cc,PCR,1956,EGFR
GO:0005925,focal adhesion,1/17,390/18122,0.3092746213085329,0.31894488198211063,0.20224786428795855,1,cc,PCR,1956,EGFR
GO:0044441,ciliary part,1/17,389/18122,0.3086118119024732,0.31894488198211063,0.20224786428795855,1,cc,PCR,8842,PROM1
GO:0052548,regulation of endopeptidase activity,1/17,370/16992,0.312327257084398,0.31956353882551636,0.14644563387798065,1,bp,PCR,7124,TNF
GO:0051090,regulation of sequence-specific DNA binding transcription factor activity,1/17,371/16992,0.3130305681558436,0.320043949070463,0.14666579035484673,1,bp,PCR,7124,TNF
hsa04514,Cell adhesion molecules (CAMs),1/17,144/7430,0.2832814305177276,0.3210522879200913,0.1931141581474233,1,kg,PCR,3696,ITGB8
hsa04150,mTOR signaling pathway,1/17,151/7430,0.29491050989849465,0.32981599175076826,0.19838555894783055,1,kg,PCR,7124,TNF
hsa04921,Oxytocin signaling pathway,1/17,152/7430,0.29655723628010255,0.32981599175076826,0.19838555894783055,1,kg,PCR,1956,EGFR
hsa04390,Hippo signaling pathway,1/17,154/7430,0.29983983598530084,0.33037907853935927,0.19872425776803565,1,kg,PCR,83439,TCF7L1
GO:0001819,positive regulation of cytokine production,1/17,391/16992,0.32695542211983264,0.3340313230463066,0.15307575144023586,1,bp,PCR,7124,TNF
GO:0050769,positive regulation of neurogenesis,1/17,392/16992,0.3276446431200114,0.3344858437220698,0.15328404356491762,1,bp,PCR,1946,EFNA5
GO:0001933,negative regulation of protein phosphorylation,1/17,396/16992,0.33039489002737354,0.33704217917099427,0.15445552941902474,1,bp,PCR,6422,SFRP1
GO:0052547,regulation of peptidase activity,1/17,397/16992,0.3310807954786591,0.33749040134794067,0.15466093514541743,1,bp,PCR,7124,TNF
GO:0051346,negative regulation of hydrolase activity,1/17,398/16992,0.33176603961706597,0.3379372829135144,0.15486572651297878,1,bp,PCR,7124,TNF
hsa04217,Necroptosis,1/17,162/7430,0.31282661709890847,0.3384215221342737,0.20356181782512706,1,kg,PCR,7124,TNF
hsa04630,Jak-STAT signaling pathway,1/17,162/7430,0.31282661709890847,0.3384215221342737,0.20356181782512706,1,kg,PCR,1956,EGFR
GO:0043434,response to peptide hormone,1/17,401/16992,0.33381781013037304,0.3397744104598369,0.1557076226473898,1,bp,PCR,990,CDC6
GO:0003779,actin binding,1/17,400/16982,0.3332956199541728,0.3413268397121047,0.16907831069330262,1,mf,PCR,1956,EGFR
GO:0044708,single-organism behavior,1/17,405/16992,0.33654428197599984,0.342295038651667,0.15686274502048636,1,bp,PCR,1956,EGFR
GO:0005635,nuclear envelope,1/17,436/18122,0.3391254751409546,0.3432611516670638,0.21766718558469486,1,cc,PCR,1956,EGFR
GO:0009896,positive regulation of catabolic process,1/17,412/16992,0.3412903535475268,0.34686450928475443,0.1589567856166342,1,bp,PCR,7124,TNF
hsa04530,Tight junction,1/17,170/7430,0.32558643703431944,0.3476134949937396,0.2090908240563847,1,kg,PCR,2064,ERBB2
hsa05010,Alzheimer's disease,1/17,171/7430,0.32716564234704903,0.3476134949937396,0.2090908240563847,1,kg,PCR,7124,TNF
GO:0016311,dephosphorylation,1/17,418/16992,0.34533296359504306,0.35071277979348214,0.16072032352229085,1,bp,PCR,7124,TNF
GO:0007389,pattern specification process,1/17,421/16992,0.3473455009988541,0.35249517484613135,0.1615371375251196,1,bp,PCR,6422,SFRP1
GO:0022604,regulation of cell morphogenesis,1/17,424/16992,0.3493522144602955,0.3542690234045516,0.16235003494607106,1,bp,PCR,1946,EFNA5
hsa05152,Tuberculosis,1/17,179/7430,0.33967457779680643,0.35771039608690236,0.2151641480221969,1,kg,PCR,7124,TNF
GO:0016570,histone modification,1/17,432/16992,0.3546750978045021,0.35913476989228066,0.1645798491836525,1,bp,PCR,79723,SUV39H2
GO:0042326,negative regulation of phosphorylation,1/17,432/16992,0.3546750978045021,0.35913476989228066,0.1645798491836525,1,bp,PCR,6422,SFRP1
hsa04062,Chemokine signaling pathway,1/17,185/7430,0.3489122847354542,0.35950313092748337,0.21624248476841107,1,kg,PCR,3576,CXCL8
hsa05167,Kaposi's sarcoma-associated herpesvirus infection,1/17,186/7430,0.35044002678645436,0.35950313092748337,0.21624248476841107,1,kg,PCR,3576,CXCL8
hsa05168,Herpes simplex infection,1/17,185/7430,0.3489122847354542,0.35950313092748337,0.21624248476841107,1,kg,PCR,7124,TNF
GO:0072507,divalent inorganic cation homeostasis,1/17,436/16992,0.3573211443428401,0.3615466715486682,0.16568514570220774,1,bp,PCR,1956,EGFR
GO:0000785,chromatin,1/17,472/18122,0.36163552714702973,0.36163552714702973,0.2293186602073746,1,cc,PCR,79723,SUV39H2
GO:0004674,protein serine/threonine kinase activity,1/17,446/16982,0.36406344354643017,0.36839753216007814,0.1824879416272833,1,mf,PCR,1956,EGFR
GO:1901652,response to peptide,1/17,448/16992,0.36519814820616336,0.36924391794256844,0.1692125447647309,1,bp,PCR,990,CDC6
GO:0060627,regulation of vesicle-mediated transport,1/17,450/16992,0.3665021149342327,0.3702888526531104,0.1696914045451953,1,bp,PCR,7124,TNF
GO:0044723,single-organism carbohydrate metabolic process,1/17,451/16992,0.36715315253827785,0.3706730573929959,0.16986747315076353,1,bp,PCR,7124,TNF
GO:0007067,mitotic nuclear division,1/17,453/16992,0.3684533390843614,0.37089163324006674,0.1699676393918571,1,bp,PCR,990,CDC6
GO:0010720,positive regulation of cell development,1/17,453/16992,0.3684533390843614,0.37089163324006674,0.1699676393918571,1,bp,PCR,1946,EFNA5
GO:0042110,T cell activation,1/17,453/16992,0.3684533390843614,0.37089163324006674,0.1699676393918571,1,bp,PCR,2064,ERBB2
GO:0051962,positive regulation of nervous system development,1/17,453/16992,0.3684533390843614,0.37089163324006674,0.1699676393918571,1,bp,PCR,1946,EFNA5
hsa05203,Viral carcinogenesis,1/17,201/7430,0.3729551231045882,0.3793304243542393,0.22816867630330184,1,kg,PCR,898,CCNE1
GO:1901615,organic hydroxy compound metabolic process,1/17,467/16992,0.3774844961751749,0.3797033616927365,0.17400576953509744,1,bp,PCR,7124,TNF
GO:0002250,adaptive immune response,1/17,468/16992,0.378124905468066,0.38006827869734383,0.17417299919543033,1,bp,PCR,7124,TNF
GO:0003682,chromatin binding,1/17,482/16982,0.3872050711345345,0.3872050711345345,0.1918043696022462,1,mf,PCR,1956,EGFR
GO:0007264,small GTPase mediated signal transduction,1/17,490/16992,0.3920580171238254,0.3934951799431942,0.18032611375659818,1,bp,PCR,4233,MET
GO:0042119,neutrophil activation,1/17,490/16992,0.3920580171238254,0.3934951799431942,0.18032611375659818,1,bp,PCR,3576,CXCL8
GO:0044057,regulation of system process,1/17,493/16992,0.3939350615162932,0.395089449974949,0.18105671614706823,1,bp,PCR,1956,EGFR
GO:0036230,granulocyte activation,1/17,495/16992,0.3951833926762788,0.3960512917817172,0.1814974971372907,1,bp,PCR,3576,CXCL8
GO:0008015,blood circulation,1/17,496/16992,0.39580665037916407,0.3960959827259325,0.1815179775515403,1,bp,PCR,1956,EGFR
GO:0098542,defense response to other organism,1/17,496/16992,0.39580665037916407,0.3960959827259325,0.1815179775515403,1,bp,PCR,7124,TNF
GO:0003013,circulatory system process,1/17,500/16992,0.3982936415090993,0.3982936415090993,0.18252509349077173,1,bp,PCR,1956,EGFR
hsa04144,Endocytosis,1/17,244/7430,0.4334966837313178,0.4371703844409052,0.26295962973889037,1,kg,PCR,1956,EGFR
hsa05166,HTLV-I infection,1/17,255/7430,0.44807558082572074,0.44807558082572074,0.2695191463613358,1,kg,PCR,7124,TNF
